@article{abreu2021,
  title = {Impaired Memory {{B-cell}} Recall Responses in the Elderly Following Recurrent Influenza Vaccination},
  author = {Abreu, Rodrigo B. and Kirchenbaum, Greg A. and Sautto, Giuseppe A. and Clutter, Emily F. and Ross, Ted M.},
  editor = {Huber, Victor C.},
  year = {2021},
  month = aug,
  journal = {PLOS ONE},
  volume = {16},
  number = {8},
  pages = {e0254421},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0254421},
  urldate = {2023-05-16},
  abstract = {Influenza is a highly contagious viral respiratory disease that affects million of people worldwide each year. Annual vaccination is recommended by the World Health Organization with the goal of reducing influenza severity and limiting transmission through elicitation of antibodies targeting the hemagglutinin (HA) glycoprotein. The antibody response elicited by current seasonal influenza virus vaccines is predominantly strain-specific, but pre-existing influenza virus immunity can greatly impact the serological antibody response to vaccination. However, it remains unclear how B cell memory is shaped by recurrent annual vaccination over the course of multiple seasons, especially in high-risk elderly populations. Here, we systematically profiled the B cell response in young adult (18--34 year old) and elderly (65+ year old) vaccine recipients that received annual split inactivated influenza virus vaccination for 3 consecutive seasons. Specifically, the antibody serological and memory B-cell compartments were profiled for reactivity against current and historical influenza A virus strains. Moreover, multiparametric analysis and antibody landscape profiling revealed a transient increase in strain-specific antibodies in the elderly, but with an impaired recall response of pre-existing memory B-cells, plasmablast (PB) differentiation and long-lasting serological changes. This study thoroughly profiles and compares the immune response to recurrent influenza virus vaccination in young and elderly participants unveiling the pitfalls of current influenza virus vaccines in high-risk populations.},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\HFAVIWX8\abreu21plosone - ross - Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination.pdf}
}

@article{adabor2018,
  title = {Bayesian Inference of Antigenic and Non-Antigenic Variables from Haemagglutination Inhibition Assays for Influenza Surveillance},
  author = {Adabor, Emmanuel S. and Ndifon, Wilfred},
  year = {2018},
  month = jul,
  journal = {Royal Society Open Science},
  volume = {5},
  number = {7},
  pages = {180113},
  issn = {2054-5703},
  doi = {10.1098/rsos.180113},
  urldate = {2023-03-28},
  abstract = {Haemagglutination inhibition (HI) assays are typically used for comparing and characterizing influenza viruses. Data obtained from the assays (titres) are used quantitatively to determine antigenic differences between influenza strains. However, the use of these titres has been criticized as they sometimes fail to capture accurate antigenic differences between strains. Our previous analytical work revealed how antigenic and non-antigenic variables contribute to the titres. Building on this previous work, we have developed a Bayesian method for decoupling antigenic and non-antigenic contributions to the titres in this paper. We apply this method to a compendium of HI titres of influenza A (H3N2) viruses curated from 1968 to 2016. Remarkably, the results of this fit indicate that the non-antigenic variable, which is inversely correlated with viral avidity for the red blood cells used in HI assays, oscillates during the course of influenza virus evolution, with a period that corresponds roughly to the timescale on which antigenic variants replace each other. Together, the results suggest that the new Bayesian method is applicable to the analysis of long-term dynamics of both antigenic and non-antigenic properties of influenza virus.},
  langid = {english},
  keywords = {Bayesian inference,haemagglutination inhibitions assays,influenza surveillance,influenza virus},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\56NLSDZM\\Adabor and Ndifon - 2018 - Bayesian inference of antigenic and non-antigenic .pdf;C\:\\Users\\Zane\\Zotero\\storage\\VQ4R6J5M\\Adabor and Ndifon - 2018 - Bayesian inference of antigenic and non-antigenic variables from haemagglutination inhibition assays.pdf;C\:\\Users\\Zane\\Zotero\\storage\\XQAYP24I\\Adabor and Ndifon - 2018 - Bayesian inference of antigenic and non-antigenic variables from haemagglutination inhibition assays.pdf}
}

@article{allen2021,
  title = {Evaluation of {{Next-Generation H3 Influenza Vaccines}} in {{Ferrets Pre-Immune}} to {{Historical H3N2 Viruses}}},
  author = {Allen, James D. and Ross, Ted M.},
  year = {2021},
  journal = {Frontiers in Immunology},
  volume = {12},
  pages = {707339},
  issn = {1664-3224},
  doi = {10.3389/fimmu.2021.707339},
  abstract = {Each person has a unique immune history to past influenza virus infections. Exposure to influenza viruses early in life establishes memory B cell populations that influence future immune responses to influenza vaccination. Current influenza vaccines elicit antibodies that are typically strain specific and do not offer broad protection against antigenically drifted influenza strains in all age groups of people. This is particularly true for vaccine antigens of the A(H3N2) influenza virus subtype, where continual antigenic drift necessitates frequent vaccine reformulation. Broadly-reactive influenza virus vaccine antigens offer a solution to combat antigenic drift, but they also need to be equally effective in all populations, regardless of prior influenza virus exposure history. This study examined the role that pre-existing immunity plays on influenza virus vaccination. Ferrets were infected with historical A(H3N2) influenza viruses isolated from either the 1970's, 1980's, or 1990's and then vaccinated with computationally optimized broadly reactive antigens (COBRA) or wild-type (WT) influenza virus like particles (VLPs) expressing hemagglutinin (HA) vaccine antigens to examine the expansion of immune breadth. Vaccines with the H3 COBRA HA antigens had more cross-reactive antibodies following a single vaccination in all three pre-immune regimens than vaccines with WT H3 HA antigens against historical, contemporary, and future drifted A(H3N2) influenza viruses. The H3 COBRA HA vaccines also induced antibodies capable of neutralizing live virus infections against modern drifted A(H3N2) strains at higher titers than the WT H3 HA vaccine comparators.},
  langid = {english},
  pmcid = {PMC8406686},
  pmid = {34475872},
  keywords = {Animals,Antibodies Viral,Antigenic Drift and Shift,Antigens Viral,Broadly Neutralizing Antibodies,broadly reactive antibody,COBRA,Cross Reactions,Female,Ferrets,H3N2,Hemagglutinin Glycoproteins Influenza Virus,hemagglutinin vaccine,imprinting,influenza,Influenza A Virus H3N2 Subtype,Influenza Vaccines,Orthomyxoviridae Infections,pre-immunity}
}

@article{altman2019,
  title = {Human {{Influenza A Virus Hemagglutinin Glycan Evolution Follows}} a {{Temporal Pattern}} to a {{Glycan Limit}}},
  author = {Altman, Meghan O. and Angel, Matthew and Ko{\v s}{\'i}k, Ivan and Trov{\~a}o, N{\'i}dia S. and Zost, Seth J. and Gibbs, James S. and Casalino, Lorenzo and Amaro, Rommie E. and Hensley, Scott E. and Nelson, Martha I. and Yewdell, Jonathan W.},
  year = {2019},
  month = apr,
  journal = {mBio},
  volume = {10},
  number = {2},
  pages = {e00204-19},
  issn = {2150-7511},
  doi = {10.1128/mBio.00204-19},
  abstract = {Human antibody-based immunity to influenza A virus is limited by antigenic drift resulting from amino acid substitutions in the hemagglutinin (HA) head domain. Glycan addition can cause large antigenic changes but is limited by fitness costs to viral replication. Here, we report that glycans are added to H1 and H3 HAs at discrete 5-to-7-year intervals, until they reach a functional glycan limit, after which glycans are swapped at approximately 2-fold-longer intervals. Consistent with this pattern, 2009 pandemic H1N1 added a glycan at residue N162 over the 2015-2016 season, an addition that required two epistatic HA head mutations for complete glycosylation. These strains rapidly replaced H1N1 strains globally, by 2017 dominating H3N2 and influenza B virus strains for the season. The pattern of glycan modulation that we outline should aid efforts for tracing the epidemic potential of evolving human IAV strains.IMPORTANCE Frequent mutation of its major antibody target, the glycoprotein hemagglutinin, ensures that the influenza virus is perennially both a rapidly emerging virus and a major threat to public health. One type of mutation escapes immunity by adding a glycan onto an area of hemagglutinin that many antibodies recognize. This study revealed that these glycan changes follow a simple temporal pattern. Every 5 to 7 years, hemagglutinin adds a new glycan, up to a limit. After this limit is reached, no net additions of glycans occur. Instead, glycans are swapped or lost at longer intervals. Eventually, a pandemic replaces the terminally glycosylated hemagglutinin with a minimally glycosylated one from the animal reservoir, restarting the cycle. This pattern suggests the following: (i) some hemagglutinins are evolved for this decades-long process, which is both defined by and limited by successive glycan addition; and (ii) hemagglutinin's antibody dominance and its capacity for mutations are highly adapted features that allow influenza to outpace our antibody-based immunity.},
  langid = {english},
  pmcid = {PMC6445938},
  pmid = {30940704},
  keywords = {Evolution Molecular,glycosylation,Glycosylation,hemagglutinin,Hemagglutinin Glycoproteins Influenza Virus,Humans,immune evasion,influenza,Influenza A virus,Mutation,Polysaccharides,Protein Processing Post-Translational,viral evolution},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\9PZ8RY4M\\Altman et al. - 2019 - Human Influenza A Virus Hemagglutinin Glycan Evolu.pdf;C\:\\Users\\Zane\\Zotero\\storage\\SSJWRYCX\\Altman et al. - 2019 - Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit.pdf}
}

@article{anderson2018,
  title = {Antigenic Cartography of {{H1N1}} Influenza Viruses Using Sequence-Based Antigenic Distance Calculation},
  author = {Anderson, Christopher S. and McCall, Patrick R. and Stern, Harry A. and Yang, Hongmei and Topham, David J.},
  year = {2018},
  month = feb,
  journal = {BMC bioinformatics},
  volume = {19},
  number = {1},
  pages = {51},
  issn = {1471-2105},
  doi = {10.1186/s12859-018-2042-4},
  abstract = {BACKGROUND: The ease at which influenza virus sequence data can be used to estimate antigenic relationships between strains and the existence of databases containing sequence data for hundreds of thousands influenza strains make sequence-based antigenic distance estimates an attractive approach to researchers. Antigenic mismatch between circulating strains and vaccine strains results in significantly decreased vaccine effectiveness. Furthermore, antigenic relatedness between the vaccine strain and the strains an individual was originally primed with can affect the cross-reactivity of the antibody response. Thus, understanding the antigenic relationships between influenza viruses that have circulated is important to both vaccinologists and immunologists. RESULTS: Here we develop a method of mapping antigenic relationships between influenza virus stains using a sequence-based antigenic distance approach (SBM). We used a modified version of the p-all-epitope sequence-based antigenic distance calculation, which determines the antigenic relatedness between strains using influenza hemagglutinin (HA) genetic coding sequence data and provide experimental validation of the p-all-epitope calculation. We calculated the antigenic distance between 4838 H1N1 viruses isolated from infected humans between 1918 and 2016. We demonstrate, for the first time, that sequence-based antigenic distances of H1N1 Influenza viruses can be accurately represented in 2-dimenstional antigenic cartography using classic multidimensional scaling. Additionally, the model correctly predicted decreases in cross-reactive antibody levels with 87\% accuracy and was highly reproducible with even when small numbers of sequences were used. CONCLUSION: This work provides a highly accurate and precise bioinformatics tool that can be used to assess immune risk as well as design optimized vaccination strategies. SBM accurately estimated the antigenic relationship between strains using HA sequence data. Antigenic maps of H1N1 virus strains reveal that strains cluster antigenically similar to what has been reported for H3N2 viruses. Furthermore, we demonstrated that genetic variation differs across antigenic sites and discuss the implications.},
  langid = {english},
  pmcid = {PMC5809904},
  pmid = {29433425},
  keywords = {Algorithms,Amino Acid Sequence,Antigenic cartography,Antigenic distance,Antigens Viral,Epitope Mapping,Epitopes,H1N1,Hamming distance,Hemagglutinin,Hemagglutinin Glycoproteins Influenza Virus,Humans,Influenza,Influenza A Virus H1N1 Subtype,Reproducibility of Results},
  file = {C:\Users\Zane\Zotero\storage\PJPLEDTR\Anderson et al. - 2018 - Antigenic cartography of H1N1 influenza viruses us.pdf}
}

@article{anderson2020,
  title = {Implementing Sequence-Based Antigenic Distance Calculation into Immunological Shape Space Model},
  author = {Anderson, Christopher S. and Sangster, Mark Y. and Yang, Hongmei and Mariani, Thomas J. and Chaudhury, Sidhartha and Topham, David J.},
  year = {2020-06-19, 2020-06},
  journal = {BMC Bioinformatics},
  volume = {21},
  number = {1},
  pages = {256},
  issn = {1471-2105},
  doi = {10.1186/s12859-020-03594-3},
  urldate = {2023-03-28},
  abstract = {Background: In 2009, a novel influenza vaccine was distributed worldwide to combat the H1N1 influenza ``swine flu'' pandemic. However, antibodies induced by the vaccine display differences in their specificity and cross-reactivity dependent on pre-existing immunity. Here, we present a computational model that can capture the effect of pre-existing immunity on influenza vaccine responses. The model predicts the region of the virus hemagglutinin (HA) protein targeted by antibodies after vaccination as well as the level of cross-reactivity induced by the vaccine. We tested our model by simulating a scenario similar to the 2009 pandemic vaccine and compared the results to antibody binding data obtained from human subjects vaccinated with the monovalent 2009 H1N1 influenza vaccine. Results: We found that both specificity and cross-reactivity of the antibodies induced by the 2009 H1N1 influenza HA protein were affected by the viral strain the individual was originally exposed. Specifically, the level of antigenic relatedness between the original exposure HA antigen and the 2009 HA protein affected antigenic-site immunodominance. Moreover, antibody cross-reactivity was increased when the individual's pre-existing immunity was specific to an HA protein antigenically distinct from the 2009 pandemic strain. Comparison of simulation data with antibody binding data from human serum samples demonstrated qualitative and quantitative similarities between the model and real-life immune responses to the 2009 vaccine. Conclusion: We provide a novel method to evaluate expected outcomes in antibody specificity and cross-reactivity after influenza vaccination in individuals with different influenza HA antigen exposure histories. The model produced similar outcomes as what has been previously reported in humans after receiving the 2009 influenza pandemic vaccine. Our results suggest that differences in cross-reactivity after influenza vaccination should be expected in individuals with different exposure histories.},
  langid = {english},
  keywords = {*Models Immunological,2009 pandemic,Amino Acid Sequence,Antibodies Viral/blood/*immunology,Antigenic distance,Antigenic sites,Antigens Viral/chemistry/immunology,Artificial immune systems,Computational immunology,Computer Simulation,Cross Reactions,Epitopes,Gillespie algorithm,H1N1,HA,Hemagglutinin,Hemagglutinin Glycoproteins Influenza Virus/chemistry/*immunology,Humans,Humoral immune system,Influenza,Influenza A Virus H1N1 Subtype/*immunology,Influenza Vaccines/*immunology,pH1N1,Shape space,Simulations,Stalk,Stem,Vaccines},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\FH8ISSBV\\Anderson et al. - 2020 - Implementing sequence-based antigenic distance cal.pdf;C\:\\Users\\Zane\\Zotero\\storage\\QNCPFR9X\\s12859-020-03594-3.html}
}

@article{andrews2022,
  title = {A Single Residue in Influenza Virus {{H2}} Hemagglutinin Enhances the Breadth of the {{B}} Cell Response Elicited by {{H2}} Vaccination},
  author = {Andrews, Sarah F. and Raab, Julie E. and Gorman, Jason and Gillespie, Rebecca A. and Cheung, Crystal S. F. and Rawi, Reda and Cominsky, Lauren Y. and Boyington, Jeffrey C. and Creanga, Adrian and Shen, Chen-Hsiang and Harris, Darcy R. and Olia, Adam S. and Nazzari, Alexandra F. and Zhou, Tongqing and Houser, Katherine V. and Chen, Grace L. and Mascola, John R. and Graham, Barney S. and Kanekiyo, Masaru and Ledgerwood, Julie E. and Kwong, Peter D. and McDermott, Adrian B.},
  year = {2022},
  month = feb,
  journal = {Nature Medicine},
  volume = {28},
  number = {2},
  pages = {373--382},
  issn = {1078-8956, 1546-170X},
  doi = {10.1038/s41591-021-01636-8},
  urldate = {2023-03-21},
  langid = {english}
}

@article{angeletti2018a,
  title = {Understanding and {{Manipulating Viral Immunity}}: {{Antibody Immunodominance Enters Center Stage}}},
  shorttitle = {Understanding and {{Manipulating Viral Immunity}}},
  author = {Angeletti, Davide and Yewdell, Jonathan W.},
  year = {2018},
  month = jul,
  journal = {Trends in Immunology},
  volume = {39},
  number = {7},
  pages = {549--561},
  issn = {1471-4906},
  doi = {10.1016/j.it.2018.04.008},
  urldate = {2020-01-27},
  abstract = {Adaptive immune responses against antigenically variable viruses and cellular pathogens are efficient in many cases, but largely limited to the infecting or immunizing strain. A major factor that limits immunity is immunodominance (ID), the hierarchical focusing of adaptive immune responses on a subset of antigenic determinants. While CD8+ T cell ID has been extensively studied, studies of basic mechanisms of B cell ID are limited, despite the importance of antibodies (Abs) for durable protection against pathogens. Here, we review recent progress in understanding the basic rules and mechanisms of B cell ID, compare B and CD8+ T cell ID, and outline challenges to overcoming ID to develop Ab-based `universal' vaccines for influenza A and other highly variable viruses.},
  langid = {english},
  keywords = {Adaptive Immunity,Animals,Antibodies Viral,Antigens Viral,B-Lymphocytes,CD8-Positive T-Lymphocytes,Humans,Influenza A virus,Influenza Human,Orthomyxoviridae Infections},
  file = {C:\Users\Zane\Zotero\storage\2H64THEQ\S1471490618300851.html}
}

@article{arevalo2020,
  title = {Earliest Infections Predict the Age Distribution of Seasonal Influenza {{A}} Cases},
  author = {Arevalo, Philip and McLean, Huong Q and Belongia, Edward A and Cobey, Sarah},
  editor = {Cooper, Ben S and Ferguson, Neil M and Cooper, Ben S and Baguelin, Marc},
  year = {2020},
  month = jul,
  journal = {eLife},
  volume = {9},
  pages = {e50060},
  issn = {2050-084X},
  doi = {10.7554/eLife.50060},
  urldate = {2021-06-09},
  abstract = {Seasonal variation in the age distribution of influenza A cases suggests that factors other than age shape susceptibility to medically attended infection. We ask whether these differences can be partly explained by protection conferred by childhood influenza infection, which has lasting impacts on immune responses to influenza and protection against new influenza A subtypes (phenomena known as original antigenic sin and immune imprinting). Fitting a statistical model to data from studies of influenza vaccine effectiveness (VE), we find that primary infection appears to reduce the risk of medically attended infection with that subtype throughout life. This effect is stronger for H1N1 compared to H3N2. Additionally, we find evidence that VE varies with both age and birth year, suggesting that VE is sensitive to early exposures. Our findings may improve estimates of age-specific risk and VE in similarly vaccinated populations and thus improve forecasting and vaccination strategies to combat seasonal influenza.},
  keywords = {imprinting,influenza,original antigenic sin,vaccine effectiveness},
  file = {C:\Users\Zane\Zotero\storage\8TYUTNV6\Arevalo et al. - 2020 - Earliest infections predict the age distribution o.pdf}
}

@article{arhami2025,
  title = {Topolow: {{A}} Mapping Algorithm for Antigenic Cross-Reactivity and Binding Affinity Assays},
  shorttitle = {Topolow},
  author = {Arhami, Omid and Rohani, Pejman},
  year = {2025},
  month = jun,
  journal = {Bioinformatics},
  pages = {btaf372},
  issn = {1367-4811},
  doi = {10.1093/bioinformatics/btaf372},
  abstract = {MOTIVATION: Understanding antigenic evolution through cross-reactivity assays is crucial for tracking rapidly evolving pathogens requiring regular vaccine updates. However, existing cartography methods, commonly based on multidimensional scaling (MDS), face significant challenges with sparse and complex data, producing incomplete and inconsistent maps. There is an urgent need for robust computational methods that can accurately map antigenic relationships from incomplete experimental data while maintaining biological relevance, especially given that more than 95\% of possible measurements could be missing in large-scale studies. RESULTS: We present Topolow, an algorithm that transforms cross-reactivity and binding affinity measurements into accurate positions in a phenotype space. Using a physics-inspired model, Topolow achieved comparable prediction accuracy to MDS for H3N2 influenza and 56\% and 41\% improved accuracy for Dengue and HIV, while maintaining complete positioning of all antigens. The method effectively reduces experimental noise and bias, determines optimal dimensionality through likelihood-based estimation, avoiding distortions due to insufficient dimensions, and demonstrates orders of magnitude better stability across multiple runs. We also introduce antigenic velocity vectors, which measure the rate of antigenic advancement of each isolate per unit of time against its temporal and evolutionary related background, revealing the underlying antigenic relationships and cluster transitions. AVAILABILITY AND IMPLEMENTATION: Topolow is implemented in R and freely available at [https://doi.org/10.5281/zenodo.15620983] and [https://github.com/omid-arhami/topolow]. SUPPLEMENTARY INFORMATION: Available at Bioinformatics online.},
  langid = {english},
  pmid = {40563242},
  keywords = {antigenic cartography,binding affinity,cross-reactivity assay,dimensionality reduction,multidimensional scaling,viral evolution}
}

@article{auladell2022,
  title = {Influenza Virus Infection History Shapes Antibody Responses to Influenza Vaccination},
  author = {Auladell, Maria and Phuong, Hoang Vu Mai and Mai, Le Thi Quynh and Tseng, Yeu-Yang and Carolan, Louise and Wilks, Sam and Thai, Pham Quang and Price, David and Duong, Nguyen Thanh and Hang, Nguyen Le Khang and Thanh, Le Thi and Thuong, Nguyen Thi Hong and Huong, Tran Thi Kieu and Diep, Nguyen Thi Ngoc and Bich, Vu Thi Ngoc and Khvorov, Arseniy and Hensen, Luca and Duong, Tran Nhu and Kedzierska, Katherine and Anh, Dang Duc and Wertheim, Heiman and Boyd, Scott D. and {Good-Jacobson}, Kim L. and Smith, Derek and Barr, Ian and Sullivan, Sheena and {van Doorn}, H. Rogier and Fox, Annette},
  year = {2022},
  month = feb,
  journal = {Nature Medicine},
  volume = {28},
  number = {2},
  pages = {363--372},
  issn = {1546-170X},
  doi = {10.1038/s41591-022-01690-w},
  abstract = {Studies of successive vaccination suggest that immunological memory against past influenza viruses may limit responses to vaccines containing current strains. The impact of memory induced by prior infection is rarely considered and is difficult to ascertain, because infections are often subclinical. This study investigated influenza vaccination among adults from the Ha Nam cohort (Vietnam), who were purposefully selected to include 72 with and 28 without documented influenza A(H3N2) infection during the preceding 9 years (Australian New Zealand Clinical Trials Registry 12621000110886). The primary outcome was the effect of prior influenza A(H3N2) infection on hemagglutinin-inhibiting antibody responses induced by a locally available influenza vaccine administered in November 2016. Baseline and postvaccination sera were titrated against 40 influenza A(H3N2) strains spanning 1968-2018. At each time point (baseline, day 14 and day 280), geometric mean antibody titers against 2008-2018 strains were higher among participants with recent infection (34 (29-40), 187 (154-227) and 86 (72-103)) than among participants without recent infection (19 (17-22), 91 (64-130) and 38 (30-49)). On days 14 and 280, mean titer rises against 2014-2018 strains were 6.1-fold (5.0- to 7.4-fold) and 2.6-fold (2.2- to 3.1-fold) for participants with recent infection versus 4.8-fold (3.5- to 6.7-fold) and 1.9-fold (1.5- to 2.3-fold) for those without. One of 72 vaccinees with recent infection versus 4 of 28 without developed symptomatic A(H3N2) infection in the season after vaccination (P\,=\,0.021). The range of A(H3N2) viruses recognized by vaccine-induced antibodies was associated with the prior infection strain. These results suggest that recall of immunological memory induced by prior infection enhances antibody responses to inactivated influenza vaccine and is important to attain protective antibody titers.},
  langid = {english},
  pmid = {35177857},
  keywords = {Adult,Antibodies Viral,Antibody Formation,Australia,Hemagglutination Inhibition Tests,Humans,Influenza A Virus H3N2 Subtype,Influenza Human,Influenza Vaccines,Vaccination,Vaccines Inactivated},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\HMRJ95ZA\\Auladell et al. - 2022 - Influenza virus infection history shapes antibody .pdf;C\:\\Users\\Zane\\Zotero\\storage\\IBD8V7R7\\Auladell et al. - 2022 - Influenza virus infection history shapes antibody responses to influenza vaccination.pdf}
}

@article{azulay2023,
  title = {Mapping Antibody Footprints Using Binding Profiles},
  author = {Azulay, Asaf and {Cohen-Lavi}, Liel and Friedman, Lilach M. and McGargill, Maureen A. and Hertz, Tomer},
  year = {2023},
  month = aug,
  journal = {Cell Reports Methods},
  volume = {3},
  number = {8},
  pages = {100566},
  issn = {2667-2375},
  doi = {10.1016/j.crmeth.2023.100566},
  urldate = {2025-02-26},
  abstract = {The increasing use of monoclonal antibodies (mAbs) in biology and medicine necessitates efficient methods for characterizing their binding epitopes. Here, we developed a high-throughput antibody footprinting method based on binding profiles. We used an antigen microarray to profile 23 human anti-influenza hemagglutinin (HA) mAbs using HA proteins of 43 human influenza strains isolated between 1918 and 2018. We showed that the mAb's binding profile can be used to characterize its influenza subtype specificity, binding region, and binding site. We present mAb-Patch---an epitope prediction method that is based on a mAb's binding profile and the 3D structure of its antigen. mAb-Patch was evaluated using four mAbs with known solved mAb-HA structures. mAb-Patch identifies over 67\% of the true epitope when considering only 50--60 positions along the antigen. Our work provides proof of concept for utilizing antibody binding profiles to screen large panels of mAbs and to down-select antibodies for further functional studies.,                                        {$\bullet$}               Antibody footprinting can be used to assess breadth and specificity of mAbs                                         {$\bullet$}               We develop mAb-Patch, an algorithm for mAb epitope prediction using its binding profile                                         {$\bullet$}               Influenza mAbs can be characterized using binding profiles to multiple influenza strains                                 , Monoclonal antibodies (mAbs) have gained significant importance in the field of biology and medicine, as they have been utilized in a wide range of applications such as diagnostic methods, therapeutic interventions, and vaccination strategies. Recent advances have enabled the rapid high-throughput isolation of antigen-specific mAbs. However, characterizing the binding and functional properties of mAbs, and in particular their binding epitope, is time consuming and cannot be readily scaled to study thousands or even hundreds of mAbs., Azulay et~al. describe a method for antibody footprinting based on antibody binding profiles measured using an antigen microarray. By comparing the amino acid distributions of strains that a mAb binds vs. those that it does not bind, the authors develop mAb-Patch---an algorithm for predicting the antibody's epitope.},
  pmcid = {PMC10475849},
  pmid = {37671022},
  file = {C:\Users\Zane\Zotero\storage\53NKL7ST\Azulay et al. - 2023 - Mapping antibody footprints using binding profiles.pdf}
}

@article{barman2012,
  title = {Pathogenicity and Transmissibility of {{North American}} Triple Reassortant Swine Influenza {{A}} Viruses in Ferrets},
  author = {Barman, Subrata and Krylov, Petr S. and Fabrizio, Thomas P. and Franks, John and Turner, Jasmine C. and Seiler, Patrick and Wang, David and Rehg, Jerold E. and Erickson, Gene A. and Gramer, Marie and Webster, Robert G. and Webby, Richard J.},
  year = {2012},
  journal = {PLoS pathogens},
  volume = {8},
  number = {7},
  pages = {e1002791},
  issn = {1553-7374},
  doi = {10.1371/journal.ppat.1002791},
  abstract = {North American triple reassortant swine (TRS) influenza A viruses have caused sporadic human infections since 2005, but human-to-human transmission has not been documented. These viruses have six gene segments (PB2, PB1, PA, HA, NP, and NS) closely related to those of the 2009 H1N1 pandemic viruses. Therefore, understanding of these viruses' pathogenicity and transmissibility may help to identify determinants of virulence of the 2009 H1N1 pandemic viruses and to elucidate potential human health threats posed by the TRS viruses. Here we evaluated in a ferret model the pathogenicity and transmissibility of three groups of North American TRS viruses containing swine-like and/or human-like HA and NA gene segments. The study was designed only to detect informative and significant patterns in the transmissibility and pathogenicity of these three groups of viruses. We observed that irrespective of their HA and NA lineages, the TRS viruses were moderately pathogenic in ferrets and grew efficiently in both the upper and lower respiratory tracts. All North American TRS viruses studied were transmitted between ferrets via direct contact. However, their transmissibility by respiratory droplets was related to their HA and NA lineages: TRS viruses with human-like HA and NA were transmitted most efficiently, those with swine-like HA and NA were transmitted minimally or not transmitted, and those with swine-like HA and human-like NA (N2) showed intermediate transmissibility. We conclude that the lineages of HA and NA may play a crucial role in the respiratory droplet transmissibility of these viruses. These findings have important implications for pandemic planning and warrant confirmation.},
  langid = {english},
  pmcid = {PMC3400563},
  pmid = {22829764},
  file = {C:\Users\Zane\Zotero\storage\H2K6HFX6\Barman et al. - 2012 - Pathogenicity and transmissibility of North American triple reassortant swine influenza A viruses in.pdf}
}

@article{barnett2012,
  title = {{{AntigenMap 3D}}: An Online Antigenic Cartography Resource},
  shorttitle = {{{AntigenMap 3D}}},
  author = {Barnett, J. Lamar and Yang, Jialiang and Cai, Zhipeng and Zhang, Tong and Wan, Xiu-Feng},
  year = {2012},
  month = may,
  journal = {Bioinformatics},
  volume = {28},
  number = {9},
  pages = {1292--1293},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bts105},
  urldate = {2025-02-26},
  abstract = {Summary: Antigenic cartography is a useful technique to visualize and minimize errors in immunological data by projecting antigens to 2D or 3D cartography. However, a 2D cartography may not be sufficient to capture the antigenic relationship from high-dimensional immunological data. AntigenMap 3D presents an online, interactive, and robust 3D antigenic cartography construction and visualization resource. AntigenMap 3D can be applied to identify antigenic variants and vaccine strain candidates for pathogens with rapid antigenic variations, such as influenza A virus.Availability and implementation: ~http://sysbio.cvm.msstate.edu/AntigenMap3DContact: ~wan@cvm.msstate.edu; wanhenry@yahoo.com},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\WSC5F5QM\\Barnett et al. - 2012 - AntigenMap 3D an online antigenic cartography resource.pdf;C\:\\Users\\Zane\\Zotero\\storage\\GTVRQVTD\\311363.html}
}

@article{bauer2007,
  title = {Neuraminidase Inhibitor Susceptibility of Porcine {{H3N2}} Influenza {{A}} Viruses Isolated in {{Germany}} between 1982 and 1999},
  author = {Bauer, Katja and Schrader, Christina and Suess, Jochen and Wutzler, Peter and Schmidtke, Michaela},
  year = {2007},
  month = sep,
  journal = {Antiviral Research},
  volume = {75},
  number = {3},
  pages = {219--226},
  issn = {0166-3542},
  doi = {10.1016/j.antiviral.2007.03.007},
  abstract = {As an intermediate host of avian and human influenza A viruses (FLUAV) pigs may play a potential role in interspecies virus transmission and reassortment of viral genes including those conferring antiviral drug resistance. Porcine FLUAV isolated in Germany between 1989 and 2001 contains mutations in the M2 gene inducing amantadine resistance. No data exist on neuraminidase inhibitor (NAI) susceptibility of these porcine FLUAV. We studied the antiviral activity of NAI against seven selected H3N2 FLUAV isolated from pigs in Germany between 1982 and 1999. All isolates were susceptible towards oseltamivir and zanamivir in neuraminidase enzyme-inhibition assays. Both compounds inhibited virus spreading and reduced the virus yields and plaque size at low concentrations. Higher concentrations were necessary to reduce the plaque number. Two isolates that differed in glycosylation pattern of viral hemagglutinin (HA) showed markedly reduced drug susceptibility in cell culture-based assays.},
  langid = {english},
  pmid = {17445913}
}

@article{bedford2011,
  title = {Strength and Tempo of Selection Revealed in Viral Gene Genealogies},
  author = {Bedford, Trevor and Cobey, Sarah and Pascual, Mercedes},
  year = {2011},
  month = jul,
  journal = {BMC Evolutionary Biology},
  volume = {11},
  pages = {220},
  issn = {1471-2148},
  doi = {10.1186/1471-2148-11-220},
  urldate = {2025-02-26},
  abstract = {Background RNA viruses evolve extremely quickly, allowing them to rapidly adapt to new environmental conditions. Viral pathogens, such as influenza virus, exploit this capacity for evolutionary change to persist within the human population despite substantial immune pressure. Understanding the process of adaptation in these viral systems is essential to our efforts to combat infectious disease. Results Through analysis of simulated populations and sequence data from influenza A (H3N2) and measles virus, we show how phylogenetic and population genetic techniques can be used to assess the strength and temporal pattern of adaptive evolution. The action of natural selection affects the shape of the genealogical tree connecting members of an evolving population, causing deviations from the neutral expectation. The magnitude and distribution of these deviations lends insight into the historical pattern of evolution and adaptation in the viral population. We quantify the degree of ongoing adaptation in influenza and measles virus through comparison of census population size and effective population size inferred from genealogical patterns, finding a 60-fold greater deviation in influenza than in measles. We also examine the tempo of adaptation in influenza, finding evidence for both continuous and episodic change. Conclusions Our results have important consequences for understanding the epidemiological and evolutionary dynamics of the influenza virus. Additionally, these general techniques may prove useful to assess the strength and pattern of adaptive evolution in a variety of evolving systems. They are especially powerful when assessing selection in fast-evolving populations, where temporal patterns become highly visible.},
  pmcid = {PMC3199772},
  pmid = {21787390},
  file = {C:\Users\Zane\Zotero\storage\MRDUT7M6\Bedford et al. - 2011 - Strength and tempo of selection revealed in viral gene genealogies.pdf}
}

@article{bedford2014,
  title = {Integrating Influenza Antigenic Dynamics with Molecular Evolution},
  author = {Bedford, Trevor and Suchard, Marc A. and Lemey, Philippe and Dudas, Gytis and Gregory, Victoria and Hay, Alan J. and McCauley, John W. and Russell, Colin A. and Smith, Derek J. and Rambaut, Andrew},
  year = {2014},
  journal = {eLife},
  volume = {3},
  pages = {e01914},
  issn = {2050-084X},
  doi = {10.7554/eLife.01914},
  abstract = {Influenza viruses undergo continual antigenic evolution allowing mutant viruses to evade host immunity acquired to previous virus strains. Antigenic phenotype is often assessed through pairwise measurement of cross-reactivity between influenza strains using the hemagglutination inhibition (HI) assay. Here, we extend previous approaches to antigenic cartography, and simultaneously characterize antigenic and genetic evolution by modeling the diffusion of antigenic phenotype over a shared virus phylogeny. Using HI data from influenza lineages A/H3N2, A/H1N1, B/Victoria and B/Yamagata, we determine patterns of antigenic drift across viral lineages, showing that A/H3N2 evolves faster and in a more punctuated fashion than other influenza lineages. We also show that year-to-year antigenic drift appears to drive incidence patterns within each influenza lineage. This work makes possible substantial future advances in investigating the dynamics of influenza and other antigenically-variable pathogens by providing a model that intimately combines molecular and antigenic evolution. DOI: http://dx.doi.org/10.7554/eLife.01914.001.},
  langid = {english},
  pmcid = {PMC3909918},
  pmid = {24497547},
  keywords = {antigenic cartography,Antigens Viral,Bayesian inference,evolution,Evolution Molecular,Genetic Drift,Genotype,Humans,influenza,Influenza A Virus H1N1 Subtype,Influenza A Virus H3N2 Subtype,Influenza B virus,Influenza Human,Influenza Vaccines,Models Genetic,multidimensional scaling,Phenotype,phylogenetics,Phylogeny,Seasons,Time Factors,Virulence},
  file = {C:\Users\Zane\Zotero\storage\VQ5J3BNS\Bedford et al. - 2014 - Integrating influenza antigenic dynamics with molecular evolution.pdf}
}

@article{bedford2015,
  title = {Global Circulation Patterns of Seasonal Influenza Viruses Vary with Antigenic Drift},
  author = {Bedford, Trevor and Riley, Steven and Barr, Ian G. and Broor, Shobha and Chadha, Mandeep and Cox, Nancy J. and Daniels, Rodney S. and Gunasekaran, C. Palani and Hurt, Aeron C. and Kelso, Anne and Klimov, Alexander and Lewis, Nicola S. and Li, Xiyan and McCauley, John W. and Odagiri, Takato and Potdar, Varsha and Rambaut, Andrew and Shu, Yuelong and Skepner, Eugene and Smith, Derek J. and Suchard, Marc A. and Tashiro, Masato and Wang, Dayan and Xu, Xiyan and Lemey, Philippe and Russell, Colin A.},
  year = {2015-06-08, 2015-06},
  journal = {Nature},
  volume = {523},
  number = {7559},
  pages = {217--220},
  issn = {1476-4687},
  doi = {10.1038/nature14460},
  urldate = {2025-03-13},
  abstract = {The analysis of more than 9,000 haemagglutinin sequences of human seasonal influenza viruses over a 12-year time period shows that the global circulation patterns of A/H1N1 and B viruses are different from those of the well characterised A/H3N2 viruses; in particular the A/H1N1 and B viruses are shown to persist locally across several seasons and do not display the same degree of global movement as the H3N2 viruses.},
  copyright = {2015 Springer Nature Limited},
  langid = {english},
  keywords = {Computational models,Data integration,Influenza virus,Phylogenetics},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\JAJVQJEN\\Bedford et al. - 2015 - Global circulation patterns of seasonal influenza viruses vary with antigenic drift.pdf;C\:\\Users\\Zane\\Zotero\\storage\\UJN9KR46\\Bedford et al. - 2015 - Global circulation patterns of seasonal influenza .pdf}
}

@article{bi2024,
  title = {Reduced Effectiveness of Repeat Influenza Vaccination: Distinguishing among within-Season Waning, Recent Clinical Infection, and Subclinical Infection},
  shorttitle = {Reduced Effectiveness of Repeat Influenza Vaccination},
  author = {Bi, Qifang and Dickerman, Barbra A and Nguyen, Huong Q and Martin, Emily T and Gaglani, Manjusha and Wernli, Karen J and Balasubramani, G K and Flannery, Brendan and Lipsitch, Marc and Cobey, Sarah and {the US Flu Vaccine Effectiveness Network Investigators}},
  year = {2024},
  month = apr,
  journal = {The Journal of Infectious Diseases},
  pages = {jiae220},
  issn = {0022-1899},
  doi = {10.1093/infdis/jiae220},
  urldate = {2024-06-10},
  abstract = {Studies have reported that prior-season influenza vaccination is associated with higher risk of clinical influenza infection among vaccinees. This effect might arise from incomplete consideration of within-season waning and recent infection. Using data from the US Flu Vaccine Effectiveness (VE) Network (2011-2012 to 2018-2019 seasons), we found that repeat vaccinees were vaccinated earlier in a season by one week. After accounting for waning VE, repeat vaccinees were still more likely to test positive for A(H3N2) (OR=1.11, 95\%CI:1.02-1.21) but not for influenza B or A(H1N1). We found that clinical infection influenced individuals' decision to vaccinate in the following season while protecting against clinical infection of the same (sub)type. However, adjusting for recent clinical infections did not strongly influence the estimated effect of prior-season vaccination. In contrast, we found that adjusting for subclinical infection could theoretically attenuate this effect. Additional investigation is needed to determine the impact of subclinical infections on VE.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\FILTC6FM\\Bi et al. - 2024 - Reduced effectiveness of repeat influenza vaccinat.pdf;C\:\\Users\\Zane\\Zotero\\storage\\5SW6235T\\7660490.html}
}

@article{billings2025,
  title = {High-{{Dose Inactivated Influenza Vaccine Inconsistently Improves Heterologous Antibody Responses}} in an {{Older Human Cohort}}},
  author = {Billings, W Zane and Ge, Yang and Knight, Jessica H and Hemme, Hayley and Hammerton, Savannah M and Skarlupka, Amanda L and Cao, Wangnan and Shen, Ye and Bahl, Justin and Thomas, Paul G and Ross, Ted M and Handel, Andreas},
  year = {2025},
  month = jan,
  journal = {The Journal of Infectious Diseases},
  pages = {jiaf003},
  issn = {0022-1899},
  doi = {10.1093/infdis/jiaf003},
  urldate = {2025-02-05},
  abstract = {Older adults often mount a weak immune response to standard inactivated influenza vaccines. To induce a stronger response and better protection, a high-dose (HD) version of the inactivated Fluzone vaccine is recommended for individuals \&gt;65 years of age. While better immunogenicity and protection against the vaccine strain have been shown, it is not known if the HD vaccine also induces a robust antibody response to heterologous strains.We fit bayesian multilevel regression models to hemagglutination inhibition antibody data from an influenza vaccine cohort spanning the influenza seasons of 2013--2014 to 2021--2022. We used this model to estimate the average causal effect of obtaining the HD vaccine relative to the standard-dose vaccine.We show that while there is generally a benefit derived from the HD vaccine, the impact is small and inconsistent. For some strains, the HD vaccine might even result in less robust heterologous responses.We suggest that further increases in dose might be worth investigating to help induce a stronger broad response.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\2ZRYEDCP\\Billings et al. - 2025 - High-Dose Inactivated Influenza Vaccine Inconsistently Improves Heterologous Antibody Responses in a.pdf;C\:\\Users\\Zane\\Zotero\\storage\\VNM2YFD3\\billings-2025-jid_supplementary_data.pdf;C\:\\Users\\Zane\\Zotero\\storage\\AUTXL7VY\\7945323.html;C\:\\Users\\Zane\\Zotero\\storage\\HGR7CELT\\7945323.html}
}

@article{borkenhagen2021,
  title = {Influenza Virus Genotype to Phenotype Predictions through Machine Learning: A Systematic Review: {{Computational Prediction}} of {{Influenza Phenotype}}},
  shorttitle = {Influenza Virus Genotype to Phenotype Predictions through Machine Learning},
  author = {Borkenhagen, Laura K. and Allen, Martin W. and Runstadler, Jonathan A.},
  year = {2021},
  month = jan,
  journal = {Emerging Microbes \& Infections},
  volume = {10},
  number = {1},
  pages = {1896--1907},
  publisher = {Taylor \& Francis},
  issn = {null},
  doi = {10.1080/22221751.2021.1978824},
  urldate = {2025-02-04},
  abstract = {Background: There is great interest in understanding the viral genomic predictors of phenotypic traits that allow influenza A viruses to adapt to or become more virulent in different hosts. Machine learning techniques have demonstrated promise in addressing this critical need for other pathogens because the underlying algorithms are especially well equipped to uncover complex patterns in large datasets and produce generalizable predictions for new data. As the body of research where these techniques are applied for influenza A virus phenotype prediction continues to grow, it is useful to consider the strengths and weaknesses of these approaches to understand what has prevented these models from seeing widespread use by surveillance laboratories and to identify gaps that are underexplored with this technology. Methods and Results: We present a systematic review of English literature published through 15 April 2021 of studies employing machine learning methods to generate predictions of influenza A virus phenotypes from genomic or proteomic input. Forty-nine studies were included in this review, spanning the topics of host discrimination, human adaptability, subtype and clade assignment, pandemic lineage assignment, characteristics of infection, and antiviral drug resistance. Conclusions: Our findings suggest that biases in model design and a dearth of wet laboratory follow-up may explain why these models often go underused. We, therefore, offer guidance to overcome these limitations, aid in improving predictive models of previously studied influenza A virus phenotypes, and extend those models to unexplored phenotypes in the ultimate pursuit of tools to enable the characterization of virus isolates across surveillance laboratories.},
  pmid = {34498543},
  keywords = {classification,Influenza virus,machine learning,phenotype,prediction},
  file = {C:\Users\Zane\Zotero\storage\HWBTWP9D\Borkenhagen et al. - 2021 - Influenza virus genotype to phenotype predictions through machine learning a systematic review Com.pdf}
}

@article{boyoglu-barnum2021,
  title = {Quadrivalent Influenza Nanoparticle Vaccines Induce Broad Protection},
  author = {{Boyoglu-Barnum}, Seyhan and Ellis, Daniel and Gillespie, Rebecca A. and Hutchinson, Geoffrey B. and Park, Young-Jun and Moin, Syed M. and Acton, Oliver J. and Ravichandran, Rashmi and Murphy, Mike and Pettie, Deleah and Matheson, Nick and Carter, Lauren and Creanga, Adrian and Watson, Michael J. and Kephart, Sally and Ataca, Sila and Vaile, John R. and Ueda, George and Crank, Michelle C. and Stewart, Lance and Lee, Kelly K. and Guttman, Miklos and Baker, David and Mascola, John R. and Veesler, David and Graham, Barney S. and King, Neil P. and Kanekiyo, Masaru},
  year = {2021-03-24, 2021-03},
  journal = {Nature},
  volume = {592},
  number = {7855},
  pages = {623--628},
  issn = {1476-4687},
  doi = {10.1038/s41586-021-03365-x},
  urldate = {2025-03-13},
  abstract = {Influenza vaccines that confer broad and durable protection against diverse viral strains would have a major effect on global health, as they would lessen the need for annual vaccine reformulation and immunization1. Here we show that computationally designed, two-component nanoparticle immunogens2 induce potently neutralizing and broadly protective antibody responses against a wide variety of influenza viruses. The nanoparticle immunogens contain 20 haemagglutinin glycoprotein trimers in an ordered array, and their assembly in vitro enables the precisely controlled co-display of multiple distinct haemagglutinin proteins in defined ratios. Nanoparticle immunogens that co-display the four haemagglutinins of licensed quadrivalent influenza vaccines elicited antibody responses in several animal models against vaccine-matched strains that were equivalent to or better than commercial quadrivalent influenza vaccines, and simultaneously induced broadly protective antibody responses to heterologous viruses by targeting the subdominant yet conserved haemagglutinin stem. The combination of potent receptor-blocking and cross-reactive stem-directed antibodies induced by the nanoparticle immunogens makes them attractive candidates for a supraseasonal influenza vaccine candidate with the potential to replace conventional seasonal vaccines3.},
  copyright = {2021 The Author(s), under exclusive licence to Springer Nature Limited},
  langid = {english},
  keywords = {Influenza virus,Protein vaccines},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\BCUFGEFM\\Boyoglu-Barnum et al. - 2021 - Quadrivalent influenza nanoparticle vaccines induce broad protection.pdf;C\:\\Users\\Zane\\Zotero\\storage\\YYJCWA9M\\Boyoglu-Barnum et al. - 2021 - Quadrivalent influenza nanoparticle vaccines induc.pdf}
}

@book{breen1996,
  title = {Regression {{Models}}: {{Censored}}, {{Sample Selected}}, or {{Truncated Data}}},
  author = {Breen, Richard},
  year = {1996},
  publisher = {SAGE Publications, Inc.},
  doi = {10.4135/9781412985611},
  urldate = {2023-09-18},
  abstract = {{$<$}p{$>$}What techniques can social scientists use when an outcome variable for a sample is not representative of the population for whom they would like to generaliz},
  isbn = {978-1-4129-8561-1},
  langid = {english},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\K9QH4QAI\\Breen - 1996 - Regression Models Censored, Sample Selected, or T.pdf;C\:\\Users\\Zane\\Zotero\\storage\\PIG4CV57\\regression-models.html}
}

@article{cai2010,
  title = {A Computational Framework for Influenza Antigenic Cartography},
  author = {Cai, Zhipeng and Zhang, Tong and Wan, Xiu-Feng},
  editor = {Fraser, Christophe},
  year = {2010-10-07, 2010-10},
  journal = {PLoS Computational Biology},
  volume = {6},
  number = {10},
  pages = {e1000949},
  issn = {1553-7358 1553-734X},
  doi = {10.1371/journal.pcbi.1000949},
  abstract = {Influenza viruses have been responsible for large losses of lives around the world and continue to present a great public health challenge. Antigenic  characterization based on hemagglutination inhibition (HI) assay is one of the  routine procedures for influenza vaccine strain selection. However, HI assay is  only a crude experiment reflecting the antigenic correlations among testing  antigens (viruses) and reference antisera (antibodies). Moreover, antigenic  characterization is usually based on more than one HI dataset. The combination of  multiple datasets results in an incomplete HI matrix with many unobserved  entries. This paper proposes a new computational framework for constructing an  influenza antigenic cartography from this incomplete matrix, which we refer to as  Matrix Completion-Multidimensional Scaling (MC-MDS). In this approach, we first  reconstruct the HI matrices with viruses and antibodies using low-rank matrix  completion, and then generate the two-dimensional antigenic cartography using  multidimensional scaling. Moreover, for influenza HI tables with herd immunity  effect (such as those from Human influenza viruses), we propose a temporal model  to reduce the inherent temporal bias of HI tables caused by herd immunity. By  applying our method in HI datasets containing H3N2 influenza A viruses isolated  from 1968 to 2003, we identified eleven clusters of antigenic variants,  representing all major antigenic drift events in these 36 years. Our results  showed that both the completed HI matrix and the antigenic cartography obtained  via MC-MDS are useful in identifying influenza antigenic variants and thus can be  used to facilitate influenza vaccine strain selection. The webserver is available  at http://sysbio.cvm.msstate.edu/AntigenMap.},
  langid = {english},
  keywords = {*Algorithms,Animals,Antibodies,Antigenic cartography,Antigens Viral/*chemistry,Computational Biology/*methods,Databases Factual,Ferrets,Hemagglutination inhibition test,Hemagglutination Inhibition Tests/*methods,Humans,Immune Sera,Immune serum,Immunity Herd,Influenza,Influenza A virus,Influenza A Virus H3N2 Subtype/*chemistry,Influenza viruses,Protein Interaction Mapping/*methods,Reproducibility of Results,Time Factors,Viral vaccines},
  file = {C:\Users\Zane\Zotero\storage\CU7VS87J\Cai et al. - 2010 - A computational framework for influenza antigenic .pdf}
}

@article{cai2011a,
  title = {Antigenic {{Distance Measurements}} for {{Seasonal Influenza Vaccine Selection}}},
  author = {Cai, Zhipeng and Zhang, Tong and Wan, Xiu-Feng},
  year = {2011},
  month = nov,
  journal = {Vaccine},
  volume = {30},
  number = {2},
  pages = {448},
  issn = {1873-2518 0264-410X},
  doi = {10.1016/j.vaccine.2011.10.051},
  urldate = {2025-02-26},
  abstract = {Influenza vaccination is one of the major options to counteract the effects of influenza diseases. Selection of an effective vaccine strain is the key to the success of an effective vaccination program since vaccine protection can only be achieved ...},
  copyright = {Copyright {\copyright} 2011 Elsevier Ltd. All rights reserved.},
  langid = {english},
  pmid = {22063385},
  keywords = {*Cross Reactions,Antibodies Viral/*immunology,Antigenic cartography,Antigenic distance,Antigenic drift,Antigens Viral/*immunology,Computer Simulation,Humans,Immunoassay/methods,Influenza,Influenza Human/*prevention & control/*virology,Influenza Vaccines/*immunology,Vaccination,Vaccine strain selection},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\66AC2ELC\\Cai et al. - 2012 - Antigenic distance measurements for seasonal influ.pdf;C\:\\Users\\Zane\\Zotero\\storage\\GG4YWDQV\\Cai et al. - 2011 - Antigenic Distance Measurements for Seasonal Influenza Vaccine Selection.pdf;C\:\\Users\\Zane\\Zotero\\storage\\YYL9U3VK\\Cai et al. - 2012 - Antigenic distance measurements for seasonal influenza vaccine selection.pdf;C\:\\Users\\Zane\\Zotero\\storage\\JQIREREP\\S0264410X11016884.html;C\:\\Users\\Zane\\Zotero\\storage\\N8EXDBU8\\S0264410X11016884.html}
}

@article{carlock2023,
  title = {A Computationally Optimized Broadly Reactive Hemagglutinin Vaccine Elicits Neutralizing Antibodies against Influenza {{B}} Viruses from Both Lineages},
  author = {Carlock, Michael A. and Ross, Ted M.},
  year = {2023},
  month = sep,
  journal = {Scientific Reports},
  volume = {13},
  pages = {15911},
  issn = {2045-2322},
  doi = {10.1038/s41598-023-43003-2},
  urldate = {2025-02-11},
  abstract = {Influenza B viruses (IBV) can cause severe disease and death much like influenza A viruses (IAV), with a disproportionate number of infections in children. Despite moving to a quadrivalent vaccine to include strains from both the B/Victoria and B/Yamagata lineages, vaccine effectiveness rates continue to be variable and low in many past seasons. To develop more effective influenza B virus vaccines, three novel IBV hemagglutinin (HA) vaccines were designed using a computationally optimized broadly reactive antigen (COBRA) methodology. These IBV HA proteins were expressed on the surface of a virus-like particle (VLP) and used to vaccinate ferrets that were pre-immune to historical B/Victoria or B/Yamagata lineage viruses. Ferrets vaccinated with B-COBRA HA vaccines had neutralizing antibodies with high titer HAI titer against all influenza B viruses regardless of pre-immunization history. Conversely, VLPs expressing wild-type IBV HA antigens preferentially boosted titers against viruses from the same lineage and there was little-to-no seroprotective antibodies detected in ferrets with mismatched IBV pre-immune infections. Overall, a single IBV HA developed using the COBRA methodology elicited protective broadly-reactive antibodies against current and future drifted IBVs from both lineages.},
  pmcid = {PMC10517972},
  pmid = {37741893},
  file = {C:\Users\Zane\Zotero\storage\Q79J47E4\Carlock and Ross - 2023 - A computationally optimized broadly reactive hemag.pdf}
}

@article{carlock2024,
  title = {Longitudinal Assessment of Human Antibody Binding to Hemagglutinin Elicited by Split-Inactivated Influenza Vaccination over Six Consecutive Seasons},
  author = {Carlock, Michael A. and Allen, James D. and Hanley, Hannah B. and Ross, Ted M.},
  year = {2024},
  month = jun,
  journal = {PLOS ONE},
  volume = {19},
  number = {6},
  pages = {e0301157},
  publisher = {Public Library of Science},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0301157},
  urldate = {2024-07-01},
  abstract = {Participants between the ages of 10--86 years old were vaccinated with split-inactivated influenza vaccine (Fluzone{\textregistered}) in six consecutive influenza seasons from 2016--2017 to 2021--2022. Vaccine effectiveness varies from season to season as a result of both host immune responses as well as evolutionary changes in the influenza virus surface glycoproteins that provide challenges to vaccine manufacturers to produce more effective annual vaccines. Next generation influenza vaccines are in development and may provide protective immune responses against a broader number of influenza viruses and reduce the need for annual vaccination. An improved understanding how current influenza vaccines are influenced by human host immune responses in people of different ages and co-morbidities is necessary for designing the next-generation of 'universal' or broadly-protective influenza vaccines. Overall, pre-existing immune responses to previous influenza virus exposures, either by past infections or vaccinations, is a critical factor influencing host responses to seasonal influenza vaccination. Participants vaccinated in consecutive seasons had reduced serum hemagglutination-inhibition (HAI) activity against strains included in the vaccine compared to participants that had not been vaccinated in the preceding 1--2 years prior to entering this study. The magnitude and breadth of these antibody responses were also modulated by the age of the participant. Elderly participants over 65 years of age, in general, had lower pre-existing HAI titers each season prior to vaccination with lower post-vaccination titers compared to children or young adults under the age of 35. The administration of higher doses (HD) of the split-inactivated vaccine enhanced the antibody titers in the elderly. This report showcases 6 consecutive years of antibody HAI activity in human subjects receiving seasonal split-inactivated influenza vaccine.},
  langid = {english},
  keywords = {Age groups,Antibodies,H1N1,Influenza,Influenza viruses,Vaccination and immunization,Vaccines,Viral vaccines},
  file = {C:\Users\Zane\Zotero\storage\TWJ8H8DD\Carlock et al. - 2024 - Longitudinal assessment of human antibody binding .pdf}
}

@article{carpenter2017,
  title = {Stan: {{A Probabilistic Programming Language}}},
  shorttitle = {Stan},
  author = {Carpenter, Bob and Gelman, Andrew and Hoffman, Matthew D. and Lee, Daniel and Goodrich, Ben and Betancourt, Michael and Brubaker, Marcus and Guo, Jiqiang and Li, Peter and Riddell, Allen},
  year = {2017},
  month = jan,
  journal = {Journal of Statistical Software},
  volume = {76},
  number = {1},
  pages = {1--32},
  issn = {1548-7660},
  doi = {10.18637/jss.v076.i01},
  urldate = {2021-05-29},
  copyright = {Copyright (c) 2017 Bob Carpenter, Andrew Gelman, Matthew D. Hoffman, Daniel Lee, Ben Goodrich, Michael Betancourt, Marcus Brubaker, Jiqiang Guo, Peter Li, Allen Riddell},
  langid = {english},
  keywords = {algorithmic differentiation,Bayesian inference,probabilistic programming,Stan},
  file = {C:\Users\Zane\Zotero\storage\EPW7GSIC\v076i01.html}
}

@article{castro2020,
  title = {Early Prediction of Antigenic Transitions for Influenza {{A}}/{{H3N2}}},
  author = {Castro, Lauren A. and Bedford, Trevor and Ancel Meyers, Lauren},
  editor = {Kouyos, Roger Dimitri},
  year = {2020-02-18, 2020-02},
  journal = {PLOS Computational Biology},
  volume = {16},
  number = {2},
  pages = {e1007683},
  issn = {1553-7358},
  doi = {10.1371/journal.pcbi.1007683},
  urldate = {2024-02-05},
  abstract = {Influenza A/H3N2 is a rapidly evolving virus which experiences major antigenic transitions every two to eight years. Anticipating the timing and outcome of transitions is critical to developing effective seasonal influenza vaccines. Using a published phylodynamic model of influenza transmission, we identified indicators of future evolutionary success for an emerging antigenic cluster and quantified fundamental trade-offs in our ability to make such predictions. The eventual fate of a new cluster depends on its initial epidemiological growth rate----which is a function of mutational load and population susceptibility to the cluster----along with the variance in growth rate across co-circulating viruses. Logistic regression can predict whether a cluster at 5\% relative frequency will eventually succeed with {\textasciitilde}80\% sensitivity, providing up to eight months advance warning. As a cluster expands, the predictions improve while the lead-time for vaccine development and other interventions decreases. However, attempts to make comparable predictions from 12 years of empirical influenza surveillance data, which are far sparser and more coarse-grained, achieve only 56\% sensitivity. By expanding influenza surveillance to obtain more granular estimates of the frequencies of and population-wide susceptibility to emerging viruses, we can better anticipate major antigenic transitions. This provides added incentives for accelerating the vaccine production cycle to reduce the lead time required for strain selection.},
  langid = {english},
  keywords = {Forecasting,Infectious disease surveillance,Influenza,Influenza viruses,Microbial mutation,Simulation and modeling,Viral evolution,Viral vaccines},
  file = {C:\Users\Zane\Zotero\storage\JLI5UTTR\Castro et al. - 2020 - Early prediction of antigenic transitions for infl.pdf}
}

@article{catani2024,
  title = {The Antigenic Landscape of Human Influenza {{N2}} Neuraminidases from 2009 until 2017},
  author = {Catani, Jo{\~a}o Paulo Portela and Smet, Anouk and Ysenbaert, Tine and Vuylsteke, Marnik and Bottu, Guy and Mathys, Janick and Botzki, Alexander and {Cortes-Garcia}, Guadalupe and Strugnell, Tod and Gomila, Raul and Hamberger, John and Catalan, John and Ustyugova, Irina V and Farrell, Timothy and Stegalkina, Svetlana and Ray, Satyajit and LaRue, Lauren and Saelens, Xavier and Vogel, Thorsten U},
  editor = {Neher, Richard A and Diamond, Betty},
  year = {2024},
  month = may,
  journal = {eLife},
  volume = {12},
  pages = {RP90782},
  publisher = {eLife Sciences Publications, Ltd},
  issn = {2050-084X},
  doi = {10.7554/eLife.90782},
  urldate = {2025-02-26},
  abstract = {Human H3N2 influenza viruses are subject to rapid antigenic evolution which translates into frequent updates of the composition of seasonal influenza vaccines. Despite these updates, the effectiveness of influenza vaccines against H3N2-associated disease is suboptimal. Seasonal influenza vaccines primarily induce hemagglutinin-specific antibody responses. However, antibodies directed against influenza neuraminidase (NA) also contribute to protection. Here, we analysed the antigenic diversity of a panel of N2 NAs derived from human H3N2 viruses that circulated between 2009 and 2017. The antigenic breadth of these NAs was determined based on the NA inhibition (NAI) of a broad panel of ferret and mouse immune sera that were raised by infection and recombinant N2 NA immunisation. This assessment allowed us to distinguish at least four antigenic groups in the N2 NAs derived from human H3N2 viruses that circulated between 2009 and 2017. Computational analysis further revealed that the amino acid residues in N2 NA that have a major impact on susceptibility to NAI by immune sera are in proximity of the catalytic site. Finally, a machine learning method was developed that allowed to accurately predict the impact of mutations that are present in our N2 NA panel on NAI. These findings have important implications for the renewed interest to develop improved influenza vaccines based on the inclusion of a protective NA antigen formulation.},
  keywords = {H3N2,influenza,neuraminidase},
  file = {C:\Users\Zane\Zotero\storage\PYLV96AB\Catani et al. - 2024 - The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.pdf}
}

@misc{CDCSeason,
  title = {{{CDC Seasonal Flu Vaccine Effectiveness Studies}} {\textbar} {{Flu Vaccines Work}} {\textbar} {{CDC}}},
  year = {2025},
  month = mar,
  urldate = {2025-03-11},
  howpublished = {https://web.archive.org/web/20250311230637/https://www.cdc.gov/flu-vaccines-work/php/effectiveness-studies/index.html},
  file = {C:\Users\Zane\Zotero\storage\M4PZVLZX\index.html}
}

@misc{CDCVE,
  title = {National, {{Regional}}, and {{State Level Outpatient Illness}} and {{Viral Surveillance}}},
  author = {{Centers for Disease Control and Prevention (CDC)}},
  urldate = {2024-10-29},
  howpublished = {https://gis.cdc.gov/grasp/fluview/fluportaldashboard.html},
  file = {C:\Users\Zane\Zotero\storage\WCKK4IAN\fluportaldashboard.html}
}

@article{chardes2023,
  title = {Evolutionary Stability of Antigenically Escaping Viruses},
  author = {Chardes, Victor and Mazzolini, Andrea and Mora, Thierry and Walczak, Aleksandra M.},
  year = {2023},
  month = oct,
  journal = {PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA},
  volume = {120},
  number = {44},
  pages = {e2307712120},
  publisher = {Natl Acad Sciences},
  address = {Washington},
  issn = {0027-8424, 1091-6490},
  doi = {10.1073/pnas.2307712120},
  urldate = {2025-02-20},
  abstract = {Antigenic variation is the main immune escape mechanism for RNA viruses like influenza or SARS-CoV-2. While high mutation rates promote antigenic escape, they also induce large mutational loads and reduced fitness. It remains unclear how this cost-benefit trade-off selects the mutation rate of viruses. Using a traveling wave model for the coevolution of viruses and host immune systems in a finite population, we investigate how immunity affects the evolution of the mutation rate and other nonantigenic traits, such as virulence. We first show that the nature of the wave depends on how cross-reactive immune systems are, reconciling previous approaches. The immune-virus system behaves like a Fisher wave at low cross-reactivities, and like a fitness wave at high cross-reactivities. These regimes predict different outcomes for the evolution of nonantigenic traits. At low cross-reactivities, the evolutionarily stable strategy is to maximize the speed of the wave, implying a higher mutation rate and increased virulence. At large cross-reactivities, where our estimates place H3N2 influenza, the stable strategy is to increase the basic reproductive number, keeping the mutation rate to a minimum and virulence low.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001127129700003},
  file = {C:\Users\Zane\Zotero\storage\HP3VNF3R\Chardes et al. - 2023 - Evolutionary stability of antigenically escaping viruses.pdf}
}

@article{clark2016,
  title = {{{GenBank}}},
  author = {Clark, Karen and {Karsch-Mizrachi}, Ilene and Lipman, David J. and Ostell, James and Sayers, Eric W.},
  year = {2016},
  month = jan,
  journal = {Nucleic Acids Research},
  volume = {44},
  number = {D1},
  pages = {D67-D72},
  issn = {0305-1048},
  doi = {10.1093/nar/gkv1276},
  urldate = {2025-06-09},
  abstract = {GenBank{\textregistered} (www.ncbi.nlm.nih.gov/genbank/) is a comprehensive database that contains publicly available nucleotide sequences for over 340 000 formally described species. Recent developments include a new starting page for submitters, a shift toward using accession.version identifiers rather than GI numbers, a wizard for submitting 16S rRNA sequences, and an Identical Protein Report to address growing issues of data redundancy. GenBank organizes the sequence data received from individual laboratories and large-scale sequencing projects into 18 divisions, and GenBank staff assign unique accession.version identifiers upon data receipt. Most submitters use the web-based BankIt or standalone Sequin programs. Daily data exchange with the European Nucleotide Archive (ENA) and the DNA Data Bank of Japan (DDBJ) ensures worldwide coverage. GenBank is accessible through the nuccore, nucest, and nucgss databases of the Entrez retrieval system, which integrates these records with a variety of other data including taxonomy nodes, genomes, protein structures, and biomedical journal literature in PubMed. BLAST provides sequence similarity searches of GenBank and other sequence databases. Complete bimonthly releases and daily updates of the GenBank database are available by FTP.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\ZCTQWG6K\\Clark et al. - 2016 - GenBank.pdf;C\:\\Users\\Zane\\Zotero\\storage\\NYFF99CH\\2503088.html}
}

@article{cobey2024,
  title = {Vaccination against Rapidly Evolving Pathogens and the Entanglements of Memory},
  author = {Cobey, Sarah},
  year = {2024},
  month = nov,
  journal = {Nature Immunology},
  volume = {25},
  number = {11},
  pages = {2015--2023},
  issn = {1529-2916},
  doi = {10.1038/s41590-024-01970-2},
  urldate = {2024-11-04},
  abstract = {Immune memory determines infection risk and responses to future infections and vaccinations over potentially decades of life. Despite its centrality, the dynamics of memory to antigenically variable pathogens remains poorly understood. This Review examines how past exposures shape B cell responses to vaccinations with influenza and SARS-CoV-2. An overriding feature of vaccinations with these pathogens is the recall of primary responses, often termed 'imprinting' or 'original antigenic sin'. These recalled responses can inhibit the generation of new responses unless some incompletely defined conditions are met. Depending on the context, immune memory can increase or decrease the total neutralizing antibody response to variant antigens, with apparent consequences for protection. These effects are easier to measure experimentally than epidemiologically, but there is evidence that both early and recent exposures influence vaccine effectiveness. A few immunological interactions between adaptive immune responses and antigens might explain the seemingly discrepant effects of memory. Overall, the complex observations point to a need for more quantitative approaches to integrate high-dimensional immune data from populations with diverse exposure histories. Such approaches could help identify optimal vaccination strategies against antigenically diverse pathogens.},
  copyright = {2024 Springer Nature America, Inc.},
  langid = {english},
  pmid = {39384979},
  keywords = {Adaptive immunity,Animals,Antibodies Neutralizing,Antibodies Viral,B-Lymphocytes,COVID-19,COVID-19 Vaccines,Humans,Immunologic Memory,Influenza Human,Influenza Vaccines,SARS-CoV-2,Vaccination,Vaccines,Viral infection},
  file = {C:\Users\Zane\Zotero\storage\ZIWUB446\Cobey - 2024 - Vaccination against rapidly evolving pathogens and the entanglements of memory.pdf}
}

@article{couch2007c,
  title = {Safety and Immunogenicity of a High Dosage Trivalent Influenza Vaccine among Elderly Subjects},
  author = {Couch, Robert B. and Winokur, Patricia and Brady, Rebecca and Belshe, Robert and Chen, Wilbur H. and Cate, Thomas R. and Sigurdardottir, Bryndis and Hoeper, Amy and Graham, Irene L. and Edelman, Robert and He, Fenhua and Nino, Diane and Capellan, Jose and Ruben, Frederick L.},
  year = {2007},
  month = nov,
  journal = {Vaccine},
  volume = {25},
  number = {44},
  pages = {7656--7663},
  issn = {0264410X},
  doi = {10.1016/j.vaccine.2007.08.042},
  urldate = {2024-05-17},
  abstract = {To improve immune responses to influenza vaccine, a trivalent inactivated vaccine containing 60 microg of the HA of each component (A/H3N2, A/H1N1, B) was compared to a licensed vaccine containing 15 microg of the HA of each. More local and systemic reactions were reported by subjects given the high dosage but only local pain and myalgias were significantly increased. The high dosage vaccine induced a higher frequency of serum antibody increases ({$>$} or =4-fold) in both hemagglutination-inhibiting (HAI) and neutralization tests for all three vaccine viruses in the total group as well as subjects vaccinated and those not vaccinated the previous year. Mean titers of antibody attained, the magnitude of antibody increases and the frequencies of persons with final HAI antibody titers {$>$} or =1:32, {$>$} or =1:64, and {$>$} or =1:128 were all greater for the high dosage group in both serologic tests, for all groups, and for all vaccine viruses. These increased immune responses should provide increased protection against influenza in the elderly.},
  copyright = {https://www.elsevier.com/tdm/userlicense/1.0/},
  langid = {english},
  keywords = {Aged,Aged 80 and over,Antibodies Viral,Dose-Response Relationship Immunologic,Female,Hemagglutination Inhibition Tests,Hemagglutinin Glycoproteins Influenza Virus,Humans,Influenza A Virus H1N1 Subtype,Influenza A Virus H3N2 Subtype,Influenza B virus,Influenza Vaccines,Male},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\GM86LLAW\\Couch et al. - 2007 - Safety and immunogenicity of a high dosage trivale.pdf;C\:\\Users\\Zane\\Zotero\\storage\\YWCBTUDZ\\Couch et al. - 2007 - Safety and immunogenicity of a high dosage trivale.pdf}
}

@article{cowling2011,
  title = {Reply to {{Skowronski}}},
  author = {Cowling, Benjamin J. and Ng, Sophia and Ip, Dennis K. M. and Peiris, J.S. and Leung, Gabriel M.},
  year = {2011},
  month = mar,
  journal = {Clinical Infectious Diseases},
  volume = {52},
  number = {6},
  pages = {832--833},
  issn = {1058-4838},
  doi = {10.1093/cid/cir041},
  urldate = {2023-04-11},
  abstract = {TO THE EDITOR---We thank Skowronski et al for encouraging further discussion of the effect of seasonal trivalent inactivated influenza vaccination (TIV) on the risk of pandemic H1N1 (pH1N1) infection [1]. Using the original data from our paper (made available on the corresponding author's homepage [2]) the crude odds ratio [OR] for pH1N1 infection among TIV versus placebo recipients was 3.04 (95\% confidence interval [CI]: 1.04 --8.91) and the corresponding relative risk was 2.42 (95\% CI: .99 --5.95). We found that infection with seasonal influenza was associated with a reduced risk of pH1N1. This effect was statistically significant in all participants combined (Table 6 [2]) and of a similar magnitude although not statistically significant in randomized participants, possibly because of reduced power with a smaller sample size (Table 7 [2]). After adjustment for prior seasonal infection, the effect of TIV was not statistically significant with a point estimate of 2.74 (95\% CI: .84 - --8.91). Although the point estimate is large [1], we caution against overinterpretation of nonsignificant effects. The infection-block hypothesis is sufficient to explain the excess risk of pH1N1 in TIV recipients in our study.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\4EN3E5XZ\\Cowling et al. - 2011 - Reply to Skowronski.pdf;C\:\\Users\\Zane\\Zotero\\storage\\QZUNNSTT\\364794.html}
}

@article{cowling2024b,
  title = {Influenza {{Vaccine Effectiveness}} and {{Progress Towards}} a {{Universal Influenza Vaccine}}},
  author = {Cowling, Benjamin J. and Okoli, George N.},
  year = {2024},
  journal = {Drugs},
  volume = {84},
  number = {9},
  pages = {1013--1023},
  issn = {0012-6667},
  doi = {10.1007/s40265-024-02083-8},
  urldate = {2025-02-03},
  abstract = {At various times in recent decades, surges have occurred in optimism about the potential for universal influenza vaccines that provide strong, broad, and long-lasting protection and could substantially reduce the disease burden associated with seasonal influenza epidemics as well as the threat posed by pandemic influenza. Each year more than 500 million doses of seasonal influenza vaccine are administered around the world, with most doses being egg-grown inactivated subunit or split-virion vaccines. These vaccines tend to have moderate effectiveness against medically attended influenza for influenza A(H1N1) and influenza B, and somewhat lower for influenza A(H3N2) where differences between vaccine strains and circulating strains can occur more frequently due to antigenic drift and egg adaptations in the vaccine strains. Several enhanced influenza vaccine platforms have been developed including cell-grown antigen, the inclusion of adjuvants, or higher antigen doses, to improve immunogenicity and protection. During the COVID-19 pandemic there was unprecedented speed in development and roll-out of relatively new vaccine platforms, including mRNA vaccines and viral vector vaccines. These new platforms present opportunities to improve protection for influenza beyond existing products. Other approaches continue to be explored. Incremental improvements in influenza vaccine performance should be achievable in the short to medium term.},
  langid = {english},
  pmcid = {PMC11438668},
  pmid = {39167316},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\6UK5V8RD\\Cowling and Okoli - 2024 - Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine.pdf;C\:\\Users\\Zane\\Zotero\\storage\\762RKM6U\\Cowling and Okoli - 2024 - Influenza Vaccine Effectiveness and Progress Towar.pdf}
}

@article{dang2010,
  title = {{{FLU}}, an Amino Acid Substitution Model for Influenza Proteins},
  author = {Dang, Cuong Cao and Le, Quang Si and Gascuel, Olivier and Le, Vinh Sy},
  year = {2010},
  month = apr,
  journal = {BMC Evolutionary Biology},
  volume = {10},
  number = {1},
  pages = {99},
  issn = {1471-2148},
  doi = {10.1186/1471-2148-10-99},
  urldate = {2025-04-02},
  abstract = {The amino acid substitution model is the core component of many protein analysis systems such as sequence similarity search, sequence alignment, and phylogenetic inference. Although several general amino acid substitution models have been estimated from large and diverse protein databases, they remain inappropriate for analyzing specific species, e.g., viruses. Emerging epidemics of influenza viruses raise the need for comprehensive studies of these dangerous viruses. We propose an influenza-specific amino acid substitution model to enhance the understanding of the evolution of influenza viruses.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\53KCWFRI\\Dang et al. - 2010 - FLU, an amino acid substitution model for influenza proteins.pdf;C\:\\Users\\Zane\\Zotero\\storage\\MCLCARX2\\1471-2148-10-99.html}
}

@article{dugan2020,
  title = {Preexisting Immunity Shapes Distinct Antibody Landscapes after Influenza Virus Infection and Vaccination in Humans},
  author = {Dugan, Haley L. and Guthmiller, Jenna J. and Arevalo, Philip and Huang, Min and Chen, Yao-Qing and Neu, Karlynn E. and Henry, Carole and Zheng, Nai-Ying and Lan, Linda Yu-Ling and Tepora, Micah E. and Stovicek, Olivia and Bitar, Dalia and Palm, Anna-Karin E. and Stamper, Christopher T. and Changrob, Siriruk and Utset, Henry A. and Coughlan, Lynda and Krammer, Florian and Cobey, Sarah and Wilson, Patrick C.},
  year = {2020},
  month = dec,
  journal = {Science Translational Medicine},
  volume = {12},
  number = {573},
  pages = {eabd3601},
  issn = {1946-6242},
  doi = {10.1126/scitranslmed.abd3601},
  abstract = {Humans are repeatedly exposed to variants of influenza virus throughout their lifetime. As a result, preexisting influenza-specific memory B cells can dominate the response after infection or vaccination. Memory B cells recalled by adulthood exposure are largely reactive to conserved viral epitopes present in childhood strains, posing unclear consequences on the ability of B cells to adapt to and neutralize newly emerged strains. We sought to investigate the impact of preexisting immunity on generation of protective antibody responses to conserved viral epitopes upon influenza virus infection and vaccination in humans. We accomplished this by characterizing monoclonal antibodies (mAbs) from plasmablasts, which are predominantly derived from preexisting memory B cells. We found that, whereas some influenza infection-induced mAbs bound conserved and neutralizing epitopes on the hemagglutinin (HA) stalk domain or neuraminidase, most of the mAbs elicited by infection targeted non-neutralizing epitopes on nucleoprotein and other unknown antigens. Furthermore, most infection-induced mAbs had equal or stronger affinity to childhood strains, indicating recall of memory B cells from childhood exposures. Vaccination-induced mAbs were similarly induced from past exposures and exhibited substantial breadth of viral binding, although, in contrast to infection-induced mAbs, they targeted neutralizing HA head epitopes. Last, cocktails of infection-induced mAbs displayed reduced protective ability in mice compared to vaccination-induced mAbs. These findings reveal that both preexisting immunity and exposure type shape protective antibody responses to conserved influenza virus epitopes in humans. Natural infection largely recalls cross-reactive memory B cells against non-neutralizing epitopes, whereas vaccination harnesses preexisting immunity to target protective HA epitopes.},
  langid = {english},
  pmcid = {PMC8115023},
  pmid = {33298562},
  keywords = {Adult,Animals,Antibodies Neutralizing,Antibodies Viral,Hemagglutinin Glycoproteins Influenza Virus,Humans,Influenza Human,Influenza Vaccines,Mice,Orthomyxoviridae,Orthomyxoviridae Infections,Vaccination},
  file = {C:\Users\Zane\Zotero\storage\AAGPHD9G\Dugan et al. - 2020 - Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccina.pdf}
}

@article{einav2022,
  title = {Extrapolating Missing Antibody-Virus Measurements across Serological Studies},
  author = {Einav, Tal and Cleary, Brian},
  year = {2022},
  month = jul,
  journal = {Cell Systems},
  volume = {13},
  number = {7},
  pages = {561-573.e5},
  issn = {2405-4720},
  doi = {10.1016/j.cels.2022.06.001},
  abstract = {The development of new vaccines, as well as our understanding of key processes that shape viral evolution and host antibody repertoires, relies on measuring multiple antibody responses against large panels of viruses. Given the enormous diversity of circulating virus strains and antibody responses, comprehensively testing all antibody-virus interactions is infeasible. Even within individual studies with limited panels, exhaustive testing is not always performed, and there is no common framework for combining information across studies with partially overlapping panels, especially when the assay type or host species differ. Prior studies have demonstrated that antibody-virus interactions can be characterized in a vastly simpler and lower dimensional space, suggesting that relatively few measurements could predict unmeasured antibody-virus interactions. Here, we apply matrix completion to several large-scale influenza and HIV-1 studies. We explore how prediction accuracy evolves as the number of measurements changes and approximates the number of additional measurements necessary in several highly incomplete datasets (suggesting {$\sim$}250,000 measurements could be saved). In addition, we show how the method can combine disparate datasets, even when the number of available measurements is below the theoretical limit that guarantees successful prediction. This approach can be readily generalized to other viruses or more broadly to other low-dimensional biological datasets.},
  langid = {english},
  pmid = {35798005},
  keywords = {Antibodies Viral,antibody-virus interactions,hemagglutination inhibition,HIV-1,Humans,imputation,influenza,Influenza Human,Influenza Vaccines,matrix completion,nuclear norm minimization,serology,Viruses},
  file = {C:\Users\Zane\Zotero\storage\TAZ35EWS\Einav and Cleary - 2022 - Extrapolating missing antibody-virus measurements .pdf}
}

@article{einav2023,
  title = {Harnessing Low Dimensionality to Visualize the Antibody--Virus Landscape for Influenza},
  author = {Einav, Tal and Creanga, Adrian and Andrews, Sarah F. and McDermott, Adrian B. and Kanekiyo, Masaru},
  year = {2023},
  month = feb,
  journal = {Nature Computational Science},
  volume = {3},
  number = {2},
  pages = {164--173},
  publisher = {Nature Publishing Group},
  issn = {2662-8457},
  doi = {10.1038/s43588-022-00375-1},
  urldate = {2024-01-09},
  abstract = {Antibodies constitute a key line of defense against the diverse pathogens we encounter in our lives. Although the interactions between a single antibody and a single virus are routinely characterized in exquisite detail, the inherent tradeoffs between attributes such as potency and breadth remain unclear. Moreover, there is a wide gap between the discrete interactions of single antibodies and the collective behavior of antibody mixtures. Here we develop a form of antigenic cartography called a `neutralization landscape' that visualizes and quantifies antibody--virus interactions for antibodies targeting the influenza hemagglutinin stem. This landscape transforms the potency--breadth tradeoff into a readily solvable geometry problem. With it, we decompose the collective neutralization from multiple antibodies to characterize the composition and functional properties of the stem antibodies within. Looking forward, this framework can leverage the serological assays routinely performed for influenza surveillance to analyze how an individual's antibody repertoire evolves after vaccination or infection.},
  copyright = {2022 The Author(s)},
  langid = {english},
  keywords = {Antibodies,Computational models,Influenza virus},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\VKYP5UF5\\Einav et al. - 2023 - Harnessing low dimensionality to visualize the ant.pdf;C\:\\Users\\Zane\\Zotero\\storage\\XYGAKKJ7\\supplement.pdf}
}

@article{elbe2017,
  title = {Data, Disease and Diplomacy: {{GISAID}}'s Innovative Contribution to Global Health},
  shorttitle = {Data, Disease and Diplomacy},
  author = {Elbe, Stefan and {Buckland-Merrett}, Gemma},
  year = {2017},
  journal = {Global Challenges},
  volume = {1},
  number = {1},
  pages = {33--46},
  issn = {2056-6646},
  doi = {10.1002/gch2.1018},
  urldate = {2025-06-09},
  abstract = {The international sharing of virus data is critical for protecting populations against lethal infectious disease outbreaks. Scientists must rapidly share information to assess the nature of the threat and develop new medical countermeasures. Governments need the data to trace the extent of the outbreak, initiate public health responses, and coordinate access to medicines and vaccines. Recent outbreaks suggest, however, that the sharing of such data cannot be taken for granted -- making the timely international exchange of virus data a vital global challenge. This article undertakes the first analysis of the Global Initiative on Sharing All Influenza Data as an innovative policy effort to promote the international sharing of genetic and associated influenza virus data. Based on more than 20 semi-structured interviews conducted with key informants in the international community, coupled with analysis of a wide range of primary and secondary sources, the article finds that the Global Initiative on Sharing All Influenza Data contributes to global health in at least five ways: (1) collating the most complete repository of high-quality influenza data in the world; (2) facilitating the rapid sharing of potentially pandemic virus information during recent outbreaks; (3) supporting the World Health Organization's biannual seasonal flu vaccine strain selection process; (4) developing informal mechanisms for conflict resolution around the sharing of virus data; and (5) building greater trust with several countries key to global pandemic preparedness.},
  copyright = {{\copyright}2017 The Authors. Global Challenges published by John Wiley \& Sons Ltd.},
  langid = {english},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\AL42CYE3\\Elbe and Buckland-Merrett - 2017 - Data, disease and diplomacy GISAID's innovative c.pdf;C\:\\Users\\Zane\\Zotero\\storage\\UGYY83F9\\Elbe and Buckland-Merrett - 2017 - Data, disease and diplomacy GISAID's innovative contribution to global health.pdf;C\:\\Users\\Zane\\Zotero\\storage\\C9HNY4SP\\gch2.html}
}

@article{erbelding2018,
  title = {A {{Universal Influenza Vaccine}}: {{The Strategic Plan}} for the {{National Institute}} of {{Allergy}} and {{Infectious Diseases}}},
  shorttitle = {A {{Universal Influenza Vaccine}}},
  author = {Erbelding, Emily J. and Post, Diane J. and Stemmy, Erik J. and Roberts, Paul C. and Augustine, Alison Deckhut and Ferguson, Stacy and Paules, Catharine I. and Graham, Barney S. and Fauci, Anthony S.},
  year = {2018},
  month = jul,
  journal = {The Journal of Infectious Diseases},
  volume = {218},
  number = {3},
  pages = {347--354},
  issn = {1537-6613},
  doi = {10.1093/infdis/jiy103},
  abstract = {A priority for the National Institute of Allergy and Infectious Diseases is development of a universal influenza vaccine providing durable protection against multiple influenza strains. NIAID will use this strategic plan as a foundation for future investments in influenza research.},
  langid = {english},
  pmcid = {PMC6279170},
  pmid = {29506129},
  keywords = {Animals,Biomedical Research,Humans,Influenza Human,Influenza Vaccines,National Institute of Allergy and Infectious Diseases (U.S.),United States,Zoonoses},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\5G6BRTZA\\Erbelding et al. - 2018 - A Universal Influenza Vaccine The Strategic Plan .pdf;C\:\\Users\\Zane\\Zotero\\storage\\38DCKL34\\4904047.html}
}

@article{estrada2019,
  title = {Development of a {{Universal Influenza Vaccine}}},
  author = {Estrada, Leonardo D. and {Schultz-Cherry}, Stacey},
  year = {2019},
  month = jan,
  journal = {Journal of immunology (Baltimore, Md. : 1950)},
  volume = {202},
  number = {2},
  pages = {392--398},
  issn = {0022-1767},
  doi = {10.4049/jimmunol.1801054},
  urldate = {2025-02-03},
  abstract = {The severity of the 2017 -- 2018 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our current seasonal influenza vaccine. Thus, the National Institute of Allergy and Infectious Diseases (NIAID) recently announced a strategic plan to improve current influenza vaccines and eventually develop a ``universal'' influenza vaccine. This review will highlight the many different strategies being undertaken in pursuit of this goal and the exciting advances made by the influenza community. There is no doubt that an improved influenza vaccine is on the horizon.},
  langid = {english},
  pmcid = {PMC6327971},
  pmid = {30617121},
  keywords = {Humans,Influenza A virus,Influenza Human,Influenza Vaccines,Mass Vaccination,National Institute of Allergy and Infectious Diseases (U.S.),Quality Improvement,United States},
  file = {C:\Users\Zane\Zotero\storage\8UVSPMSV\Estrada and Schultz-Cherry - 2019 - Development of a Universal Influenza Vaccine.pdf}
}

@misc{figgins2024,
  title = {Frequency Dynamics Predict Viral Fitness, Antigenic Relationships and Epidemic Growth},
  author = {Figgins, Marlin D. and Bedford, Trevor},
  year = {2024},
  month = dec,
  pages = {2024.12.02.24318334},
  publisher = {medRxiv},
  doi = {10.1101/2024.12.02.24318334},
  urldate = {2025-02-20},
  abstract = {During the COVID-19 pandemic, SARS-CoV-2 variants drove large waves of infections, fueled by increased transmissibility and immune escape. Current models focus on changes in variant frequencies without linking them to underlying transmission mechanisms of intrinsic transmissibility and immune escape. We introduce a framework connecting variant dynamics to these mechanisms, showing how host population immunity interacts with viral transmissibility and immune escape to determine relative variant fitness. We advance a selective pressure metric that provides an early signal of epidemic growth using genetic data alone, crucial with current underreporting of cases. Additionally, we show that a latent immunity space model approximates immunological distances, offering insights into population susceptibility and immune evasion. These insights refine real-time forecasting and lay the groundwork for research into the interplay between viral genetics, immunity, and epidemic growth.},
  archiveprefix = {medRxiv},
  copyright = {{\copyright} 2024, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\JH9NET2B\Figgins and Bedford - 2024 - Frequency dynamics predict viral fitness, antigenic relationships and epidemic growth.pdf}
}

@article{fonville2014,
  title = {Antibody Landscapes after Influenza Virus Infection or Vaccination},
  author = {Fonville, J. M. and Wilks, S. H. and James, S. L. and Fox, A. and Ventresca, M. and Aban, M. and Xue, L. and Jones, T. C. and Le, N. M. H. and Pham, Q. T. and Tran, N. D. and Wong, Y. and Mosterin, A. and Katzelnick, L. C. and Labonte, D. and Le, T. T. and {van der Net}, G. and Skepner, E. and Russell, C. A. and Kaplan, T. D. and Rimmelzwaan, G. F. and Masurel, N. and {de Jong}, J. C. and Palache, A. and Beyer, W. E. P. and Le, Q. M. and Nguyen, T. H. and Wertheim, H. F. L. and Hurt, A. C. and Osterhaus, A. D. M. E. and Barr, I. G. and Fouchier, R. a. M. and Horby, P. W. and Smith, D. J.},
  year = {2014},
  month = nov,
  journal = {Science (New York, N.Y.)},
  volume = {346},
  number = {6212},
  pages = {996--1000},
  issn = {1095-9203},
  doi = {10.1126/science.1256427},
  abstract = {We introduce the antibody landscape, a method for the quantitative analysis of antibody-mediated immunity to antigenically variable pathogens, achieved by accounting for antigenic variation among pathogen strains. We generated antibody landscapes to study immune profiles covering 43 years of influenza A/H3N2 virus evolution for 69 individuals monitored for infection over 6 years and for 225 individuals pre- and postvaccination. Upon infection and vaccination, titers increased broadly, including previously encountered viruses far beyond the extent of cross-reactivity observed after a primary infection. We explored implications for vaccination and found that the use of an antigenically advanced virus had the dual benefit of inducing antibodies against both advanced and previous antigenic clusters. These results indicate that preemptive vaccine updates may improve influenza vaccine efficacy in previously exposed individuals.},
  langid = {english},
  pmcid = {PMC4246172},
  pmid = {25414313},
  keywords = {Antibodies Viral,Antigenic Variation,Evolution Molecular,Humans,Influenza A Virus H3N2 Subtype,Influenza Human,Influenza Vaccines,Vaccination},
  file = {C:\Users\Zane\Zotero\storage\7ZW32CZ5\Fonville et al. - 2014 - Antibody landscapes after influenza virus infection or vaccination.pdf}
}

@article{forghani2020,
  title = {Convolutional {{Neural Network Based Approach}} to {{In Silico Non-Anticipating Prediction}} of {{Antigenic Distance}} for {{Influenza Virus}}},
  author = {Forghani, Majid and Khachay, Michael},
  year = {2020},
  month = sep,
  journal = {Viruses},
  volume = {12},
  number = {9},
  pages = {1019},
  publisher = {Multidisciplinary Digital Publishing Institute},
  issn = {1999-4915},
  doi = {10.3390/v12091019},
  urldate = {2025-02-04},
  abstract = {Evaluation of the antigenic similarity degree between the strains of the influenza virus is highly important for vaccine production. The conventional method used to measure such a degree is related to performing the immunological assays of hemagglutinin inhibition. Namely, the antigenic distance between two strains is calculated on the basis of HI assays. Usually, such distances are visualized by using some kind of antigenic cartography method. The known drawback of the HI assay is that it is rather time-consuming and expensive. In this paper, we propose a novel approach for antigenic distance approximation based on deep learning in the feature spaces induced by hemagglutinin protein sequences and Convolutional Neural Networks (CNNs). To apply a CNN to compare the protein sequences, we utilize the encoding based on the physical and chemical characteristics of amino acids. By varying (hyper)parameters of the CNN architecture design, we find the most robust network. Further, we provide insight into the relationship between approximated antigenic distance and antigenicity by evaluating the network on the HI assay database for the H1N1 subtype. The results indicate that the best-trained network gives a high-precision approximation for the ground-truth antigenic distances, and can be used as a good exploratory tool in practical tasks.},
  copyright = {http://creativecommons.org/licenses/by/3.0/},
  langid = {english},
  keywords = {*Computer Simulation,*Neural Networks Computer,Amino Acid Sequence,antigenic distance,Antigens Viral,Antigens Viral/immunology,Computer Simulation,convolutional neural network,evolution,Hemagglutinin Glycoproteins Influenza Virus,Hemagglutinin Glycoproteins Influenza Virus/immunology,Humans,influenza,Influenza A Virus H1N1 Subtype,Influenza A Virus H1N1 Subtype/immunology,Influenza Human,Influenza Human/*immunology/virology,Neural Networks Computer,Orthomyxoviridae,vaccine},
  file = {C:\Users\Zane\Zotero\storage\4VLDDFW7\Forghani and Khachay - 2020 - Convolutional Neural Network Based Approach to In Silico Non-Anticipating Prediction of Antigenic Di.pdf}
}

@article{forna2024,
  title = {Sequence-Based Detection of Emerging Antigenically Novel Influenza {{A}} Viruses},
  author = {Forna, Alpha and Weedop, K. Bodie and Damodaran, Lambodhar and Hassell, Norman and Kondor, Rebecca and Bahl, Justin and Drake, John M. and Rohani, Pejman},
  year = {2024},
  month = aug,
  journal = {Proceedings of the Royal Society B: Biological Sciences},
  volume = {291},
  number = {2028},
  pages = {20240790},
  publisher = {Royal Society},
  doi = {10.1098/rspb.2024.0790},
  urldate = {2024-08-16},
  abstract = {The detection of evolutionary transitions in influenza A (H3N2) viruses' antigenicity is a major obstacle to effective vaccine design and development. In this study, we describe Novel Influenza Virus A Detector (NIAViD), an unsupervised machine learning tool, adept at identifying these transitions, using the HA1 sequence and associated physico-chemical properties. NIAViD performed with 88.9\% (95\% CI, 56.5--98.0\%) and 72.7\% (95\% CI, 43.4--90.3\%) sensitivity in training and validation, respectively, outperforming the uncalibrated null model---33.3\% (95\% CI, 12.1--64.6\%) and does not require potentially biased, time-consuming and costly laboratory assays. The pivotal role of the Boman's index, indicative of the virus's cell surface binding potential, is underscored, enhancing the precision of detecting antigenic transitions. NIAViD's efficacy is not only in identifying influenza isolates that belong to novel antigenic clusters, but also in pinpointing potential sites driving significant antigenic changes, without the reliance on explicit modelling of haemagglutinin inhibition titres. We believe this approach holds promise to augment existing surveillance networks, offering timely insights for the development of updated, effective influenza vaccines. Consequently, NIAViD, in conjunction with other resources, could be used to support surveillance efforts and inform the development of updated influenza vaccines.},
  keywords = {antigenic transition,infectious disease forecasting,influenza virus,unsupervised machine learning,viral evolution},
  file = {C:\Users\Zane\Zotero\storage\I8LWZT87\Forna et al. - 2024 - Sequence-based detection of emerging antigenically novel influenza A viruses.pdf}
}

@article{fox2023,
  title = {Drift and Shape-New Insights into Human Immunity against Influenza Virus Neuraminidase},
  author = {Fox, Annette},
  year = {2023},
  month = dec,
  journal = {MBIO},
  volume = {14},
  number = {6},
  publisher = {Amer Soc Microbiology},
  address = {Washington},
  issn = {2150-7511},
  doi = {10.1128/mbio.01654-23},
  urldate = {2025-02-20},
  abstract = {Influenza virus hemagglutinin mediates infection by binding sialic acids, whereas neuraminidase cleaves sialic acids to release progeny virions. Both are targets of protective antibodies, but influenza vaccine strain selection and antigen dose are based on hemagglutinin alone. Virus characterization using first infection ferret sera indicates that escape from hemagglutination inhibiting (HI) antibodies occurs more frequently and is not coordinated with escape from neuraminidase inhibiting (NI) antibodies. A key question addressed by Daulagala et al. (P. Daulagala, B. R. Mann, K. Leung, E. H. Y. Lau, et al., mBio 14:e00084-23, 2023, https://doi.org/10.1128/mbio.00084-23) is how this translates to humans who encounter multiple influenza viruses throughout life. Their cross-sectional study, using sera from a wide age range of participants and H1N1 viruses spanning 1977-2015, indicates that NI antibodies are more broadly cross-reactive than HI antibodies. Both HI and NI titers were highest against strains encountered in childhood indicating that both are shaped by priming exposures. The study further supports the development of NA-optimized vaccines.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001100807600001},
  file = {C:\Users\Zane\Zotero\storage\UYFB6THL\Fox - 2023 - Drift and shape-new insights into human immunity against influenza virus neuraminidase.pdf}
}

@article{gambaryan1999,
  title = {Effects of {{Egg-Adaptation}} on the {{Receptor-Binding Properties}} of {{Human Influenza A}} and {{B Viruses}}},
  author = {Gambaryan, A. S. and Robertson, J. S. and Matrosovich, M. N.},
  year = {1999},
  month = jun,
  journal = {Virology},
  volume = {258},
  number = {2},
  pages = {232--239},
  issn = {0042-6822},
  doi = {10.1006/viro.1999.9732},
  urldate = {2025-02-26},
  abstract = {Propagation of human influenza viruses in embryonated chicken eggs (CE) results in the selection of variants with amino acid substitutions near the receptor-binding site of the hemagglutinin (HA) molecule. To evaluate the mechanisms by which these substitutions enable human virus growth in CE, we studied the binding of 10 human influenza A (H1N1, H3N2) and B strains, isolated and propagated solely in MDCK cells, and of their egg-adapted counterparts to preparations of cellular membranes, gangliosides, sialylglycoproteins, and sialyloligosaccharides. All egg-adapted variants differed from nonadapted strains by increased binding to the plasma membranes of chorio-allantoic (CAM) cells of CE and by the ability to bind to CAM gangliosides. In addition, there was no decrease in affinity for inhibitors within allantoic fluid. These findings indicate that growth of human influenza viruses in CE is restricted because of their inefficient binding to receptors on CAM cells and that gangliosides can play an important role in virus binding and/or penetration. The effects of the egg-adaptation substitutions on the receptor-binding properties of the viruses include (i) enhancement of virus binding to the terminal Sia({$\alpha$}2--3)Gal determinant (substitutions in HA positions 190, 225 of H1N1 strains and in position 186 of H3N2 strains); (ii) a decrease of steric interference with more distant parts of the Sia({$\alpha$}2--3Gal)-containing receptors (a loss of glycosylation sites in positions 163 of H1 HA and 187 of type B HA); and (iii) enhanced ionic interactions with the negatively charged molecules due to charged substitutions at the tip of the HA [187, 189, 190 (H1), and 145, 156 (H3)]. Concomitantly with enhanced binding to Sia({$\alpha$}2--3)Gal-terminated receptors, all egg-adapted variants decreased their affinity for equine macroglobulin, a glycoprotein bearing terminal 6{$\prime$}-sialyl(N-acetyllactosamine)-moieties.},
  file = {C:\Users\Zane\Zotero\storage\UACH797I\Gambaryan et al. - 1999 - Effects of Egg-Adaptation on the Receptor-Binding Properties of Human Influenza A and B Viruses.pdf}
}

@article{garten2009,
  title = {Antigenic and Genetic Characteristics of Swine-Origin 2009 {{A}}({{H1N1}}) Influenza Viruses Circulating in Humans},
  author = {Garten, Rebecca J. and Davis, C. Todd and Russell, Colin A. and Shu, Bo and Lindstrom, Stephen and Balish, Amanda and Sessions, Wendy M. and Xu, Xiyan and Skepner, Eugene and Deyde, Varough and {Okomo-Adhiambo}, Margaret and Gubareva, Larisa and Barnes, John and Smith, Catherine B. and Emery, Shannon L. and Hillman, Michael J. and Rivailler, Pierre and Smagala, James and {de Graaf}, Miranda and Burke, David F. and Fouchier, Ron A. M. and Pappas, Claudia and {Alpuche-Aranda}, Celia M. and {L{\'o}pez-Gatell}, Hugo and Olivera, Hiram and L{\'o}pez, Irma and Myers, Christopher A. and Faix, Dennis and Blair, Patrick J. and Yu, Cindy and Keene, Kimberly M. and Dotson, P. David and Boxrud, David and Sambol, Anthony R. and Abid, Syed H. and St George, Kirsten and Bannerman, Tammy and Moore, Amanda L. and Stringer, David J. and Blevins, Patricia and {Demmler-Harrison}, Gail J. and Ginsberg, Michele and Kriner, Paula and Waterman, Steve and Smole, Sandra and Guevara, Hugo F. and Belongia, Edward A. and Clark, Patricia A. and Beatrice, Sara T. and Donis, Ruben and Katz, Jacqueline and Finelli, Lyn and Bridges, Carolyn B. and Shaw, Michael and Jernigan, Daniel B. and Uyeki, Timothy M. and Smith, Derek J. and Klimov, Alexander I. and Cox, Nancy J.},
  year = {2009},
  month = jul,
  journal = {Science (New York, N.Y.)},
  volume = {325},
  number = {5937},
  pages = {197--201},
  issn = {1095-9203},
  doi = {10.1126/science.1176225},
  abstract = {Since its identification in April 2009, an A(H1N1) virus containing a unique combination of gene segments from both North American and Eurasian swine lineages has continued to circulate in humans. The lack of similarity between the 2009 A(H1N1) virus and its nearest relatives indicates that its gene segments have been circulating undetected for an extended period. Its low genetic diversity suggests that the introduction into humans was a single event or multiple events of similar viruses. Molecular markers predictive of adaptation to humans are not currently present in 2009 A(H1N1) viruses, suggesting that previously unrecognized molecular determinants could be responsible for the transmission among humans. Antigenically the viruses are homogeneous and similar to North American swine A(H1N1) viruses but distinct from seasonal human A(H1N1).},
  langid = {english},
  pmcid = {PMC3250984},
  pmid = {19465683},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\7JX35LHH\\Garten et al. - 2009 - Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in.pdf;C\:\\Users\\Zane\\Zotero\\storage\\HVHBJTZ2\\Garten et al. - 2009 - Antigenic and genetic characteristics of swine-ori.pdf}
}

@book{gelman,
  title = {Regression and {{Other Stories}}},
  author = {Gelman, Andrew and Hill, Jennifer and Vehtari, Aki},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\YMH82VP4\Gelman et al. - Regression and Other Stories.pdf}
}

@book{gelman2007,
  title = {Data Analysis Using Regression and Multilevel/Hierarchical Models},
  author = {Gelman, Andrew and Hill, Jennifer},
  year = {2007},
  series = {Analytical Methods for Social Research},
  publisher = {Cambridge University Press},
  address = {Cambridge ; New York},
  isbn = {978-0-521-86706-1 978-0-521-68689-1},
  lccn = {HA31.3 .G45 2007},
  keywords = {/unread,Multilevel models (Statistics),Regression analysis},
  annotation = {OCLC: ocm67375137},
  file = {C:\Users\Zane\Zotero\storage\QATQWBHS\Data Analysis Using Regression - Unknown.pdf}
}

@misc{gelman2020,
  title = {Bayesian {{Workflow}}},
  author = {Gelman, Andrew and Vehtari, Aki and Simpson, Daniel and Margossian, Charles C. and Carpenter, Bob and Yao, Yuling and Kennedy, Lauren and Gabry, Jonah and B{\"u}rkner, Paul-Christian and Modr{\'a}k, Martin},
  year = {2020},
  month = nov,
  number = {arXiv:2011.01808},
  eprint = {2011.01808},
  primaryclass = {stat},
  publisher = {arXiv},
  doi = {10.48550/arXiv.2011.01808},
  urldate = {2025-04-15},
  abstract = {The Bayesian approach to data analysis provides a powerful way to handle uncertainty in all observations, model parameters, and model structure using probability theory. Probabilistic programming languages make it easier to specify and fit Bayesian models, but this still leaves us with many options regarding constructing, evaluating, and using these models, along with many remaining challenges in computation. Using Bayesian inference to solve real-world problems requires not only statistical skills, subject matter knowledge, and programming, but also awareness of the decisions made in the process of data analysis. All of these aspects can be understood as part of a tangled workflow of applied Bayesian statistics. Beyond inference, the workflow also includes iterative model building, model checking, validation and troubleshooting of computational problems, model understanding, and model comparison. We review all these aspects of workflow in the context of several examples, keeping in mind that in practice we will be fitting many models for any given problem, even if only a subset of them will ultimately be relevant for our conclusions.},
  archiveprefix = {arXiv},
  keywords = {Statistics - Methodology},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\C784GTSW\\Gelman et al. - 2020 - Bayesian Workflow.pdf;C\:\\Users\\Zane\\Zotero\\storage\\SMBY87UR\\Gelman et al. - 2020 - Bayesian Workflow.pdf;C\:\\Users\\Zane\\Zotero\\storage\\KZK9XYMM\\2011.html;C\:\\Users\\Zane\\Zotero\\storage\\XR5FJ6KA\\2011.html}
}

@misc{genbank,
  title = {{{GenBank}}},
  author = {{National Library of Medicine (US), National Center for Biotechnology Information}},
  year = {1982},
  address = {Bethesda, MD}
}

@article{ggdist1,
  title = {{{ggdist}}: {{Visualizations}} of Distributions and Uncertainty in the Grammar of Graphics},
  author = {Kay, Matthew},
  year = {2024},
  journal = {IEEE Transactions on Visualization and Computer Graphics},
  volume = {30},
  number = {1},
  pages = {414--424},
  doi = {10.1109/TVCG.2023.3327195}
}

@manual{ggdist2,
  type = {Manual},
  title = {{{ggdist}}: {{Visualizations}} of Distributions and Uncertainty},
  author = {Kay, Matthew},
  year = {2024},
  doi = {10.5281/zenodo.3879620}
}

@misc{glatt-holtz2024,
  title = {Sacred and {{Profane}}: From the {{Involutive Theory}} of {{MCMC}} to {{Helpful Hamiltonian Hacks}}},
  shorttitle = {Sacred and {{Profane}}},
  author = {{Glatt-Holtz}, Nathan E. and Holbrook, Andrew J. and Krometis, Justin A. and Mondaini, Cecilia F. and Sheth, Ami},
  year = {2024},
  month = oct,
  number = {arXiv:2410.17398},
  eprint = {2410.17398},
  primaryclass = {stat},
  publisher = {arXiv},
  doi = {10.48550/arXiv.2410.17398},
  urldate = {2025-02-20},
  abstract = {In the first edition of this Handbook, two remarkable chapters consider seemingly distinct yet deeply connected subjects ...},
  archiveprefix = {arXiv},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\HZBEW4KD\\Glatt-Holtz et al. - 2024 - Sacred and Profane from the Involutive Theory of MCMC to Helpful Hamiltonian Hacks.pdf;C\:\\Users\\Zane\\Zotero\\storage\\93HPZCEC\\2410.html}
}

@article{gostic2016,
  title = {Potent Protection against {{H5N1}} and {{H7N9}} Influenza via Childhood Hemagglutinin Imprinting},
  author = {Gostic, Katelyn M. and Ambrose, Monique and Worobey, Michael and {Lloyd-Smith}, James O.},
  year = {2016},
  month = nov,
  journal = {Science},
  volume = {354},
  number = {6313},
  pages = {722--726},
  publisher = {American Association for the Advancement of Science},
  issn = {0036-8075, 1095-9203},
  doi = {10.1126/science.aag1322},
  urldate = {2021-06-22},
  abstract = {{$<$}p{$>$}Two zoonotic influenza A viruses (IAV) of global concern, H5N1 and H7N9, exhibit unexplained differences in age distribution of human cases. Using data from all known human cases of these viruses, we show that an individual's first IAV infection confers lifelong protection against severe disease from novel hemagglutinin (HA) subtypes in the same phylogenetic group. Statistical modeling shows that protective HA imprinting is the crucial explanatory factor, and it provides 75\% protection against severe infection and 80\% protection against death for both H5N1 and H7N9. Our results enable us to predict age distributions of severe disease for future pandemics and demonstrate that a novel strain's pandemic potential increases yearly when a group-mismatched HA subtype dominates seasonal influenza circulation. These findings open new frontiers for rational pandemic risk assessment.{$<$}/p{$>$}},
  chapter = {Research Article},
  copyright = {Copyright {\copyright} 2016, American Association for the Advancement of Science},
  langid = {english},
  pmid = {27846599},
  file = {C:\Users\Zane\Zotero\storage\IQTTNLZ5\Gostic et al. - 2016 - Potent protection against H5N1 and H7N9 influenza .pdf}
}

@article{grantham1974,
  title = {Amino {{Acid Difference Formula}} to {{Help Explain Protein Evolution}}},
  author = {Grantham, R.},
  year = {1974},
  month = sep,
  journal = {Science},
  volume = {185},
  number = {4154},
  pages = {862--864},
  publisher = {American Association for the Advancement of Science},
  issn = {0036-8075},
  doi = {10.1126/science.185.4154.862},
  urldate = {2025-02-03},
  abstract = {A formula for difference between amino acids combines properties that correlate best with protein residue substitution frequencies: composition, polarity, and molecular volume. Substitution frequencies agree much better with overall chemical difference between exchanging residues than with minimum base changes between their codons. Correlation coefficients show that fixation of mutations between dissimilar amino acids is generally rare.},
  langid = {english},
  keywords = {Amino Acids,Biological Evolution,Genetic Code,Mathematics,Models Biological,Mutation,Protein Biosynthesis,Protein Conformation,RNA Messenger},
  file = {C:\Users\Zane\Zotero\storage\Y6YGGFC6\Grantham - 1974 - Amino Acid Difference Formula to Help Explain Protein Evolution.pdf}
}

@article{gupta2006,
  title = {Quantifying Influenza Vaccine Efficacy and Antigenic Distance},
  author = {Gupta, Vishal and Earl, David J. and Deem, Michael W.},
  year = {2006},
  month = may,
  journal = {Vaccine},
  series = {3rd {{International Conference}} on {{Vaccines}} for {{Enteric Diseases}}},
  volume = {24},
  number = {18},
  pages = {3881--3888},
  issn = {0264-410X},
  doi = {10.1016/j.vaccine.2006.01.010},
  urldate = {2024-08-13},
  abstract = {We introduce a new measure of antigenic distance between influenza A vaccine and circulating strains. The measure correlates well with efficacies of the H3N2 influenza A component of the annual vaccine between 1971 and 2004, as do results of a theory of the immune response to influenza following vaccination. This new measure of antigenic distance is correlated with vaccine efficacy to a greater degree than are current state of the art phylogenetic sequence analyses or ferret antisera inhibition assays. We suggest that this new measure of antigenic distance be used in the design of the annual influenza vaccine and in the interpretation of vaccine efficacy monitoring.},
  keywords = {Antigenic distance,Influenza,Original antigenic sin},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\E4RMF9KD\\Gupta et al. - 2006 - Quantifying influenza vaccine efficacy and antigenic distance.pdf;C\:\\Users\\Zane\\Zotero\\storage\\NX4B8UUF\\S0264410X06000041.html}
}

@article{hamming1950,
  title = {Error Detecting and Error Correcting Codes},
  author = {Hamming, R. W.},
  year = {1950},
  month = apr,
  journal = {The Bell System Technical Journal},
  volume = {29},
  number = {2},
  pages = {147--160},
  issn = {0005-8580},
  doi = {10.1002/j.1538-7305.1950.tb00463.x},
  urldate = {2025-04-02},
  abstract = {The author was led to the study given in this paper from a consideration of large scale computing machines in which a large number of operations must be performed without a single error in the end result. This problem of ``doing things right'' on a large scale is not essentially new; in a telephone central office, for example, a very large number of operations are performed while the errors leading to wrong numbers are kept well under control, though they have not been completely eliminated. This has been achieved, in part, through the use of self-checking circuits. The occasional failure that escapes routine checking is still detected by the customer and will, if it persists, result in customer complaint, while if it is transient it will produce only occasional wrong numbers. At the same time the rest of the central office functions satisfactorily. In a digital computer, on the other hand, a single failure usually means the complete failure, in the sense that if it is detected no more computing can be done until the failure is located and corrected, while if it escapes detection then it invalidates all subsequent operations of the machine. Put in other words, in a telephone central office there are a number of parallel paths which are more or less independent of each other; in a digital machine there is usually a single long path which passes through the same piece of equipment many, many times before the answer is obtained.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\99TINYUH\\Hamming - 1950 - Error detecting and error correcting codes.pdf;C\:\\Users\\Zane\\Zotero\\storage\\A5IKJIA5\\6772729.html}
}

@article{han2019,
  title = {Graph-Guided Multi-Task Sparse Learning Model: A Method for Identifying Antigenic Variants of Influenza {{A}}({{H3N2}}) Virus},
  shorttitle = {Graph-Guided Multi-Task Sparse Learning Model},
  author = {Han, Lei and Li, Lei and Wen, Feng and Zhong, Lei and Zhang, Tong and Wan, Xiu-Feng},
  year = {2019},
  month = jan,
  journal = {Bioinformatics},
  volume = {35},
  number = {1},
  pages = {77--87},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/bty457},
  urldate = {2025-02-26},
  abstract = {Influenza virus antigenic variants continue to emerge and cause disease outbreaks. Time-consuming, costly and middle-throughput serologic methods using virus isolates are routinely used to identify influenza antigenic variants for vaccine strain selection. However, the resulting data are notoriously noisy and difficult to interpret and integrate because of variations in reagents, supplies and protocol implementation. A novel method without such limitations is needed for antigenic variant identification.We developed a Graph-Guided Multi-Task Sparse Learning (GG-MTSL) model that uses multi-sourced serologic data to learn antigenicity-associated mutations and infer antigenic variants. By applying GG-MTSL to influenza H3N2 hemagglutinin sequences, we showed the method enables rapid characterization of antigenic profiles and identification of antigenic variants in real time and on a large scale. Furthermore, sequences can be generated directly by using clinical samples, thus minimizing biases due to culture-adapted mutation during virus isolation.MATLAB source codes developed for GG-MTSL are available through http://sysbio.cvm.msstate.edu/files/GG-MTSL/.Supplementary data are available at Bioinformatics online.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\H7PNRZFF\\Han et al. - 2019 - Graph-guided multi-task sparse learning model a method for identifying antigenic variants of influe.pdf;C\:\\Users\\Zane\\Zotero\\storage\\6WS874QT\\5034430.html}
}

@article{harvey2016,
  title = {Identification of {{Low-}} and {{High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift}} of {{Influenza A}}({{H1N1}}) {{Viruses}}},
  author = {Harvey, William T. and Benton, Donald J. and Gregory, Victoria and Hall, James P. J. and Daniels, Rodney S. and Bedford, Trevor and Haydon, Daniel T. and Hay, Alan J. and McCauley, John W. and Reeve, Richard},
  year = {2016},
  month = apr,
  journal = {PLoS pathogens},
  volume = {12},
  number = {4},
  pages = {e1005526},
  issn = {1553-7374},
  doi = {10.1371/journal.ppat.1005526},
  abstract = {Determining phenotype from genetic data is a fundamental challenge. Identification of emerging antigenic variants among circulating influenza viruses is critical to the vaccine virus selection process, with vaccine effectiveness maximized when constituents are antigenically similar to circulating viruses. Hemagglutination inhibition (HI) assay data are commonly used to assess influenza antigenicity. Here, sequence and 3-D structural information of hemagglutinin (HA) glycoproteins were analyzed together with corresponding HI assay data for former seasonal influenza A(H1N1) virus isolates (1997-2009) and reference viruses. The models developed identify and quantify the impact of eighteen amino acid substitutions on the antigenicity of HA, two of which were responsible for major transitions in antigenic phenotype. We used reverse genetics to demonstrate the causal effect on antigenicity for a subset of these substitutions. Information on the impact of substitutions allowed us to predict antigenic phenotypes of emerging viruses directly from HA gene sequence data and accuracy was doubled by including all substitutions causing antigenic changes over a model incorporating only the substitutions with the largest impact. The ability to quantify the phenotypic impact of specific amino acid substitutions should help refine emerging techniques that predict the evolution of virus populations from one year to the next, leading to stronger theoretical foundations for selection of candidate vaccine viruses. These techniques have great potential to be extended to other antigenically variable pathogens.},
  langid = {english},
  pmcid = {PMC4825936},
  pmid = {27057693},
  keywords = {Amino Acid Substitution,Animals,Antigenic Variation,Antigens Viral,Hemagglutinin Glycoproteins Influenza Virus,Humans,Influenza A Virus H1N1 Subtype,Influenza Human,Influenza Vaccines,Mice,Orthomyxoviridae Infections,Phylogeny},
  file = {C:\Users\Zane\Zotero\storage\F6NMCISV\Harvey et al. - 2016 - Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic D.pdf}
}

@article{harvey2023,
  title = {A {{Bayesian}} Approach to Incorporate Structural Data into the Mapping of Genotype to Antigenic Phenotype of Influenza {{A}}({{H3N2}}) Viruses},
  author = {Harvey, William T. and Davies, Vinny and Daniels, Rodney S. and Whittaker, Lynne and Gregory, Victoria and Hay, Alan J. and Husmeier, Dirk and McCauley, John W. and Reeve, Richard},
  year = {2023},
  month = mar,
  journal = {PLOS Computational Biology},
  volume = {19},
  number = {3},
  pages = {e1010885},
  publisher = {Public Library of Science},
  issn = {1553-7358},
  doi = {10.1371/journal.pcbi.1010885},
  urldate = {2025-02-26},
  abstract = {Surface antigens of pathogens are commonly targeted by vaccine-elicited antibodies but antigenic variability, notably in RNA viruses such as influenza, HIV and SARS-CoV-2, pose challenges for control by vaccination. For example, influenza A(H3N2) entered the human population in 1968 causing a pandemic and has since been monitored, along with other seasonal influenza viruses, for the emergence of antigenic drift variants through intensive global surveillance and laboratory characterisation. Statistical models of the relationship between genetic differences among viruses and their antigenic similarity provide useful information to inform vaccine development, though accurate identification of causative mutations is complicated by highly correlated genetic signals that arise due to the evolutionary process. Here, using a sparse hierarchical Bayesian analogue of an experimentally validated model for integrating genetic and antigenic data, we identify the genetic changes in influenza A(H3N2) virus that underpin antigenic drift. We show that incorporating protein structural data into variable selection helps resolve ambiguities arising due to correlated signals, with the proportion of variables representing haemagglutinin positions decisively included, or excluded, increased from 59.8\% to 72.4\%. The accuracy of variable selection judged by proximity to experimentally determined antigenic sites was improved simultaneously. Structure-guided variable selection thus improves confidence in the identification of genetic explanations of antigenic variation and we also show that prioritising the identification of causative mutations is not detrimental to the predictive capability of the analysis. Indeed, incorporating structural information into variable selection resulted in a model that could more accurately predict antigenic assay titres for phenotypically-uncharacterised virus from genetic sequence. Combined, these analyses have the potential to inform choices of reference viruses, the targeting of laboratory assays, and predictions of the evolutionary success of different genotypes, and can therefore be used to inform vaccine selection processes.},
  langid = {english},
  keywords = {Amino acid substitution,Antigenic variation,Antigens,Evolutionary genetics,Immune serum,Influenza viruses,Phylogenetics,Viral evolution},
  file = {C:\Users\Zane\Zotero\storage\3P877BB4\Harvey et al. - 2023 - A Bayesian approach to incorporate structural data into the mapping of genotype to antigenic phenoty.pdf}
}

@article{hay2019a,
  title = {Characterising Antibody Kinetics from Multiple Influenza Infection and Vaccination Events in Ferrets},
  author = {Hay, James A. and Laurie, Karen and White, Michael and Riley, Steven},
  year = {2019},
  month = aug,
  journal = {PLoS Computational Biology},
  volume = {15},
  number = {8},
  pages = {e1007294},
  issn = {1553-734X},
  doi = {10.1371/journal.pcbi.1007294},
  urldate = {2024-05-24},
  abstract = {The strength and breadth of an individual's antibody repertoire is an important predictor of their response to influenza infection or vaccination. Although progress has been made in understanding qualitatively how repeated exposures shape the antibody mediated immune response, quantitative understanding remains limited. We developed a set of mathematical models describing short-term antibody kinetics following influenza infection or vaccination and fit them to haemagglutination inhibition (HI) titres from 5 groups of ferrets which were exposed to different combinations of trivalent inactivated influenza vaccine (TIV with or without adjuvant), A/H3N2 priming inoculation and post-vaccination A/H1N1 inoculation. We fit models with various immunological mechanisms that have been empirically observed but have not previously been included in mathematical models of antibody landscapes, including: titre ceiling effects, antigenic seniority and exposure-type specific cross reactivity. Based on the parameter estimates of the best supported models, we describe a number of key immunological features. We found quantifiable differences in the degree of homologous and cross-reactive antibody boosting elicited by different exposure types. Infection and adjuvanted vaccination generally resulted in strong, broadly reactive responses whereas unadjuvanted vaccination resulted in a weak, narrow response. We found that the order of exposure mattered: priming with A/H3N2 improved subsequent vaccine response, and the second dose of adjuvanted vaccination resulted in substantially greater antibody boosting than the first. Either antigenic seniority or a titre ceiling effect were included in the two best fitting models, suggesting a role for a mechanism describing diminishing antibody boosting with repeated exposures. Although there was considerable uncertainty in our estimates of antibody waning parameters, our results suggest that both short and long term waning were present and would be identifiable with a larger set of experiments. These results highlight the potential use of repeat exposure animal models in revealing short-term, strain-specific immune dynamics of influenza., Despite most individuals having some preexisting immunity from past influenza infections and vaccinations, a significant proportion of the human population is infected with influenza each year. Predicting how an individual's antibody profile will change following exposure is therefore useful for evaluating which populations are at greatest risk and how effective vaccination strategies might be. However, interpretation of antibody data from humans is complicated by immunological interactions between all previous, unobserved exposures in an individual's life. We developed a mathematical model to describe short-term antibody kinetics that are important in building an individual's immune profile but are difficult to observe in human populations. We validated this model using antibody data from ferrets with known, varied infection and vaccination histories. We were able to quantify the independent contributions of various exposures and immunological mechanisms in generating observed antibody titres. These results suggest that data from experimental systems may be included in models of human antibody dynamics, which may improve predictions of vaccination strategy effectiveness and how population susceptibility changes over time.},
  pmcid = {PMC6715255},
  pmid = {31425503},
  keywords = {Antibodies,Antibody response,Cross reactivity,Ferrets,Immunologic adjuvants,Influenza,Vaccination and immunization,Vaccines},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\4A6929FG\\Hay et al. - 2019 - Characterising antibody kinetics from multiple inf.pdf;C\:\\Users\\Zane\\Zotero\\storage\\CBM27J58\\Hay et al. - 2019 - Characterising antibody kinetics from multiple inf.pdf}
}

@article{hay2020,
  title = {An Open Source Tool to Infer Epidemiological and Immunological Dynamics from Serological Data: Serosolver},
  shorttitle = {An Open Source Tool to Infer Epidemiological and Immunological Dynamics from Serological Data},
  author = {Hay, James A. and Minter, Amanda and Ainslie, Kylie E. C. and Lessler, Justin and Yang, Bingyi and Cummings, Derek A. T. and Kucharski, Adam J. and Riley, Steven},
  year = {2020},
  month = may,
  journal = {PLOS Computational Biology},
  volume = {16},
  number = {5},
  pages = {e1007840},
  publisher = {Public Library of Science},
  issn = {1553-7358},
  doi = {10.1371/journal.pcbi.1007840},
  urldate = {2023-04-04},
  abstract = {We present a flexible, open source R package designed to obtain biological and epidemiological insights from serological datasets. Characterising past exposures for multi-strain pathogens poses a specific statistical challenge: observed antibody responses measured in serological assays depend on multiple unobserved prior infections that produce cross-reactive antibody responses. We provide a general modelling framework to jointly infer infection histories and describe immune responses generated by these infections using antibody titres against current and historical strains. We do this by linking latent infection dynamics with a mechanistic model of antibody kinetics that generates expected antibody titres over time. Our aim is to provide a flexible package to identify infection histories that can be applied to a range of pathogens. We present two case studies to illustrate how our model can infer key immunological parameters, such as antibody titre boosting, waning and cross-reaction, as well as latent epidemiological processes such as attack rates and age-stratified infection risk.},
  langid = {english},
  keywords = {Antibodies,Antibody response,Antigenic variation,Epidemiology,Influenza,Pathogens,Serology,Vaccination and immunization},
  file = {C:\Users\Zane\Zotero\storage\A46BUGD3\Hay et al. - 2020 - An open source tool to infer epidemiological and i.pdf}
}

@article{hensley2009,
  title = {Hemagglutinin Receptor Binding Avidity Drives Influenza {{A}} Virus Antigenic Drift},
  author = {Hensley, Scott E. and Das, Suman R. and Bailey, Adam L. and Schmidt, Loren M. and Hickman, Heather D. and Jayaraman, Akila and Viswanathan, Karthik and Raman, Rahul and Sasisekharan, Ram and Bennink, Jack R. and Yewdell, Jonathan W.},
  year = {2009},
  month = oct,
  journal = {Science (New York, N.Y.)},
  volume = {326},
  number = {5953},
  pages = {734--736},
  issn = {1095-9203},
  doi = {10.1126/science.1178258},
  abstract = {Rapid antigenic evolution in the influenza A virus hemagglutinin precludes effective vaccination with existing vaccines. To understand this phenomenon, we passaged virus in mice immunized with influenza vaccine. Neutralizing antibodies selected mutants with single-amino acid hemagglutinin substitutions that increased virus binding to cell surface glycan receptors. Passaging these high-avidity binding mutants in na{\"i}ve mice, but not immune mice, selected for additional hemagglutinin substitutions that decreased cellular receptor binding avidity. Analyzing a panel of monoclonal antibody hemagglutinin escape mutants revealed a positive correlation between receptor binding avidity and escape from polyclonal antibodies. We propose that in response to variation in neutralizing antibody pressure between individuals, influenza A virus evolves by adjusting receptor binding avidity via amino acid substitutions throughout the hemagglutinin globular domain, many of which simultaneously alter antigenicity.},
  langid = {english},
  pmcid = {PMC2784927},
  pmid = {19900932},
  keywords = {Animals,Antibodies Neutralizing,Antibodies Viral,Antigenic Variation,Cell Line,Hemagglutinin Glycoproteins Influenza Virus,Influenza A Virus H1N1 Subtype,Influenza Vaccines,Mice,Mice Inbred BALB C,Mice Inbred C57BL,Models Immunological,Mutation,Receptors Virus,Serial Passage},
  file = {C:\Users\Zane\Zotero\storage\2LJE4ZWA\Hensley et al. - 2009 - Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift.pdf}
}

@article{hensley2014,
  title = {Challenges of Selecting Seasonal Influenza Vaccine Strains for Humans with Diverse Pre-Exposure Histories},
  author = {Hensley, Scott E},
  year = {2014},
  month = oct,
  journal = {Current Opinion in Virology},
  series = {Antivirals and Resistance / {{Virus}} Evolution},
  volume = {8},
  pages = {85--89},
  issn = {1879-6257},
  doi = {10.1016/j.coviro.2014.07.007},
  urldate = {2025-02-26},
  abstract = {Seasonal influenza vaccine strains are routinely updated when influenza viruses acquire mutations in exposed regions of the hemagglutinin and neuraminidase glycoproteins. Ironically, although thousands of viral isolates are sequenced each year, today's influenza surveillance community places less emphasis on viral genetic information and more emphasis on classical serological assays when choosing vaccine strains. Here, I argue that these classical serological assays are oversimplified and that they fail to detect influenza mutations that facilitate escape of particular types of human antibodies. I propose that influenza vaccine strains should be updated more frequently even when classical serological assays fail to detect significant antigenic alterations.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\BDPLW8JF\\Hensley - 2014 - Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure hist.pdf;C\:\\Users\\Zane\\Zotero\\storage\\A6WB5ZVR\\S1879625714001527.html}
}

@article{hilleman1958b,
  title = {{{ANTIBODY RESPONSE IN VOLUNTEERS TO ASIAN INFLUENZA VACCINE}}},
  author = {Hilleman, Maurice R.},
  year = {1958},
  month = mar,
  journal = {Journal of the American Medical Association},
  volume = {166},
  number = {10},
  pages = {1134},
  issn = {0002-9955},
  doi = {10.1001/jama.1958.02990100022005},
  urldate = {2024-05-26},
  langid = {english},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\5NR2J367\\Hilleman - 1958 - ANTIBODY RESPONSE IN VOLUNTEERS TO ASIAN INFLUENZA.pdf;C\:\\Users\\Zane\\Zotero\\storage\\GVCGEBK7\\Hilleman - 1958 - ANTIBODY RESPONSE IN VOLUNTEERS TO ASIAN INFLUENZA.pdf}
}

@article{hinojosa2020,
  title = {Impact of Immune Priming, Vaccination, and Infection on Influenza {{A}}({{H3N2}}) Antibody Landscapes in Children},
  author = {Hinojosa, Michael and Shepard, Samuel S and Chung, Jessie R and King, Jennifer P and McLean, Huong Q and Flannery, Brendan and Belongia, Edward A and Levine, Min Z},
  year = {2020-10-22, 2020-10},
  journal = {The Journal of Infectious Diseases},
  doi = {10.1093/infdis/jiaa665},
  langid = {english}
}

@article{huang2017,
  title = {Matrix Completion with Side Information and Its Applications in Predicting the Antigenicity of Influenza Viruses},
  author = {Huang, Li and Li, Xianhong and Guo, Pengfei and Yao, Yuhua and Liao, Bo and Zhang, Weiwei and Wang, Fayou and Yang, Jiasheng and Zhao, Yulong and Sun, Hailiang and He, Pingan and Yang, Jialiang},
  year = {2017},
  month = oct,
  journal = {Bioinformatics},
  volume = {33},
  number = {20},
  pages = {3195--3201},
  issn = {1367-4803},
  doi = {10.1093/bioinformatics/btx390},
  urldate = {2025-02-26},
  abstract = {Low-rank matrix completion has been demonstrated to be powerful in predicting antigenic distances among influenza viruses and vaccines from partially revealed hemagglutination inhibition table. Meanwhile, influenza hemagglutinin (HA) protein sequences are also effective in inferring antigenic distances. Thus, it is natural to integrate HA protein sequence information into low-rank matrix completion model to help infer influenza antigenicity, which is critical to influenza vaccine development.We have proposed a novel algorithm called biological matrix completion with side information (BMCSI), which first measures HA protein sequence similarities among influenza viruses (especially on epitopes) and then integrates the similarity information into a low-rank matrix completion model to predict influenza antigenicity. This algorithm exploits both the correlations among viruses and vaccines in serological tests and the power of HA sequence in predicting influenza antigenicity. We applied this model into H3N2 seasonal influenza virus data. Comparing to previous methods, we significantly reduced the prediction root-mean-square error in a 10-fold cross validation analysis. Based on the cartographies constructed from imputed data, we showed that the antigenic evolution of H3N2 seasonal influenza is generally S-shaped while the genetic evolution is half-circle shaped. We also showed that the Spearman correlation between genetic and antigenic distances (among antigenic clusters) is 0.83, demonstrating a globally high correspondence and some local discrepancies between influenza genetic and antigenic evolution. Finally, we showed that 4.4\%{\textpm}1.2\% genetic variance (corresponding to 3.11\,{\textpm}\,1.08 antigenic distances) caused an antigenic drift event for H3N2 influenza viruses historically.The software and data for this study are available at http://bi.sky.zstu.edu.cn/BMCSI/.Supplementary data are available at Bioinformatics online.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\BIGN6ZQS\\Huang et al. - 2017 - Matrix completion with side information and its applications in predicting the antigenicity of influ.pdf;C\:\\Users\\Zane\\Zotero\\storage\\9T2JAV3W\\3869230.html}
}

@article{jang2021,
  title = {Hemagglutination {{Inhibition}} ({{HAI}}) Antibody Landscapes after Vaccination with {{H7Nx}} Virus like Particles},
  author = {Jang, Hyesun and Ross, Ted M.},
  year = {2021},
  journal = {PloS One},
  volume = {16},
  number = {3},
  pages = {e0246613},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0246613},
  abstract = {BACKGROUND: A systemic evaluation of the antigenic differences of the H7 influenza hemagglutinin (HA) proteins, especially for the viruses isolated after 2016, are limited. The purpose of this study was to investigate the antigenic differences of major H7 strains with an ultimate aim to discover H7 HA proteins that can elicit protective receptor-binding antibodies against co-circulating H7 influenza strains. METHOD: A panel of eight H7 influenza strains were selected from 3,633 H7 HA amino acid sequences identified over the past two decades (2000-2018). The sequences were expressed on the surface of virus like particles (VLPs) and used to vaccinate C57BL/6 mice. Serum samples were collected and tested for hemagglutination-inhibition (HAI) activity. The vaccinated mice were challenged with lethal dose of H7N9 virus, A/Anhui/1/2013. RESULTS: VLPs expressing the H7 HA antigens elicited broadly reactive antibodies each of the selected H7 HAs, except the A/Turkey/Italy/589/2000 (Italy/00) H7 HA. A putative glycosylation due to an A169T substitution in antigenic site B was identified as a unique antigenic profile of Italy/00. Introduction of the putative glycosylation site (H7 HA-A169T) significantly altered the antigenic profile of HA of the A/Anhui/1/2013 (H7N9) strain. CONCLUSION: This study identified key amino acid mutations that result in severe vaccine mismatches for future H7 epidemics. Future universal influenza vaccine candidates will need to focus on viral variants with these key mutations.},
  langid = {english},
  pmcid = {PMC7971484},
  pmid = {33735274},
  keywords = {Animals,Antibodies Neutralizing,Antibodies Viral,Female,Hemagglutination Inhibition Tests,Hemagglutinin Glycoproteins Influenza Virus,Influenza A Virus H7N9 Subtype,Influenza Vaccines,Mice,Mice Inbred C57BL,Mutation,Phylogeny,Vaccines Virus-Like Particle}
}

@article{jia2024,
  title = {{{MetaFluAD}}: Meta-Learning for Predicting Antigenic Distances among Influenza Viruses},
  shorttitle = {{{MetaFluAD}}},
  author = {Jia, Qitao and Xia, Yuanling and Dong, Fanglin and Li, Weihua},
  year = {2024},
  month = aug,
  journal = {Briefings in Bioinformatics},
  volume = {25},
  number = {5},
  pages = {bbae395},
  issn = {1467-5463},
  doi = {10.1093/bib/bbae395},
  urldate = {2025-02-26},
  abstract = {Influenza viruses rapidly evolve to evade previously acquired human immunity. Maintaining vaccine efficacy necessitates continuous monitoring of antigenic differences among strains. Traditional serological methods for assessing these differences are labor-intensive and time-consuming, highlighting the need for efficient computational approaches. This paper proposes MetaFluAD, a meta-learning-based method designed to predict quantitative antigenic distances among strains. This method models antigenic relationships between strains, represented by their hemagglutinin (HA) sequences, as a weighted attributed network. Employing a graph neural network (GNN)-based encoder combined with a robust meta-learning framework, MetaFluAD learns comprehensive strain representations within a unified space encompassing both antigenic and genetic features. Furthermore, the meta-learning framework enables knowledge transfer across different influenza subtypes, allowing MetaFluAD to achieve remarkable performance with limited data. MetaFluAD demonstrates excellent performance and overall robustness across various influenza subtypes, including A/H3N2, A/H1N1, A/H5N1, B/Victoria, and B/Yamagata. MetaFluAD synthesizes the strengths of GNN-based encoding and meta-learning to offer a promising approach for accurate antigenic distance prediction. Additionally, MetaFluAD can effectively identify dominant antigenic clusters within seasonal influenza viruses, aiding in the development of effective vaccines and efficient monitoring of viral evolution.},
  pmcid = {PMC11317534},
  pmid = {39129362},
  file = {C:\Users\Zane\Zotero\storage\YGSI3I99\Jia et al. - 2024 - MetaFluAD meta-learning for predicting antigenic distances among influenza viruses.pdf}
}

@article{jones-gray2023,
  title = {Does Repeated Influenza Vaccination Attenuate Effectiveness? {{A}} Systematic Review and Meta-Analysis},
  shorttitle = {Does Repeated Influenza Vaccination Attenuate Effectiveness?},
  author = {{Jones-Gray}, Elenor and Robinson, Elizabeth J. and Kucharski, Adam J. and Fox, Annette and Sullivan, Sheena G.},
  year = {2023},
  month = jan,
  journal = {The Lancet. Respiratory Medicine},
  volume = {11},
  number = {1},
  pages = {27--44},
  issn = {2213-2619},
  doi = {10.1016/S2213-2600(22)00266-1},
  abstract = {BACKGROUND: Influenza vaccines require annual readministration; however, several reports have suggested that repeated vaccination might attenuate the vaccine's effectiveness. We aimed to estimate the reduction in vaccine effectiveness associated with repeated influenza vaccination. METHODS: In this systematic review and meta-analysis, we searched MEDLINE, EMBASE, and CINAHL Complete databases for articles published from Jan 1, 2016, to June 13, 2022, and Web of Science for studies published from database inception to June 13, 2022. For studies published before Jan 1, 2016, we consulted published systematic reviews. Two reviewers (EJ-G and EJR) independently screened, extracted data using a data collection form, assessed studies' risk of bias using the Risk Of Bias In Non-Randomized Studies of Interventions (ROBINS-I) and evaluated the weight of evidence by Grading of Recommendations Assessment, Development, and Evaluation (GRADE). We included observational studies and randomised controlled trials that reported vaccine effectiveness against influenza A(H1N1)pdm09, influenza A(H3N2), or influenza B using four vaccination groups: current season; previous season; current and previous seasons; and neither season (reference). For each study, we calculated the absolute difference in vaccine effectiveness ({$\Delta$}VE) for current season only and previous season only versus current and previous season vaccination to estimate attenuation associated with repeated vaccination. Pooled vaccine effectiveness and VE were calculated by season, age group, and overall. This study is registered with PROSPERO, CRD42021260242. FINDINGS: We identified 4979 publications, selected 681 for full review, and included 83 in the systematic review and 41 in meta-analyses. {$\Delta$}VE for vaccination in both seasons compared with the current season was -9\% (95\% CI -16 to -1, I2=0\%; low certainty) for influenza A(H1N1)pdm09, -18\% (-26 to -11, I2=7\%; low certainty) for influenza A(H3N2), and -7\% (-14 to 0, I2=0\%; low certainty) for influenza B, indicating lower protection with consecutive vaccination. However, for all types, A subtypes and B lineages, vaccination in both seasons afforded better protection than not being vaccinated. INTERPRETATION: Our estimates suggest that, although vaccination in the previous year attenuates vaccine effectiveness, vaccination in two consecutive years provides better protection than does no vaccination. The estimated effects of vaccination in the previous year are concerning and warrant additional investigation, but are not consistent or severe enough to support an alternative vaccination regimen at this time. FUNDING: WHO and the US National Institutes of Health.},
  langid = {english},
  pmcid = {PMC9780123},
  pmid = {36152673},
  keywords = {,Humans,Influenza A Virus H1N1 Subtype,Influenza A Virus H3N2 Subtype,Influenza Human,Influenza Vaccines,Seasons,Vaccination},
  file = {C:\Users\Zane\Zotero\storage\BAKLVHA3\Jones-Gray et al. - 2023 - Does repeated influenza vaccination attenuate effectiveness A systematic review and meta-analysis.pdf}
}

@article{kim2018,
  title = {Influenza {{Virus}}: {{Dealing}} with a {{Drifting}} and {{Shifting Pathogen}}},
  shorttitle = {Influenza {{Virus}}},
  author = {Kim, Hyunsuh and Webster, Robert G. and Webby, Richard J.},
  year = {2018},
  month = mar,
  journal = {Viral Immunology},
  volume = {31},
  number = {2},
  pages = {174--183},
  issn = {1557-8976},
  doi = {10.1089/vim.2017.0141},
  abstract = {Numerous modern technological and scientific advances have changed the vaccine industry. However, nearly 70 years of influenza vaccine usage have passed without substantial changes in the underlying principles of the vaccine. The challenge of vaccinating against influenza lies in the constantly changing nature of the virus itself. Influenza viruses undergo antigenic evolution through antigenic drift and shift in their surface glycoproteins. This has forced frequent updates of vaccine antigens to ensure that the somewhat narrowly focused vaccine-induced immune responses defend against circulating strains. Few vaccine production systems have been developed that can entertain such constant changes. Although influenza virus infection induces long-lived immunologic memory to the same or similar strains, most people do not encounter the same strain repeatedly in their lifespan, suggesting that enhancement of natural immunity is required to improve influenza vaccines. It is clear that transformative change of influenza vaccines requires a rethink of how we immunize. In this study, we review the problems associated with the changing nature of the virus, and highlight some of the approaches being employed to improve influenza vaccines.},
  langid = {english},
  pmid = {29373086},
  keywords = {antigenic drift,antigenic shift,Antigenic Variation,Disease Transmission Infectious,Evolution Molecular,Genetic Drift,Humans,Influenza Human,Influenza Vaccines,influenza virus,Orthomyxoviridae,Technology Pharmaceutical,vaccine}
}

@article{kistler2023,
  title = {An Atlas of Continuous Adaptive Evolution in Endemic Human Viruses},
  author = {Kistler, Kathryn E. and Bedford, Trevor},
  year = {2023},
  month = nov,
  journal = {CELL HOST \& MICROBE},
  volume = {31},
  number = {11},
  pages = {1898-+},
  publisher = {Cell Press},
  address = {Cambridge},
  issn = {1931-3128, 1934-6069},
  doi = {10.1016/j.chom.2023.09.012},
  urldate = {2025-02-20},
  abstract = {Through antigenic evolution, viruses such as seasonal influenza evade recognition by neutralizing antibodies. This means that a person with antibodies well tuned to an initial infection will not be protected against the same virus years later and that vaccine-mediated protection will decay. To expand our understanding of which endemic human viruses evolve in this fashion, we assess adaptive evolution across the genome of 28 endemic viruses spanning a wide range of viral families and transmission modes. Surface proteins consistently show the highest rates of adaptation, and ten viruses in this panel are estimated to undergo antigenic evolution to selectively fix mutations that enable the escape of prior immunity. Thus, antibody evasion is not an uncommon evolutionary strategy among human viruses, and monitoring this evolution will inform future vaccine efforts. Additionally, by comparing overall amino acid substitution rates, we show that SARS-CoV2 is accumulating protein-coding changes at substantially faster rates than endemic viruses.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001111389800001}
}

@article{koel2013,
  title = {Substitutions {{Near}} the {{Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution}}},
  author = {Koel, Bj{\"o}rn F. and Burke, David F. and Bestebroer, Theo M. and {van der Vliet}, Stefan and Zondag, Gerben C. M. and Vervaet, Gaby and Skepner, Eugene and Lewis, Nicola S. and Spronken, Monique I. J. and Russell, Colin A. and Eropkin, Mikhail Y. and Hurt, Aeron C. and Barr, Ian G. and {de Jong}, Jan C. and Rimmelzwaan, Guus F. and Osterhaus, Albert D. M. E. and Fouchier, Ron A. M. and Smith, Derek J.},
  year = {2013},
  month = nov,
  journal = {Science},
  volume = {342},
  number = {6161},
  pages = {976--979},
  publisher = {American Association for the Advancement of Science},
  doi = {10.1126/science.1244730},
  urldate = {2025-02-19},
  abstract = {The molecular basis of antigenic drift was determined for the hemagglutinin (HA) of human influenza A/H3N2 virus. From 1968 to 2003, antigenic change was caused mainly by single amino acid substitutions, which occurred at only seven positions in HA immediately adjacent to the receptor binding site. Most of these substitutions were involved in antigenic change more than once. Equivalent positions were responsible for the recent antigenic changes of influenza B and A/H1N1 viruses. Substitution of a single amino acid at one of these positions substantially changed the virus-specific antibody response in infected ferrets. These findings have potentially far-reaching consequences for understanding the evolutionary mechanisms that govern influenza viruses.},
  keywords = {Amino Acid Substitution,Antigens Viral,Binding Sites,Evolution Molecular,Hemagglutinin Glycoproteins Influenza Virus,Humans,Influenza A Virus H3N2 Subtype,Mutation},
  file = {C:\Users\Zane\Zotero\storage\2SRHKLI9\Koel et al. - 2013 - Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus.pdf}
}

@article{koelle2006,
  title = {Epochal {{Evolution Shapes}} the {{Phylodynamics}} of {{Interpandemic Influenza A}} ({{H3N2}}) in {{Humans}}},
  author = {Koelle, Katia and Cobey, Sarah and Grenfell, Bryan and Pascual, Mercedes},
  year = {2006},
  month = dec,
  journal = {Science},
  volume = {314},
  number = {5807},
  pages = {1898--1903},
  publisher = {American Association for the Advancement of Science},
  doi = {10.1126/science.1132745},
  urldate = {2025-02-26},
  abstract = {Human influenza A (subtype H3N2) is characterized genetically by the limited standing diversity of its hemagglutinin and antigenically by clusters that emerge and replace each other within 2 to 8 years. By introducing an epidemiological model that allows for differences between the genetic and antigenic properties of the virus's hemagglutinin, we show that these patterns can arise from cluster-specific immunity alone. Central to the formulation is a genotype-to-phenotype mapping, based on neutral networks, with antigenic phenotypes, not genotypes, determining the degree of strain cross-immunity. The model parsimoniously explains well-known, as well as previously unremarked, features of interpandemic influenza dynamics and evolution. It captures the observed boom-and-bust pattern of viral evolution, with periods of antigenic stasis during which genetic diversity grows, and with episodic contraction of this diversity during cluster transitions.},
  file = {C:\Users\Zane\Zotero\storage\D6N27AVA\Koelle et al. - 2006 - Epochal Evolution Shapes the Phylodynamics of Interpandemic Influenza A (H3N2) in Humans.pdf}
}

@article{krammer2018a,
  title = {Influenza},
  author = {Krammer, Florian and Smith, Gavin J. D. and Fouchier, Ron A. M. and Peiris, Malik and Kedzierska, Katherine and Doherty, Peter C. and Palese, Peter and Shaw, Megan L. and Treanor, John and Webster, Robert G. and {Garc{\'i}a-Sastre}, Adolfo},
  year = {2018},
  month = jun,
  journal = {Nature Reviews Disease Primers},
  volume = {4},
  number = {1},
  pages = {1--21},
  publisher = {Nature Publishing Group},
  issn = {2056-676X},
  doi = {10.1038/s41572-018-0002-y},
  urldate = {2021-11-29},
  abstract = {Influenza is an infectious respiratory disease that, in humans, is caused by influenza A and influenza B viruses. Typically characterized by annual seasonal epidemics, sporadic pandemic outbreaks involve influenza A virus strains of zoonotic origin. The WHO estimates that annual epidemics of influenza result in {\textasciitilde}1 billion infections, 3--5 million cases of severe illness and 300,000--500,000 deaths. The severity of pandemic influenza depends on multiple factors, including the virulence of the pandemic virus strain and the level of pre-existing immunity. The most severe influenza pandemic, in 1918, resulted in\,{$>$}40 million deaths worldwide. Influenza vaccines are formulated every year to match the circulating strains, as they evolve antigenically owing to antigenic drift. Nevertheless, vaccine efficacy is not optimal and is dramatically low in the case of an antigenic mismatch between the vaccine and the circulating virus strain. Antiviral agents that target the influenza virus enzyme neuraminidase have been developed for prophylaxis and therapy. However, the use of these antivirals is still limited. Emerging approaches to combat influenza include the development of universal influenza virus vaccines that provide protection against antigenically distant influenza viruses, but these vaccines need to be tested in clinical trials to ascertain their effectiveness.},
  copyright = {2018 Macmillan Publishers Ltd., part of Springer Nature},
  langid = {english},
  keywords = {Influenza virus,Respiratory tract diseases,Vaccines,Viral pathogenesis},
  annotation = {Bandiera\_abtest: a\\
Cg\_type: Nature Research Journals\\
Primary\_atype: Reviews\\
Subject\_term: Influenza virus;Respiratory tract diseases;Vaccines;Viral pathogenesis\\
Subject\_term\_id: influenza-virus;respiratory-tract-diseases;vaccines;viral-pathogenesis},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\2259F2Y7\\Krammer et al. - 2018 - Influenza.pdf;C\:\\Users\\Zane\\Zotero\\storage\\VLSCSGG2\\s41572-018-0002-y.html}
}

@article{krystal1983,
  title = {Sequential Mutations in Hemagglutinins of Influenza {{B}} Virus Isolates: Definition of Antigenic Domains},
  shorttitle = {Sequential Mutations in Hemagglutinins of Influenza {{B}} Virus Isolates},
  author = {Krystal, M. and Young, J. F. and Palese, P. and Wilson, I. A. and Skehel, J. J. and Wiley, D. C.},
  year = {1983},
  month = jul,
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {80},
  number = {14},
  pages = {4527--4531},
  issn = {0027-8424},
  doi = {10.1073/pnas.80.14.4527},
  abstract = {Comparative analysis of the amino acid sequences of hemagglutinins (HAs) of influenza B/Lee/40, B/Md/59, and B/HK/73 viruses has allowed examination of the molecular basis of antigenic variation in type B viruses. As seen with influenza type A viruses, antigenic drift in influenza B viruses proceeds mostly through the accumulation of amino acid substitutions within the HA1 portion of the HA molecule. However, the rate of variation observed among the influenza B virus HAs appears to be significantly lower than the observed rate of variation among influenza A virus HAs. The overall rate of amino acid change in the HA1s of the influenza B viruses studied is 2\% per 10 years, whereas the HA1s of H3 influenza A viruses vary by 9.2\% per 10 years. The sequences of the influenza B HAs were also examined in relation to the three-dimensional model for the A/Aichi/2/68 HA. When the primary amino acid sequences are compared, it appears that most of the important structural features of the type A HAs--such as the sialic acid binding site, the disulfide linkages, and the stem structure of the trimer--are conserved in the influenza B virus HAs. Regions are also identified where extensive amino acid substitutions have occurred among the three antigenically distinct influenza B virus HAs. The locations of these areas in the B HA structure correspond to antigenic regions proposed for the A virus HAs. In addition, modulation of antigenic regions in B virus HAs may also occur through amino acid deletions and variation in glycosylation sites.},
  langid = {english},
  pmcid = {PMC384072},
  pmid = {6192436},
  file = {C:\Users\Zane\Zotero\storage\TR745236\Krystal et al. - 1983 - Sequential mutations in hemagglutinins of influenza B virus isolates definition of antigenic domain.pdf}
}

@article{kucharski2015,
  title = {Estimating the Life Course of Influenza {{A}}({{H3N2}}) Antibody Responses from Cross-Sectional Data},
  author = {Kucharski, Adam J. and Lessler, Justin and Read, Jonathan M. and Zhu, Huachen and Jiang, Chao Qiang and Guan, Yi and Cummings, Derek A. T. and Riley, Steven},
  year = {2015},
  month = mar,
  journal = {PLoS biology},
  volume = {13},
  number = {3},
  pages = {e1002082},
  issn = {1545-7885},
  doi = {10.1371/journal.pbio.1002082},
  urldate = {2021-06-30},
  abstract = {The immunity of a host population against specific influenza A strains can influence a number of important biological processes, from the emergence of new virus strains to the effectiveness of vaccination programmes. However, the development of an individual's long-lived antibody response to influenza A over the course of a lifetime remains poorly understood. Accurately describing this immunological process requires a fundamental understanding of how the mechanisms of boosting and cross-reactivity respond to repeated infections. Establishing the contribution of such mechanisms to antibody titres remains challenging because the aggregate effect of immune responses over a lifetime are rarely observed directly. To uncover the aggregate effect of multiple influenza infections, we developed a mechanistic model capturing both past infections and subsequent antibody responses. We estimated parameters of the model using cross-sectional antibody titres to nine different strains spanning 40 years of circulation of influenza A(H3N2) in southern China. We found that "antigenic seniority" and quickly decaying cross-reactivity were important components of the immune response, suggesting that the order in which individuals were infected with influenza strains shaped observed neutralisation titres to a particular virus. We also obtained estimates of the frequency and age distribution of influenza infection, which indicate that although infections became less frequent as individuals progressed through childhood and young adulthood, they occurred at similar rates for individuals above age 30 y. By establishing what are likely to be important mechanisms driving epochal trends in population immunity, we also identified key directions for future studies. In particular, our results highlight the need for longitudinal samples that are tested against multiple historical strains. This could lead to a better understanding of how, over the course of a lifetime, fast, transient antibody dynamics combine with the longer-term immune responses considered here.},
  langid = {english},
  pmcid = {PMC4348415},
  pmid = {25734701},
  keywords = {Adaptive Immunity,Adolescent,Adult,Age Distribution,Aged,Antibodies Viral,Child,Child Preschool,China,Cross Protection,Cross-Sectional Studies,Humans,Immunologic Memory,Influenza A Virus H3N2 Subtype,Influenza Human,Longitudinal Studies,Middle Aged,Models Immunological,Time Factors},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\BFAKSI72\\Kucharski et al. - 2015 - Estimating the Life Course of Influenza A(H3N2) An.pdf;C\:\\Users\\Zane\\Zotero\\storage\\XUEZBCI4\\Kucharski et al. - 2015 - Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data.pdf}
}

@article{lapedes2001,
  title = {The Geometry of Shape Space: Application to Influenza},
  shorttitle = {The Geometry of Shape Space},
  author = {Lapedes, A. and Farber, R.},
  year = {2001},
  month = sep,
  journal = {Journal of Theoretical Biology},
  volume = {212},
  number = {1},
  pages = {57--69},
  issn = {0022-5193},
  doi = {10.1006/jtbi.2001.2347},
  abstract = {Shape space was proposed over 20 years ago as a conceptual formalism in which to represent antibody/antigen binding. It has since played a key role in computational immunology. Antigens and antibodies are considered to be points in an abstract "shape space", where coordinates of points in this space represent generalized physico-chemical properties associated with various (unspecified) physical properties related to binding, such as geometric shape, hydrophobicity, charge, etc. Distances in shape space between points representing antibodies and (the shape complement) of antigens are assumed to be related to their affinity, with small distances corresponding to high affinity. In this paper, we provide algorithms, related to metric and ordinal multidimensional scaling algorithms first developed in the mathematical psychology literature, which construct explicit, quantitative coordinates for points in shape space given experimental data such as hemagglutination inhibition assays, or other general affinity assays. Previously, such coordinates had been conceptual constructs and totally implicit. The dimension of shape space deduced from hemagglutination inhibition assays for influenza is low, approximately five dimensional. The deduction of the explicit geometry of shape space given experimental affinity data provides new ways to quantify the similarity of antibodies to antibodies, antigens to antigens, and the affinity of antigens to antibodies. This has potential utility in, e.g. strain selection decisions for annual influenza vaccines, among other applications. The analysis techniques presented here are not restricted to the analysis of antibody-antigen interactions and are generally applicable to affinity data resulting from binding assays.},
  langid = {english},
  pmid = {11527445}
}

@article{lee2003,
  title = {Cross-Reactive {{H1N1}} Antibody Responses to a Live Attenuated Influenza Vaccine in Children: Implication for Selection of Vaccine Strains},
  shorttitle = {Cross-Reactive {{H1N1}} Antibody Responses to a Live Attenuated Influenza Vaccine in Children},
  author = {Lee, Min-Shi and Yang, Chin-Fen},
  year = {2003},
  month = nov,
  journal = {The Journal of Infectious Diseases},
  volume = {188},
  number = {9},
  pages = {1362--1366},
  issn = {0022-1899},
  doi = {10.1086/379045},
  abstract = {Cross-reactive antibody responses of 3 trivalent, live attenuated intranasal influenza vaccine (FluMist) formulations containing 3 different H1N1 strains (A/Texas/36/91, A/Shenzhen/227/95, and A/Beijing/262/95) were evaluated in initially seronegative children. FluMist containing A/Shenzhen/227/95 was more likely to induce cross-reactive hemagglutination inhibition (HAI) antibody against A/Texas/36/91 than against A/Beijing/262/95, and FluMist containing A/Beijing/262/95 induced low levels of cross-reactive HAI antibody against A/Shenzhen/227/95 and A/New Caledonia/20/99. The observed differences in HAI cross-reactivity seem to be partly related to the number of amino acid (aa) differences on the hemagglutinin 1 domain (328 aa residues) rather than the hemagglutinin protein (550 aa residues).},
  langid = {english},
  pmid = {14593595}
}

@article{lee2004,
  title = {Predicting Antigenic Variants of Influenza {{A}}/{{H3N2}} Viruses},
  author = {Lee, Min-Shi and Chen, Jack Si-En},
  year = {2004},
  month = aug,
  journal = {Emerging Infectious Diseases},
  volume = {10},
  number = {8},
  pages = {1385--1390},
  doi = {10.3201/eid1008.040107},
  urldate = {2025-03-13},
  abstract = {Antigenic Variants of Influenza Viruses},
  langid = {american},
  file = {C:\Users\Zane\Zotero\storage\PWWHYHV3\Lee and Chen - 2004 - Predicting antigenic variants of influenza AH3N2 .pdf}
}

@article{lee2023a,
  title = {Joint Visualization of Seasonal Influenza Serology and Phylogeny to Inform Vaccine Composition},
  author = {Lee, Jover and Hadfield, James and Black, Allison and Sibley, Thomas R. and Neher, Richard A. and Bedford, Trevor and Huddleston, John},
  year = {2023},
  month = mar,
  journal = {FRONTIERS IN BIOINFORMATICS},
  volume = {3},
  pages = {1069487},
  publisher = {Frontiers Media Sa},
  address = {Lausanne},
  issn = {2673-7647},
  doi = {10.3389/fbinf.2023.1069487},
  urldate = {2025-02-20},
  abstract = {Seasonal influenza vaccines must be updated regularly to account for mutations that allow influenza viruses to escape our existing immunity. A successful vaccine should represent the genetic diversity of recently circulating viruses and induce antibodies that effectively prevent infection by those recent viruses. Thus, linking the genetic composition of circulating viruses and the serological experimental results measuring antibody efficacy is crucial to the vaccine design decision. Historically, genetic and serological data have been presented separately in the form of static visualizations of phylogenetic trees and tabular serological results to identify vaccine candidates. To simplify this decision-making process, we have created an interactive tool for visualizing serological data that has been integrated into Nextstrain's real-time phylogenetic visualization framework, Auspice. We show how the combined interactive visualizations may be used by decision makers to explore the relationships between complex data sets for both prospective vaccine virus selection and retrospectively exploring the performance of vaccine viruses.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001086933000001},
  file = {C:\Users\Zane\Zotero\storage\6XPPD2CX\Lee et al. - 2023 - Joint visualization of seasonal influenza serology and phylogeny to inform vaccine composition.pdf}
}

@article{lefrancq2025,
  title = {Learning the Fitness Dynamics of Pathogens from Phylogenies},
  author = {Lefrancq, No{\'e}mie and Duret, Lor{\'e}na and Bouchez, Val{\'e}rie and Brisse, Sylvain and Parkhill, Julian and Salje, Henrik},
  year = {2025},
  month = jan,
  journal = {Nature},
  volume = {637},
  number = {8046},
  pages = {683--690},
  publisher = {Nature Publishing Group},
  issn = {1476-4687},
  doi = {10.1038/s41586-024-08309-9},
  urldate = {2025-02-10},
  abstract = {The dynamics of the genetic diversity of pathogens, including the emergence of lineages with increased fitness, is a foundational concept of disease ecology with key public-health implications. However, the identification of such lineages and estimation of associated fitness remain challenging, and is rarely done outside densely sampled systems1,2. Here we present phylowave,~a scalable approach that summarizes changes in population composition in phylogenetic trees, enabling the automatic detection of lineages based on shared fitness and evolutionary relationships. We use our approach on a broad set of viruses and bacteria (SARS-CoV-2, influenza A subtype H3N2, Bordetella pertussis and Mycobacterium tuberculosis), which include both well-studied and understudied threats to human health. We show that phylowave recovers the main known circulating lineages for each pathogen and that it can detect specific amino acid changes linked to fitness changes. Furthermore, phylowave identifies previously undetected lineages with increased fitness, including three co-circulating B.\,pertussis lineages. Inference using phylowave is robust to uneven and limited observations. This widely applicable approach provides an avenue to monitor evolution in real time to support public-health action and explore fundamental drivers of pathogen fitness.},
  copyright = {2025 The Author(s)},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\A9YVFCCX\Lefrancq et al. - 2025 - Learning the fitness dynamics of pathogens from phylogenies.pdf}
}

@article{li2012,
  title = {Pandemic {{H1N1}} Influenza Vaccine Induces a Recall Response in Humans That Favors Broadly Cross-Reactive Memory {{B}} Cells},
  author = {Li, Gui-Mei and Chiu, Christopher and Wrammert, Jens and McCausland, Megan and Andrews, Sarah F. and Zheng, Nai-Ying and Lee, Jane-Hwei and Huang, Min and Qu, Xinyan and Edupuganti, Srilatha and Mulligan, Mark and Das, Suman R. and Yewdell, Jonathan W. and Mehta, Aneesh K. and Wilson, Patrick C. and Ahmed, Rafi},
  year = {2012-05-21, 2012-05},
  journal = {Proceedings of the National Academy of Sciences},
  volume = {109},
  number = {23},
  pages = {9047--9052},
  doi = {10.1073/pnas.1118979109},
  urldate = {2025-03-13},
  abstract = {We have previously shown that broadly neutralizing antibodies reactive to the conserved stem region of the influenza virus hemagglutinin (HA) were generated in people infected with the 2009 pandemic H1N1 strain. Such antibodies are rarely seen in humans following infection or vaccination with seasonal influenza virus strains. However, the important question remained whether the inactivated 2009 pandemic H1N1 vaccine, like the infection, could also induce these broadly neutralizing antibodies. To address this question, we analyzed B-cell responses in 24 healthy adults immunized with the pandemic vaccine in 2009. In all cases, we found a rapid, predominantly IgG-producing vaccine-specific plasmablast response. Strikingly, the majority (25 of 28) of HA-specific monoclonal antibodies generated from the vaccine-specific plasmablasts neutralized more than one influenza strain and exhibited high levels of somatic hypermutation, suggesting they were derived from recall of B-cell memory. Indeed, memory B cells that recognized the 2009 pandemic H1N1 HA were detectable before vaccination not only in this cohort but also in samples obtained before the emergence of the pandemic strain. Three antibodies demonstrated extremely broad cross-reactivity and were found to bind the HA stem. Furthermore, one stem-reactive antibody recognized not only H1 and H5, but also H3 influenza viruses. This exceptional cross-reactivity indicates that antibodies capable of neutralizing most influenza subtypes might indeed be elicited by vaccination. The challenge now is to improve upon this result and design influenza vaccines that can elicit these broadly cross-reactive antibodies at sufficiently high levels to provide heterosubtypic protection.},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\L2H2JJYR\Li et al. - 2012 - Pandemic H1N1 influenza vaccine induces a recall r.pdf}
}

@article{li2020,
  title = {Multi-Task Learning Sparse Group Lasso: A Method for Quantifying Antigenicity of Influenza {{A}}({{H1N1}}) Virus Using Mutations and Variations in Glycosylation of {{Hemagglutinin}}},
  shorttitle = {Multi-Task Learning Sparse Group Lasso},
  author = {Li, Lei and Chang, Deborah and Han, Lei and Zhang, Xiaojian and Zaia, Joseph and Wan, Xiu-Feng},
  year = {2020-05-11, 2020-05},
  journal = {BMC Bioinformatics},
  volume = {21},
  number = {1},
  pages = {182},
  issn = {1471-2105},
  doi = {10.1186/s12859-020-3527-5},
  urldate = {2025-03-13},
  abstract = {In addition to causing the pandemic influenza outbreaks of 1918 and 2009, subtype H1N1 influenza A viruses (IAVs) have caused seasonal epidemics since 1977. Antigenic property of influenza viruses are determined by both protein sequence and N-linked glycosylation of influenza glycoproteins, especially hemagglutinin (HA). The currently available computational methods are only considered features in protein sequence but not N-linked glycosylation.},
  langid = {english},
  keywords = {Antigenic drift,Group lasso,H1N1,Influenza virus,LASSO,MTL-SGL,Multi-task learning,N-linked glycosylation,Sparse learning,Vaccine strain selection},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\AIRYYUWC\\Li et al. - 2020 - Multi-task learning sparse group lasso a method f.pdf;C\:\\Users\\Zane\\Zotero\\storage\\ZWRS9W3Q\\s12859-020-3527-5.html}
}

@article{li2021,
  title = {Antibody Landscape Analysis Following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay},
  author = {Li, Zhu-Nan and Liu, Feng and Gross, F. Liaini and Kim, Lindsay and Ferdinands, Jill and Carney, Paul and Chang, Jessie and Stevens, James and Tumpey, Terrence and Levine, Min Z.},
  editor = {Subbarao, Kanta},
  year = {2021-02-23, 2021-02},
  journal = {mBio},
  volume = {12},
  number = {1},
  doi = {10.1128/mbio.02808-20},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\MT5PNFMF\Li et al. - 2021 - Antibody landscape analysis following influenza va.pdf}
}

@article{liljequist2019,
  title = {Intraclass Correlation - {{A}} Discussion and Demonstration of Basic Features},
  author = {Liljequist, David and Elfving, Britt and Skavberg Roaldsen, Kirsti},
  year = {2019},
  journal = {PloS One},
  volume = {14},
  number = {7},
  pages = {e0219854},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0219854},
  abstract = {A re-analysis of intraclass correlation (ICC) theory is presented together with Monte Carlo simulations of ICC probability distributions. A partly revised and simplified theory of the single-score ICC is obtained, together with an alternative and simple recipe for its use in reliability studies. Our main, practical conclusion is that in the analysis of a reliability study it is neither necessary nor convenient to start from an initial choice of a specified statistical model. Rather, one may impartially use all three single-score ICC formulas. A near equality of the three ICC values indicates the absence of bias (systematic error), in which case the classical (one-way random) ICC may be used. A consistency ICC larger than absolute agreement ICC indicates the presence of non-negligible bias; if so, classical ICC is invalid and misleading. An F-test may be used to confirm whether biases are present. From the resulting model (without or with bias) variances and confidence intervals may then be calculated. In presence of bias, both absolute agreement ICC and consistency ICC should be reported, since they give different and complementary information about the reliability of the method. A clinical example with data from the literature is given.},
  langid = {english},
  pmcid = {PMC6645485},
  pmid = {31329615},
  keywords = {Correlation of Data,Data Interpretation Statistical,Electromyography,Humans,Monte Carlo Method,Software},
  file = {C:\Users\Zane\Zotero\storage\GKC2SAVR\Liljequist et al. - 2019 - Intraclass correlation - A discussion and demonstration of basic features.pdf}
}

@article{lim2022,
  title = {The Impact of Repeated Vaccination on Relative Influenza Vaccine Effectiveness among Vaccinated Adults in the {{United Kingdom}}},
  author = {Lim, Wey Wen and Cowling, Benjamin J. and Nakafero, Georgina and Feng, Shuo and {Nguyen-Van-Tam}, Jonathan S. and Bolt, Hikaru},
  year = {2022},
  month = nov,
  journal = {Epidemiology and Infection},
  volume = {150},
  pages = {e198},
  issn = {1469-4409},
  doi = {10.1017/S0950268822001753},
  abstract = {Annual seasonal influenza vaccination is recommended for individuals at high risk of developing post-infection complications in many locations. However, reduced vaccine immunogenicity and effectiveness have been observed among repeat vaccinees in some influenza seasons. We investigated the impact of repeated influenza vaccination on relative vaccine effectiveness (VE) among individuals who were recommended for influenza vaccination in the United Kingdom with a retrospective cohort study using primary healthcare data from the Clinical Practice Research Datalink, a primary care database in the United Kingdom. Relative VE was estimated against general practitioner-diagnosed influenza-like illnesses (GP-ILI) and medically attended acute respiratory illnesses (MAARI) among participants who have been repeatedly vaccinated compared with first-time vaccinees using proportional hazards models. Relative VE against MAARI may be reduced for individuals above 65 years old who were vaccinated in the current and previous influenza seasons for some influenza seasons. However, these findings were not conclusive as we could not exclude the possibility of residual confounding in our dataset. The use of routinely collected data from electronic health records to examine the effects of repeated vaccination needs to be complemented with sufficient efforts to include negative control outcomes to rule out residual confounding.},
  langid = {english},
  pmid = {36331053},
  keywords = {'Influenza Human' [MeSH],'Influenza vaccines' [MeSH],'vaccination' [MeSH],Adult,Aged,Clinical Practice Research Datalink,Humans,Influenza Human,Influenza Vaccines,Retrospective Studies,United Kingdom,Vaccination,vaccine effectiveness,Vaccine Efficacy},
  file = {C:\Users\Zane\Zotero\storage\PKV3JJVD\Lim et al. - 2022 - The impact of repeated vaccination on relative inf.pdf}
}

@article{martin2024,
  title = {Influenza {{A}} Genomic Diversity during Human Infections Underscores the Strength of Genetic Drift and the Existence of Tight Transmission Bottlenecks},
  author = {Martin, Michael A and Berg, Nick and Koelle, Katia},
  year = {2024},
  month = oct,
  journal = {Virus Evolution},
  volume = {10},
  number = {1},
  pages = {veae042},
  issn = {2057-1577},
  doi = {10.1093/ve/veae042},
  urldate = {2025-02-20},
  abstract = {Influenza infections result in considerable public health and economic impacts each year. One of the contributing factors to the high annual incidence of human influenza is the virus's ability to evade acquired immunity through continual antigenic evolution. Understanding the evolutionary forces that act within and between hosts is therefore critical to interpreting past trends in influenza virus evolution and in predicting future ones. Several studies have analyzed longitudinal patterns of influenza A virus genetic diversity in natural human infections to assess the relative contributions of selection and genetic drift on within-host evolution. However, in these natural infections, within-host viral populations harbor very few single-nucleotide variants, limiting our resolution in understanding the forces acting on these populations in vivo. Furthermore, low levels of within-host viral genetic diversity limit the ability to infer the extent of drift across transmission events. Here, we propose to use influenza virus genomic diversity as an alternative signal to better understand within- and between-host patterns of viral evolution. Specifically, we focus on the dynamics of defective viral genomes (DVGs), which harbor large internal deletions in one or more of influenza virus's eight gene segments. Our longitudinal analyses of DVGs show that influenza A virus populations are highly dynamic within hosts, corroborating previous findings based on viral genetic diversity that point toward the importance of genetic drift in driving within-host viral evolution. Furthermore, our analysis of DVG populations across transmission pairs indicates that DVGs rarely appeared to be shared, indicating the presence of tight transmission bottlenecks. Our analyses demonstrate that viral genomic diversity can be used to complement analyses based on viral genetic diversity to reveal processes that drive viral evolution within and between hosts.},
  file = {C:\Users\Zane\Zotero\storage\JZ5FBE6C\Martin et al. - 2024 - Influenza A genomic diversity during human infections underscores the strength of genetic drift and.pdf}
}

@misc{maurer2024,
  title = {Conserved Sites on the Influenza {{H1}} and {{H3}} Hemagglutinin Recognized by Human Antibodies},
  author = {Maurer, Daniel P. and Vu, Mya and Ramos, Ana Sofia Ferreira and Dugan, Haley L. and Khalife, Paul and Geoghegan, James C. and Walker, Laura M. and Bajic, Goran and Schmidt, Aaron G.},
  year = {2024},
  month = nov,
  primaryclass = {New Results},
  pages = {2024.10.22.619298},
  publisher = {bioRxiv},
  doi = {10.1101/2024.10.22.619298},
  urldate = {2025-02-20},
  abstract = {Monoclonal antibodies (mAbs) targeting the influenza hemagglutinin (HA) have the potential to be used as prophylactics or templates for next-generation vaccines that provide broad protection. Here, we isolated broad, subtype-neutralizing mAbs from human B cells targeting the H1 or H3 HA head as well as a unique mAb targeting the stem. The H1 mAbs target the previously defined lateral patch epitope on H1 HAs and recognize HAs from 1933 to 2021 in addition to a swine H1N1 virus with pandemic potential. Using directed evolution, we improved the neutralization potency of these H1 mAbs towards a contemporary H1 strain. Using deep mutational scanning of four antigenically distinct H1N1 viruses, we identified potential viral escape pathways. For the H3 mAbs we used cryo-EM to define the targeted epitopes: one mAb recognizes the side of the H3 head, accommodating the N133 glycan and a pocket underneath the receptor binding site. The other H3 mAb recognizes an epitope in the HA stem that overlaps with previously characterized mAbs, but with distinct antibody variable genes and mode of recognition. Collectively, these mAbs identify common sites recognized by broad, subtype-specific mAbs that may be elicited by next-generation vaccines.},
  archiveprefix = {bioRxiv},
  chapter = {New Results},
  copyright = {{\copyright} 2024, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\7PYFB7VP\Maurer et al. - 2024 - Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies.pdf}
}

@book{mcelreath2020,
  title = {Statistical {{Rethinking}}: {{A Bayesian Course}} with {{Examples}} in {{R}} and {{Stan}}},
  shorttitle = {Statistical {{Rethinking}}},
  author = {McElreath, Richard},
  year = {2020},
  series = {{{CRC Texts}} in {{Statistical Science}}},
  edition = {2},
  publisher = {{Taylor and Francis, CRC Press}},
  address = {Boca Raton},
  abstract = {"Statistical Rethinking: A Bayesian Course with Examples in R and Stan, Second Edition builds knowledge/confidence in statistical modeling. Pushes readers to perform step-by-step calculations (usually automated.) Unique, computational approach ensures readers understand details to make reasonable choices and interpretations in their modeling work"--},
  isbn = {978-0-367-13991-9},
  langid = {english},
  lccn = {QA279.5 .M3971 2020},
  keywords = {Bayes Theorem,Bayes-Entscheidungstheorie,Bayesian statistical decision theory,Computer programs,Computer software,Data Interpretation Statistical,Key refs,Logiciels,Mathematical Computing,Mathematics,R,R (Computer program language),R (Langage de programmation),software,Software,Statistisches Modell,Theoreme de Bayes,Theorie de la decision bayesienne},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\5RWYMK8H\\McElreath - 2020 - Statistical rethinking a Bayesian course with examples in R and Stan.pdf;C\:\\Users\\Zane\\Zotero\\storage\\L4AYKSA8\\McElreath - 2020 - Statistical rethinking a Bayesian course with exa.pdf}
}

@article{mcgraw1996,
  title = {Forming Inferences about Some Intraclass Correlation Coefficients},
  author = {McGraw, Kenneth O. and Wong, S. P.},
  year = {1996},
  journal = {Psychological Methods},
  volume = {1},
  number = {1},
  pages = {30--46},
  publisher = {American Psychological Association},
  address = {US},
  issn = {1939-1463},
  doi = {10.1037/1082-989X.1.1.30},
  abstract = {AIthough intraclass correlation coefficients (lCCs) are commonIy used in behavioral measurement, pychometrics, and behavioral genetics, procodures available for forming inferences about ICC are not widely known. Following a review of the distinction between various forms of the ICC, this article presents procedures available for calculating confidence intervals and conducting tests on ICCs developed using data from one-way and two-way random and mixed-efFect analysis of variance models. (PsycINFO Database Record (c) 2016 APA, all rights reserved)},
  keywords = {Confidence Limits (Statistics),Statistical Correlation,Statistical Significance,Variability Measurement},
  file = {C:\Users\Zane\Zotero\storage\PMBZK747\1996-03170-003.html}
}

@misc{meijers2024,
  title = {Concepts and Methods for Predicting Viral Evolution},
  author = {Meijers, Matthijs and Ruchnewitz, Denis and Eberhardt, Jan and Karmakar, Malancha and {\L}uksza, Marta and L{\"a}ssig, Michael},
  year = {2024},
  month = nov,
  primaryclass = {New Results},
  pages = {2024.03.19.585703},
  publisher = {bioRxiv},
  doi = {10.1101/2024.03.19.585703},
  urldate = {2025-02-20},
  abstract = {The seasonal human influenza virus undergoes rapid evolution, leading to significant changes in circulating viral strains from year to year. These changes are typically driven by adaptive mutations, particularly in the antigenic epitopes, the regions of the viral surface protein haemagglutinin targeted by human antibodies. Here we describe a consistent set of methods for data-driven predictive analysis of viral evolution. Our pipeline integrates four types of data: (1) sequence data of viral isolates collected on a worldwide scale, (2) epidemiological data on incidences, (3) antigenic characterization of circulating viruses, and (4) intrinsic viral phenotypes. From the combined analysis of these data, we obtain estimates of relative fitness for circulating strains and predictions of clade frequencies for periods of up to one year. Furthermore, we obtain comparative estimates of protection against future viral populations for candidate vaccine strains, providing a basis for pre-emptive vaccine strain selection. Continuously updated predictions obtained from the prediction pipeline for influenza and SARS-CoV-2 are available on the website previr.app.},
  archiveprefix = {bioRxiv},
  chapter = {New Results},
  copyright = {{\copyright} 2024, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at http://creativecommons.org/licenses/by/4.0/},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\P4GG5E7H\Meijers et al. - 2024 - Concepts and methods for predicting viral evolution.pdf}
}

@article{mogling2017,
  title = {Neuraminidase-Mediated Haemagglutination of Recent Human Influenza {{A}}({{H3N2}}) Viruses Is Determined by Arginine 150 Flanking the Neuraminidase Catalytic Site},
  author = {M{\"o}gling, Ramona and Richard, Mathilde J. and van der Vliet, Stefan and van Beek, Ruud and Schrauwen, Eefje J. A. and Spronken, Monique I. and Rimmelzwaan, Guus F. and Fouchier, Ron A. M.},
  year = {2017},
  journal = {Journal of General Virology},
  volume = {98},
  number = {6},
  pages = {1274--1281},
  publisher = {Microbiology Society,},
  issn = {1465-2099},
  doi = {10.1099/jgv.0.000809},
  urldate = {2025-03-13},
  abstract = {Over the last decade, an increasing proportion of circulating human influenza A(H3N2) viruses exhibited haemagglutination activity that was sensitive to neuraminidase inhibitors. This change in haemagglutination as compared to older circulating A(H3N2) viruses prompted an investigation of the underlying molecular basis. Recent human influenza A(H3N2) viruses were found to agglutinate turkey erythrocytes in a manner that could be blocked with either oseltamivir or neuraminidase-specific antisera, indicating that agglutination was driven by neuraminidase, with a low or negligible contribution of haemagglutinin. Using representative virus recombinants it was shown that the haemagglutinin of a recent A(H3N2) virus indeed had decreased activity to agglutinate turkey erythrocytes, while its neuraminidase displayed increased haemagglutinating activity. Viruses with chimeric and mutant neuraminidases were used to identify the amino acid substitution histidine to arginine at position 150 flanking the neuraminidase catalytic site as the determinant of this neuraminidase-mediated haemagglutination. An analysis of publicly available neuraminidase gene sequences showed that viruses with histidine at position 150 were rapidly replaced by viruses with arginine at this position between 2005 and 2008, in agreement with the phenotypic data. As a consequence of neuraminidase-mediated haemagglutination of recent A(H3N2) viruses and poor haemagglutination via haemagglutinin, haemagglutination inhibition assays with A(H3N2) antisera are no longer useful to characterize the antigenic properties of the haemagglutinin of these viruses for vaccine strain selection purposes. Continuous monitoring of the evolution of these viruses and potential consequences for vaccine strain selection remains important.},
  langid = {english},
  keywords = {Animals,Arginine,Catalytic Domain,DNA Mutational Analysis,Erythrocytes,Evolution Molecular,Hemagglutination,Hemagglutination Inhibition Tests,Humans,Influenza A Virus H3N2 Subtype,Influenza Human,Neuraminidase,Recombination Genetic,Reverse Genetics,Turkeys},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\3QVFPTLR\\Mgling et al. - 2017 - Neuraminidase-mediated haemagglutination of recent human influenza A(H3N2) viruses is determined by.pdf;C\:\\Users\\Zane\\Zotero\\storage\\LM9HIYEC\\jgv.0.html}
}

@article{mohr2015,
  title = {The Neuraminidases of {{MDCK}} Grown Human Influenza {{A}}({{H3N2}}) Viruses Isolated since 1994 Can Demonstrate Receptor Binding},
  author = {Mohr, Peter G. and Deng, Yi-Mo and {McKimm-Breschkin}, Jennifer L.},
  year = {2015},
  month = apr,
  journal = {Virology Journal},
  volume = {12},
  pages = {67},
  issn = {1743-422X},
  doi = {10.1186/s12985-015-0295-3},
  abstract = {BACKGROUND: The neuraminidases (NAs) of MDCK passaged human influenza A(H3N2) strains isolated since 2005 are reported to have dual functions of cleavage of sialic acid and receptor binding. NA agglutination of red blood cells (RBCs) can be inhibited by neuraminidase inhibitors (NAIs), thus distinguishing it from haemagglutinin (HA) binding. We wanted to know if viruses prior to 2005 can demonstrate this property. METHODS: Pairs of influenza A(H3N2) isolates ranging from 1993-2008 passaged in parallel only in eggs or in MDCK cells were tested for inhibition of haemagglutination by various NAIs. RESULTS: Only viruses isolated since 1994 and cultured in MDCK cells bound chicken RBCs solely through their NA. NAI inhibition of agglutination of turkey RBCs was seen for some, but not all of these same MDCK grown viruses. Efficacy of inhibition of enzyme activity and haemagglutination differed between NAIs. For many viruses lower concentrations of oseltamivir could inhibit agglutination compared to zanamivir, although they could both inhibit enzyme activity at comparable concentrations. An E119V mutation reduced sensitivity to oseltamivir and 4-aminoDANA for both the enzyme assay and inhibition of agglutination. Sequence analysis of the NAs and HAs of some paired viruses revealed mutations in the haemagglutinin of all egg passaged viruses. For many of the paired egg and MDCK cultured viruses we found no differences in their NA sequences by Sanger sequencing. However, deep sequencing of MDCK grown isolates revealed low levels of variant populations with mutations at either D151 or T148 in the NA, suggesting mutations at either site may be able to confer this property. CONCLUSIONS: The NA active site of MDCK cultured human influenza A(H3N2) viruses isolated since 1994 can express dual enzyme and receptor binding functions. Binding correlated with either D151 or T148 mutations. The catalytic and receptor binding sites do not appear to be structurally identical since relative concentrations of the NAIs to inhibit enzyme activity and agglutination differ.},
  langid = {english},
  pmcid = {PMC4409758},
  pmid = {25896455},
  file = {C:\Users\Zane\Zotero\storage\2KYQDW9V\Mohr et al. - 2015 - The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate.pdf}
}

@article{morens2010,
  title = {The 2009 {{H1N1 Pandemic Influenza Virus}}: {{What Next}}?},
  shorttitle = {The 2009 {{H1N1 Pandemic Influenza Virus}}},
  author = {Morens, David M. and Taubenberger, Jeffery K. and Fauci, Anthony S.},
  year = {2010},
  month = sep,
  journal = {mBio},
  volume = {1},
  number = {4},
  pages = {e00211-10},
  issn = {2150-7511},
  doi = {10.1128/mBio.00211-10},
  urldate = {2025-01-29},
  abstract = {History suggests that the 2009 pandemic H1N1 influenza virus faces extinction unless it mutates to avoid already high global population immunity. The immune escape mechanisms potentially at its disposal include antigenic drift, antigenic shift via genetic reassortment, and intrasubtypic reassortment. Going back to the late 19th century, the evolutionary histories of past pandemic viruses are examined in an effort to better understand the nature and extent of the immune pressures faced by the 2009 pandemic virus in the immediate future. While human influenza viruses have often surprised us, available evidence leads to the hope that the current pandemic virus will continue to cause low or moderate mortality rates if it does not become extinct.},
  pmcid = {PMC2945198},
  pmid = {20877580},
  file = {C:\Users\Zane\Zotero\storage\VH335XXG\Morens et al. - 2010 - The 2009 H1N1 Pandemic Influenza Virus What Next.pdf}
}

@article{morimoto2018,
  title = {Change in the Efficacy of Influenza Vaccination after Repeated Inoculation under Antigenic Mismatch: {{A}} Systematic Review and Meta-Analysis},
  shorttitle = {Change in the Efficacy of Influenza Vaccination after Repeated Inoculation under Antigenic Mismatch},
  author = {Morimoto, Nobuhisa and Takeishi, Kenta},
  year = {2018},
  month = feb,
  journal = {Vaccine},
  volume = {36},
  number = {7},
  pages = {949--957},
  issn = {1873-2518},
  doi = {10.1016/j.vaccine.2018.01.023},
  abstract = {OBJECTIVES: To examine the effects of repeated influenza vaccination on medically-attended influenza (MAI) and acute respiratory illness (ARI) risk according to the antigenic matching between vaccine and circulating virus strains. METHODS: We performed a systematic review and meta-analysis of randomized studies that compared the risk of MAI and ARI between subjects who had been vaccinated for two consecutive seasons (multiple vaccine group) and those who had been vaccinated in the current season and not in the previous season (single vaccine group). RESULTS: Of 1467 articles identified, eight studies covering ten seasons were included in meta-analyses. Six studies assessed efficacy against MAI in children, yielding the risk ratios (RR) of 2.04 (95\% CI 1.29-3.22) when circulating strains mismatched vaccine strains, and 0.64 (0.33-1.22) when circulating strains matched vaccine strains. When stratified by vaccine types, the reduced efficacy was significant for live-attenuated influenza vaccine only. Three studies investigated efficacy against ARI in children, with the RR of 0.96 (0.81-1.15). The results on adults and the elderly were scarce. CONCLUSIONS: Influenza vaccine efficacy against mismatch strains was lower in repeatedly vaccinated children as compared with those vaccinated for the current season only. The scarcity of available studies may call for further randomized controlled trials on repeated influenza vaccination.},
  langid = {english},
  pmid = {29373191},
  keywords = {Antigenic match,Antigens Viral,Children,Humans,Immunization Secondary,Immunogenicity Vaccine,Influenza A virus,Influenza Human,Influenza vaccine,Influenza Vaccines,Natural infection,Outcome Assessment Health Care,Publication Bias,Randomized Controlled Trials as Topic,Repeated vaccination,Vaccination}
}

@article{nachbagauer2014,
  title = {Induction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an {{H5N1}} Vaccine in Humans},
  author = {Nachbagauer, Raffael and Wohlbold, Teddy John and Hirsh, Ariana and Hai, Rong and Sjursen, Haakon and Palese, Peter and Cox, Rebecca J. and Krammer, Florian},
  editor = {Lyles, D. S.},
  year = {2014-11-15, 2014-11},
  journal = {Journal of Virology},
  volume = {88},
  number = {22},
  pages = {13260--13268},
  doi = {10.1128/jvi.02133-14},
  urldate = {2025-03-13},
  abstract = {Influenza virus infections are a major public health concern and cause significant morbidity and mortality worldwide. Current vaccines are effective but strain specific due to their focus on the immunodominant globular head domain of the hemagglutinin (HA). It has been hypothesized that sequential exposure of humans to hemagglutinins with divergent globular head domains but conserved stalk domains could refocus the immune response to broadly neutralizing epitopes in the stalk. Humans have preexisting immunity against H1 (group 1 hemagglutinin), and vaccination with H5 HA (also group 1)---which has a divergent globular head domain but a similar stalk domain---represents one such sequential-exposure scenario. To test this hypothesis, we used novel reagents based on chimeric hemagglutinins to screen sera from an H5N1 clinical trial for induction of stalk-specific antibodies by quantitative enzyme-linked immunosorbent assay (ELISA) and neutralization assays. Importantly, we also investigated the biological activity of these antibodies in a passive transfer in a mouse challenge model. We found that the H5N1 vaccine induced high titers of stalk-reactive antibodies which were biologically active and protective in the passive-transfer experiment. The induced response showed exceptional breadth toward divergent group 1 hemagglutinins but did not extend to group 2 hemagglutinins. These data provide evidence for the hypothesis that sequential exposure to hemagglutinins with divergent globular head domains but conserved stalk domains can refocus the immune response toward the conserved stalk domain. Furthermore, the results support the concept of a chimeric hemagglutinin universal influenza virus vaccine strategy that is based on the same principle. IMPORTANCE Influenza virus vaccines have to be reformulated and readministered on an annual basis. The development of a universal influenza virus vaccine could abolish the need for this cumbersome and costly process and would also enhance our pandemic preparedness. This study addressed the following questions, which are essential for the development of a hemagglutinin stalk-based universal influenza virus vaccine. (i) Can stalk-reactive antibodies be boosted by vaccination with divergent HAs that share conserved epitopes? (ii) How long-lived are these vaccine-induced stalk-reactive antibody responses? (iii) What is the breadth of this reactivity? (iv) Are these antibodies functional and protective? Our results further strengthen the concept of induction of stalk-reactive antibodies by sequential exposure to hemagglutinin immunogens with conserved stalk and divergent head domains. A universal influenza virus vaccine based on the same principles seems possible and might have a significant impact on global human health.},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\LU4UBSWF\Nachbagauer et al. - 2014 - Induction of broadly reactive anti-hemagglutinin s.pdf}
}

@article{nachbagauer2017,
  title = {Defining the Antibody Cross-Reactome Directed against the Influenza Virus Surface Glycoproteins},
  author = {Nachbagauer, Raffael and Choi, Angela and Hirsh, Ariana and Margine, Irina and Iida, Sayaka and Barrera, Aldo and Ferres, Marcela and Albrecht, Randy A and {Garc{\'i}a-Sastre}, Adolfo and Bouvier, Nicole M and Ito, Kimihito and Medina, Rafael A and Palese, Peter and Krammer, Florian},
  year = {2017-02-13, 2017-02},
  journal = {Nature Immunology},
  volume = {18},
  number = {4},
  pages = {464--473},
  issn = {1529-2916},
  doi = {10.1038/ni.3684},
  urldate = {2025-03-13},
  abstract = {Antigenic drift and reassortment alters the epitopes of influenza virus. Krammer and colleagues reveal the cross-reactivity of antibody responses to viral hemagglutinin and neuraminidase in humans and several animal models, but the most prominent responses reflect `original antigenic sin' to viral exposure.},
  copyright = {2017 Springer Nature America, Inc.},
  langid = {english},
  keywords = {Antibodies,Influenza virus,Viral infection},
  file = {C:\Users\Zane\Zotero\storage\67NWRI6K\Nachbagauer et al. - 2017 - Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.pdf}
}

@article{nakagawa2017,
  title = {The Coefficient of Determination {{R2}} and Intra-Class Correlation Coefficient from Generalized Linear Mixed-Effects Models Revisited and Expanded},
  author = {Nakagawa, Shinichi and Johnson, Paul C. D. and Schielzeth, Holger},
  year = {2017},
  month = sep,
  journal = {Journal of The Royal Society Interface},
  volume = {14},
  number = {134},
  pages = {20170213},
  publisher = {Royal Society},
  doi = {10.1098/rsif.2017.0213},
  urldate = {2025-05-26},
  abstract = {The coefficient of determination R2 quantifies the proportion of variance explained by a statistical model and is an important summary statistic of biological interest. However, estimating R2 for generalized linear mixed models (GLMMs) remains challenging. We have previously introduced a version of R2 that we called  for Poisson and binomial GLMMs, but not for other distributional families. Similarly, we earlier discussed how to estimate intra-class correlation coefficients (ICCs) using Poisson and binomial GLMMs. In this paper, we generalize our methods to all other non-Gaussian distributions, in particular to negative binomial and gamma distributions that are commonly used for modelling biological data. While expanding our approach, we highlight two useful concepts for biologists, Jensen's inequality and the delta method, both of which help us in understanding the properties of GLMMs. Jensen's inequality has important implications for biologically meaningful interpretation of GLMMs, whereas the delta method allows a general derivation of variance associated with non-Gaussian distributions. We also discuss some special considerations for binomial GLMMs with binary or proportion data. We illustrate the implementation of our extension by worked examples from the field of ecology and evolution in the R environment. However, our method can be used across disciplines and regardless of statistical environments.},
  keywords = {goodness of fit,heritability,model fit,reliability analysis,repeatability,variance decomposition},
  file = {C:\Users\Zane\Zotero\storage\LEJX8XW9\Nakagawa et al. - 2017 - The coefficient of determination R2 and intra-class correlation coefficient from generalized linear.pdf}
}

@article{ndifon2011,
  title = {New Methods for Analyzing Serological Data with Applications to Influenza Surveillance},
  author = {Ndifon, Wilfred},
  year = {2011-01-05, 2011-01},
  journal = {Influenza and Other Respiratory Viruses},
  volume = {5},
  number = {3},
  pages = {206--212},
  issn = {1750-2659},
  doi = {10.1111/j.1750-2659.2010.00192.x},
  urldate = {2025-03-13},
  abstract = {Please cite this paper as: Ndifon W. (2011) New methods for analyzing serological data with applications to influenza surveillance. Influenza and Other Respiratory Viruses DOI: 10.1111/j.1750-2659.2010.00192.x. Background Two important challenges to the use of serological assays for influenza surveillance include the substantial amount of experimental effort involved and the inherent noisiness of serological data. Results I show that log-transformed serological data exist in an effectively one-dimensional space. I use this result, together with new mechanistic insights into serological assays, to develop computational methods for accurately and efficiently recovering unmeasured serological data from a sample of measured data, for systematically minimizing noise and other types of non-antigenic variation found in the data, and for quantifying and visualizing antigenic variation. The methods can also be applied to data with effective dimensionality greater than one, under certain conditions. Conclusion Careful application of the methods developed here would enable the collection of better-quality serological data on a greater number of circulating influenza viruses than is currently possible and improve the ability to identify potential epidemic and pandemic viruses before they become widespread. Although the focus here is on influenza surveillance, the described methods are more widely applicable.},
  copyright = {{\copyright} 2011 Blackwell Publishing Ltd},
  langid = {english},
  keywords = {Data recovery,evolution,matrix completion,serological assays,surveillance},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\MJFCYW8B\\Ndifon - 2011 - New methods for analyzing serological data with ap.pdf;C\:\\Users\\Zane\\Zotero\\storage\\PAGN5ZVL\\Ndifon - 2011 - New methods for analyzing serological data with ap.pdf;C\:\\Users\\Zane\\Zotero\\storage\\4CR2AD6W\\j.1750-2659.2010.00192.html;C\:\\Users\\Zane\\Zotero\\storage\\NPB3IEGM\\j.1750-2659.2010.00192.html}
}

@article{neher2014,
  title = {Predicting Evolution from the Shape of Genealogical Trees},
  author = {Neher, Richard A and Russell, Colin A and Shraiman, Boris I},
  year = {2014},
  month = nov,
  journal = {eLife},
  volume = {3},
  pages = {e03568},
  issn = {2050-084X},
  doi = {10.7554/eLife.03568},
  urldate = {2025-02-26},
  abstract = {Given a sample of genome sequences from an asexual population, can one predict its evolutionary future? Here we demonstrate that the branching patterns of reconstructed genealogical trees contains information about the relative fitness of the sampled sequences and that this information can be used to predict successful strains. Our approach is based on the assumption that evolution proceeds by accumulation of small effect mutations, does not require species specific input and can be applied to any asexual population under persistent selection pressure. We demonstrate its performance using historical data on seasonal influenza A/H3N2 virus. We predict the progenitor lineage of the upcoming influenza season with near optimal performance in 30\% of cases and make informative predictions in 16 out of 19 years. Beyond providing a tool for prediction, our ability to make informative predictions implies persistent fitness variation among circulating influenza A/H3N2 viruses., DOI: http://dx.doi.org/10.7554/eLife.03568.001, When viruses multiply, they copy their genetic material to make clones of themselves. However, the genetic material in the clone is often slightly different from the genetic material in the original virus. These mutations can be caused by mistakes made during copying or by radiation or chemicals. Further mutations arise when the clones multiply, which means that, after many generations, there will be quite large differences in the genetic material carried by many members of the population. Most mutations have little or no effect on the `fitness' of an individual - that is, on its ability to survive and multiply - but some mutations do have an influence., Some viruses, like seasonal influenza (flu) viruses, can mutate so rapidly that the most common strains change from year to year. This is why new flu vaccines are needed every year. To date most attempts to predict the evolution of seasonal flu viruses have focused on identifying specific features within the genetic sequences that might indicate fitness. However, such approaches require lots of information about the viruses, and this information is often not available., To address this problem, Neher, Russell and Shraiman have developed a more general method to predict fitness from virus genetic sequences. First, a `family tree' for a virus population - which shows how each strain of the virus is related to other strains - was constructed by comparing the genetic sequences., The next step was based on the observation that as long as differences in fitness arise from the accumulation of multiple mutations, the branching structure of this family tree will bear a visible imprint of the natural selection process as it unfolds. Using this insight and methods borrowed from statistical physics, Neher et al. then analyzed the shape and branching pattern of the tree to work out the fitness of the different strains relative to each other., Neher et al. tested the method using historical influenza A virus data. In 16 of the 19 years studied, the family tree approach made meaningful predictions about which viruses were most likely to give rise to future epidemics. The ability to predict influenza virus evolution from tree shape alone suggests that influenza virus evolution may be more predictable than previously expected., DOI: http://dx.doi.org/10.7554/eLife.03568.002},
  pmcid = {PMC4227306},
  pmid = {25385532},
  file = {C:\Users\Zane\Zotero\storage\7SBCJZHV\Neher et al. - 2014 - Predicting evolution from the shape of genealogical trees.pdf}
}

@article{neher2016,
  title = {Prediction, Dynamics, and Visualization of Antigenic Phenotypes of Seasonal Influenza Viruses},
  author = {Neher, Richard A. and Bedford, Trevor and Daniels, Rodney S. and Russell, Colin A. and Shraiman, Boris I.},
  year = {2016-03-07, 2016-03},
  journal = {Proceedings of the National Academy of Sciences},
  volume = {113},
  number = {12},
  doi = {10.1073/pnas.1525578113},
  langid = {english},
  keywords = {Amino Acid Sequence,antigenic distance,Antigenic Variation/*genetics,Antigens Viral/genetics/*immunology,Betainfluenzavirus/genetics/*immunology,Computer Graphics,Computer Simulation,evolution,Evolution Molecular,Forecasting,Hemagglutinin Glycoproteins Influenza Virus/genetics/*immunology,Humans,Influenza A Virus H1N1 Subtype/genetics/*immunology,Influenza A Virus H3N2 Subtype/genetics/*immunology,Influenza Human/epidemiology/prevention & control,Influenza Vaccines,Models Immunological,Molecular Sequence Data,Phenotype,phylogenetic tree,Phylogeny,Seasons,Software},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\4MNFYTTQ\\Neher et al. - 2016 - Prediction, dynamics, and visualization of antigen.pdf;C\:\\Users\\Zane\\Zotero\\storage\\GWRWVJCU\\Neher et al. - 2016 - Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses.pdf}
}

@article{noah2009,
  title = {Qualification of the {{Hemagglutination Inhibition Assay}} in {{Support}} of {{Pandemic Influenza Vaccine Licensure}}},
  author = {Noah, Diana L. and Hill, Heather and Hines, David and White, E. Lucile and Wolff, Mark C.},
  year = {2009},
  month = apr,
  journal = {Clinical and Vaccine Immunology : CVI},
  volume = {16},
  number = {4},
  pages = {558--566},
  issn = {1556-6811},
  doi = {10.1128/CVI.00368-08},
  urldate = {2025-04-15},
  abstract = {Continued outbreaks of highly pathogenic avian influenza over the past decade have spurred global efforts to develop antivirals and vaccines. As part of vaccine development, standard methods are needed for determining serum antibody titers in response to vaccination. Hemagglutination inhibition (HAI) assays are appropriate for assessing the immunogenicity of pandemic influenza vaccines in support of license approval. We demonstrate that a rigorous qualification of the HAI assay for H5N1 influenza virus, evaluating for precision, intermediate precision, linearity, range, specificity, and robustness, satisfies the intent of regulatory guidance for assay validation despite the lack of availability of specific reference standard antigens and antisera.},
  pmcid = {PMC2668270},
  pmid = {19225073},
  file = {C:\Users\Zane\Zotero\storage\MAFITQEM\Noah et al. - 2009 - Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Lice.pdf}
}

@article{nunez2017,
  title = {Impact of Age and Pre-Existing Influenza Immune Responses in Humans Receiving Split Inactivated Influenza Vaccine on the Induction of the Breadth of Antibodies to Influenza {{A}} Strains},
  author = {Nu{\~n}ez, Ivette A. and Carlock, Michael A. and Allen, James D. and Owino, Simon O. and Moehling, Krissy K. and Nowalk, Patricia and Susick, Michael and Diagle, Kensington and Sweeney, Kristen and Mundle, Sophia and Vogel, Thorsten U. and Delagrave, Simon and Ramgopal, Moti and Zimmerman, Richard K. and Kleanthous, Harry and Ross, Ted M.},
  year = {2017},
  month = nov,
  journal = {PLOS ONE},
  volume = {12},
  number = {11},
  pages = {e0185666},
  publisher = {Public Library of Science},
  issn = {1932-6203},
  doi = {10.1371/journal.pone.0185666},
  urldate = {2021-06-09},
  abstract = {Most humans have pre-existing immunity to influenza viruses. In this study, volunteers (ages of 18--85 years) were vaccinated with split, inactivated Fluzone influenza vaccine in four consecutive influenza seasons from 2013 to 2016 seasons. The impact of repeated vaccination on breadth and durability of antibodies was assessed as a result of vaccine strain changes. Total IgG anti-hemagglutinin (HA) binding antibodies and hemagglutination-inhibition (HAI) activity increased in all age groups against both influenza A HA components in the vaccine post-vaccination (day 21). However, younger subjects maintained seroprotective titers to the vaccine strains, which resulted in higher seroconversion rates in the elderly, since the HAI titers in elderly subjects were more likely to decline prior to the next season. Young subjects had significant HAI activity against historical, as well as contemporary H1 and H3 vaccine strains from the mid-1980s to present. In contrast, elderly subjects had HAI activity to H1 strains from all years, but were more likely to have HAI activity to older strains from 1918-1950s. They also had a more restricted HAI profile against H3 viruses compared to young subjects recognizing H3N2 influenza viruses from the mid-2000s to present. Vaccine recipients were then categorized by whether subjects seroconverted from a seronegative or seropositive pre-vaccination state. Regardless of age, immunological recall or `back-boosting' to antigenically related strains were associated with seroconversion to the vaccine strain. Overall, both younger and older people have the ability to mount a breadth of immune responses following influenza vaccination. This report describes how imprinting exposure differs across age groups, influences antibody cross-reactivity to past hemagglutinin antigenic variants, and shapes immune responses elicited by current split inactivated influenza vaccines. Understanding how current influenza vaccines are influenced by pre-existing immunity in people of different ages is critical for designing the next-generation of `universal' or broadly-protective influenza vaccines.},
  langid = {english},
  keywords = {80 and over,Adolescent,Adult,Age groups,Aged,Aged 80 and over,Antibodies,Antibodies Viral,biosynthesis,Elderly,Enzyme-Linked Immunosorbent Assay,Female,H1N1,Humans,immunology,Influenza,Influenza Vaccines,Key refs,Male,Middle Aged,Vaccination and immunization,Vaccines,Viral,Viral vaccines,Young Adult},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\X79FGH5Y\\Nuez et al. - 2017 - Impact of age and pre-existing influenza immune re.pdf;C\:\\Users\\Zane\\Zotero\\storage\\8PMFCZSC\\article.html}
}

@article{oidtman2021,
  title = {Influenza Immune Escape under Heterogeneous Host Immune Histories},
  author = {Oidtman, Rachel J. and Arevalo, Philip and Bi, Qifang and McGough, Lauren and Russo, Christopher Joel and Cruz, Diana Vera and Vieira, Marcos Costa and Gostic, Katelyn M.},
  year = {2021},
  month = dec,
  journal = {Trends in microbiology},
  volume = {29},
  number = {12},
  pages = {1072--1082},
  issn = {0966-842X},
  doi = {10.1016/j.tim.2021.05.009},
  urldate = {2024-05-22},
  abstract = {In a pattern called immune imprinting, individuals gain the strongest immune protection against the influenza strains encountered earliest in life. In many recent examples, differences in early infection history can explain birth year-associated differences in susceptibility (cohort effects). Susceptibility shapes strain fitness, but without a clear conceptual model linking host susceptibility to the identity and order of past infections, general conclusions on the evolutionary and epidemic implications of cohort effects are not possible. Failure to differentiate between cohort effects caused by differences in the set, rather than the order (path), of past infections is a current source of confusion. We review and refine hypotheses for path-dependent cohort effects, which include imprinting. We highlight strategies to measure their underlying causes and emergent consequences.},
  langid = {english},
  pmcid = {PMC8578193},
  pmid = {34218981},
  keywords = {antigenic evolution,cohort effects,immune escape,immune imprinting,influenza,original antigenic sin},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\XTQZ696G\\Oidtman et al. - 2021 - Influenza immune escape under heterogeneous host i.pdf;C\:\\Users\\Zane\\Zotero\\storage\\MU89GG72\\S0966842X21001323.html}
}

@article{okoli2021,
  title = {Variable Seasonal Influenza Vaccine Effectiveness across Geographical Regions, Age Groups and Levels of Vaccine Antigenic Similarity with Circulating Virus Strains: {{A}} Systematic Review and {\emph{Meta}}-Analysis of the Evidence from Test-Negative Design Studies after the 2009/10 Influenza Pandemic},
  shorttitle = {Variable Seasonal Influenza Vaccine Effectiveness across Geographical Regions, Age Groups and Levels of Vaccine Antigenic Similarity with Circulating Virus Strains},
  author = {Okoli, G. N. and Racovitan, F. and Abdulwahid, T. and Righolt, C. H. and Mahmud, S. M.},
  year = {2021},
  month = feb,
  journal = {Vaccine},
  volume = {39},
  number = {8},
  pages = {1225--1240},
  issn = {0264-410X},
  doi = {10.1016/j.vaccine.2021.01.032},
  urldate = {2025-02-05},
  abstract = {Background We examined the influence of some factors on seasonal influenza vaccine effectiveness (VE) from test-negative design (TND) studies. Methods We systematically searched for full-text publications of VE against laboratory-confirmed influenza from TND studies in outpatient settings after the 2009/10 influenza pandemic. Two reviewers independently selected and extracted data from the included studies. We calculated pooled adjusted VE across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains, using an inverse variance, random-effects model. Results We included 76 full-text articles from 11,931 citations. VE estimates against A(H1N1)pdm09, A(H3N2), influenza B, and all influenza were homogenous and point pooled VE higher in the Southern hemisphere compared with the Northern hemisphere. The difference in pooled VE between the Southern and Northern hemispheres was statistically significant for A(H3N2), influenza B, and all influenza. A consistent pattern was observed in pooled VE across both hemispheres and continents, with the highest point pooled VE being against A(H1N1)pdm09, followed by influenza B, and lowest against A(H3N2). A nearly consistent pattern was observed in pooled VE across age groups in the Northern hemisphere, with pooled VE mostly decreasing with age. Point pooled VE against A(H3N2), influenza B, and all influenza were statistically significantly higher when vaccine was antigenically similar to circulating virus strains compared with when antigenically dissimilar. Similar pattern was observed in the Northern hemisphere, but there was a lack of data from the Southern hemisphere. Conclusion Consistent patterns appear to exist in seasonal influenza VE across regions, age groups, and levels of vaccine antigenic similarity with circulating virus strains, with best vaccine performance against A(H1N1)pdm09 and worst against A(H3N2). The evidence highlights the need to consider geographical location, age, and vaccine antigenic similarity with circulating virus strains when designing and evaluating influenza VE studies.},
  langid = {english},
  keywords = {Case-Control Studies,Humans,Influenza A Virus H1N1 Subtype,Influenza A Virus H3N2 Subtype,Influenza B virus,Influenza Human,Influenza Vaccines,Meta-analysis,Seasonal influenza,Seasons,Sentinel Surveillance,Systematic review,Test-negative design,Vaccine effectiveness},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\WZ6GPFBB\\Okoli et al. - 2021 - Variable seasonal influenza vaccine effectiveness .pdf;C\:\\Users\\Zane\\Zotero\\storage\\BL5X57UF\\S0264410X21000487.html}
}

@article{pan2011,
  title = {A Novel Sequence-Based Antigenic Distance Measure for {{H1N1}}, with Application to Vaccine Effectiveness and the Selection of Vaccine Strains},
  author = {Pan, K. and Subieta, K. C. and Deem, M. W.},
  year = {2011},
  month = mar,
  journal = {Protein Engineering Design and Selection},
  volume = {24},
  number = {3},
  pages = {291--299},
  issn = {1741-0126, 1741-0134},
  doi = {10.1093/protein/gzq105},
  urldate = {2023-10-05},
  langid = {english},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\9FK35I8T\\Pan et al. - 2011 - A novel sequence-based antigenic distance measure .pdf;C\:\\Users\\Zane\\Zotero\\storage\\VHSQFYQV\\Pan et al. - 2011 - A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectivenes.pdf}
}

@article{pan2016,
  title = {Prediction of Influenza {{B}} Vaccine Effectiveness from Sequence Data},
  author = {Pan, Yidan and Deem, Michael W.},
  year = {2016},
  month = aug,
  journal = {Vaccine},
  volume = {34},
  number = {38},
  pages = {4610--4617},
  issn = {0264410X},
  doi = {10.1016/j.vaccine.2016.07.015},
  urldate = {2023-10-05},
  abstract = {Influenza is a contagious respiratory illness that causes significant human morbidity and mortality, affecting 5--15\% of the population in a typical epidemic season. Human influenza epidemics are caused by types A and B, with roughly 25\% of human cases due to influenza B. Influenza B is a single-stranded RNA virus with a high mutation rate, and both prior immune history and vaccination put significant pressure on the virus to evolve. Due to the high rate of viral evolution, the influenza B vaccine component of the annual influenza vaccine is updated, roughly every other year in recent years. To predict when an update to the vaccine is needed, an estimate of expected vaccine effectiveness against a range of viral strains is required. We here introduce a method to measure antigenic distance between the influenza B vaccine and circulating viral strains. The measure correlates well with effectiveness of the influenza B component of the annual vaccine in humans between 1979 and 2014. We discuss how this measure of antigenic distance may be used in the context of annual influenza vaccine design and prediction of vaccine effectiveness.},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\E5WNCBTF\Pan and Deem - 2016 - Prediction of influenza B vaccine effectiveness fr.pdf}
}

@article{parker2016,
  title = {Effects of Egg-Adaptation on Receptor-Binding and Antigenic Properties of Recent Influenza {{A}} ({{H3N2}}) Vaccine Viruses},
  author = {Parker, Lauren and Wharton, Stephen A. and Martin, Stephen R. and Cross, Karen and Lin, Yipu and Liu, Yan and Feizi, Ten and Daniels, Rodney S. and McCauley, John W.},
  year = {2016},
  month = jun,
  journal = {The Journal of General Virology},
  volume = {97},
  number = {6},
  pages = {1333--1344},
  issn = {1465-2099},
  doi = {10.1099/jgv.0.000457},
  abstract = {Influenza A virus (subtype H3N2) causes seasonal human influenza and is included as a component of influenza vaccines. The majority of vaccine viruses are isolated and propagated in eggs, which commonly results in amino acid substitutions in the haemagglutinin (HA) glycoprotein. These substitutions can affect virus receptor-binding and alter virus antigenicity, thereby, obfuscating the choice of egg-propagated viruses for development into candidate vaccine viruses. To evaluate the effects of egg-adaptive substitutions seen in H3N2 vaccine viruses on sialic acid receptor-binding, we carried out quantitative measurement of virus receptor-binding using surface biolayer interferometry with haemagglutination inhibition (HI) assays to correlate changes in receptor avidity with antigenic properties. Included in these studies was a panel of H3N2 viruses generated by reverse genetics containing substitutions seen in recent egg-propagated vaccine viruses and corresponding cell culture-propagated wild-type viruses. These assays provide a quantitative approach to investigating the importance of individual amino acid substitutions in influenza receptor-binding. Results show that viruses with egg-adaptive HA substitutions R156Q, S219Y, and I226N, have increased binding avidity to {$\alpha$}2,3-linked receptor-analogues and decreased binding avidity to {$\alpha$}2,6-linked receptor-analogues. No measurable binding was detected for the viruses with amino acid substitution combination 156Q+219Y and receptor-binding increased in viruses where egg-adaptation mutations were introduced into cell culture-propagated virus. Substitutions at positions 156 and 190 appeared to be primarily responsible for low reactivity in HI assays with post-infection ferret antisera raised against 2012-2013 season H3N2 viruses. Egg-adaptive substitutions at position 186 caused substantial differences in binding avidity with an insignificant effect on antigenicity.},
  langid = {english},
  pmcid = {PMC5394856},
  pmid = {26974849},
  keywords = {Adaptation Biological,Amino Acid Substitution,Animals,Antibodies Viral,Chickens,Ferrets,Hemagglutination Inhibition Tests,Hemagglutinin Glycoproteins Influenza Virus,Humans,Influenza A Virus H3N2 Subtype,Influenza Vaccines,Ovum,Sialic Acids,Virus Attachment,Virus Cultivation},
  file = {C:\Users\Zane\Zotero\storage\QJG6366R\Parker et al. - 2016 - Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2).pdf}
}

@article{paules2019,
  title = {Influenza {{Vaccines}}: {{Good}}, but {{We Can Do Better}}},
  shorttitle = {Influenza {{Vaccines}}},
  author = {Paules, Catharine I and Fauci, Anthony S},
  year = {2019},
  month = apr,
  journal = {The Journal of Infectious Diseases},
  volume = {219},
  number = {Suppl 1},
  pages = {S1-S4},
  issn = {0022-1899},
  doi = {10.1093/infdis/jiy633},
  urldate = {2025-02-03},
  pmcid = {PMC6787547},
  pmid = {30715469},
  file = {C:\Users\Zane\Zotero\storage\6G5KZNPD\Paules and Fauci - 2019 - Influenza Vaccines Good, but We Can Do Better.pdf}
}

@article{peng2023,
  title = {Prediction of {{Antigenic Distance}} in {{Influenza A Using Attribute Network Embedding}}},
  author = {Peng, Fujun and Xia, Yuanling and Li, Weihua},
  year = {2023},
  month = jul,
  journal = {VIRUSES-BASEL},
  volume = {15},
  number = {7},
  pages = {1478},
  publisher = {MDPI},
  address = {Basel},
  issn = {1999-4915},
  doi = {10.3390/v15071478},
  urldate = {2025-02-20},
  abstract = {Owing to the rapid changes in the antigenicity of influenza viruses, it is difficult for humans to obtain lasting immunity through antiviral therapy. Hence, tracking the dynamic changes in the antigenicity of influenza viruses can provide a basis for vaccines and drug treatments to cope with the spread of influenza viruses. In this paper, we developed a novel quantitative prediction method to predict the antigenic distance between virus strains using attribute network embedding techniques. An antigenic network is built to model and combine the genetic and antigenic characteristics of the influenza A virus H3N2, using the continuous distributed representation of the virus strain protein sequence (ProtVec) as a node attribute and the antigenic distance between virus strains as an edge weight. The results show a strong positive correlation between supplementing genetic features and antigenic distance prediction accuracy. Further analysis indicates that our prediction model can comprehensively and accurately track the differences in antigenic distances between vaccines and influenza virus strains, and it outperforms existing methods in predicting antigenic distances between strains.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001036700700001},
  file = {C:\Users\Zane\Zotero\storage\VS4IYEVV\Peng et al. - 2023 - Prediction of Antigenic Distance in Influenza A Using Attribute Network Embedding.pdf}
}

@article{perofsky2024,
  title = {Antigenic Drift and Subtype Interference Shape {{A}}({{H3N2}}) Epidemic Dynamics in the {{United States}}},
  author = {Perofsky, Amanda C. and Huddleston, John and Hansen, Chelsea L. and Barnes, John R. and Rowe, Thomas and Xu, Xiyan and Kondor, Rebecca and Wentworth, David E. and Lewis, Nicola and Whittaker, Lynne and Ermetal, Burcu and Harvey, Ruth and Galiano, Monica and Daniels, Rodney Stuart and McCauley, John W. and Fujisaki, Seiichiro and Nakamura, Kazuya and Kishida, Noriko and Watanabe, Shinji and Hasegawa, Hideki and Sullivan, Sheena G. and Barr, Ian G. and Subbarao, Kanta and Krammer, Florian and Bedford, Trevor and Viboud, Cecile},
  year = {2024},
  month = sep,
  journal = {ELIFE},
  volume = {13},
  pages = {RP91849},
  publisher = {eLIFE SCIENCES PUBL LTD},
  address = {Cambridge},
  issn = {2050-084X},
  doi = {10.7554/eLife.91849},
  urldate = {2025-02-20},
  abstract = {Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but the contribution of this process to variability in annual epidemics is not well understood. Here, we link influenza A(H3N2) virus evolution to regional epidemic dynamics in the United States during 1997-2019. We integrate phenotypic measures of HA antigenic drift and sequence-based measures of HA and NA fitness to infer antigenic and genetic distances between viruses circulating in successive seasons. We estimate the magnitude, severity, timing, transmission rate, age-specific patterns, and subtype dominance of each regional outbreak and find that genetic distance based on broad sets of epitope sites is the strongest evolutionary predictor of A(H3N2) virus epidemiology. Increased HA and NA epitope distance between seasons correlates with larger, more intense epidemics, higher transmission, greater A(H3N2) subtype dominance, and a greater proportion of cases in adults relative to children, consistent with increased population susceptibility. Based on random forest models, A(H1N1) incidence impacts A(H3N2) epidemics to a greater extent than viral evolution, suggesting that subtype interference is a major driver of influenza A virus infection ynamics, presumably via heterosubtypic cross-immunity.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001320607400001},
  file = {C:\Users\Zane\Zotero\storage\427U738M\Perofsky et al. - 2024 - Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.pdf}
}

@article{petrova2018,
  title = {The Evolution of Seasonal Influenza Viruses},
  author = {Petrova, Velislava N. and Russell, Colin A.},
  year = {2018},
  month = jan,
  journal = {Nature Reviews Microbiology},
  volume = {16},
  number = {1},
  pages = {47--60},
  publisher = {Nature Publishing Group},
  issn = {1740-1534},
  doi = {10.1038/nrmicro.2017.118},
  urldate = {2025-02-03},
  abstract = {The evolution of seasonal influenza viruses is an important source of disease burden, as it allows for the reinfection of previously infected or vaccinated individualsGiven that 5--15\% of the global human population is infected with seasonal influenza viruses each year, it is surprising that new antigenic variants arise only every 3--5 years for A/H3N2 viruses and less frequently for A/H1N1 and B virusesThe virus surface glycoprotein haemagglutinin is the primary target of the host immune response, and evolutionary selection pressure drives it to acquire mutations to escape immune recognition without eliminating its receptor binding functionHost immunity has a dual role in governing the pace of virus evolution: innate immunity acts as a constraint on the generation of new virus variants, whereas adaptive immunity selects for immune escape mutantsThe acute nature of influenza virus infections and population-level epidemics provides limited opportunities for evolutionary selection, with most virus diversity being lost before selection can operateInfluenza virus vaccines can provide effective protection against infection when they are well matched to circulating viruses, but there remains scope for improving vaccine production and delivery to achieve better effectiveness},
  copyright = {2017 Springer Nature Limited},
  langid = {english},
  keywords = {Evolutionary theory,Glycoproteins,Influenza virus,Molecular evolution,Population genetics,Vaccines,Viral epidemiology,Viral evolution,Viral immune evasion,Viral proteins},
  file = {C:\Users\Zane\Zotero\storage\V8C4CNUZ\Petrova and Russell - 2018 - The evolution of seasonal influenza viruses.pdf}
}

@article{potter1979,
  title = {Determinants of Immunity to Influenza Infection in Man},
  author = {Potter, C. W. and Oxford, J. S.},
  year = {1979},
  month = jan,
  journal = {British Medical Bulletin},
  volume = {35},
  number = {1},
  pages = {69--75},
  issn = {0007-1420},
  doi = {10.1093/oxfordjournals.bmb.a071545},
  langid = {english},
  pmid = {367490},
  keywords = {antagonists & inhibitors,Antibodies,Antigens,Cellular,Genes,genetics,Hemagglutination Inhibition Tests,Hemagglutinins,Human,Humans,Immunity,immunology,Influenza,Influenza A virus,Innate,Neuraminidase,Viral,Virulence},
  file = {C:\Users\Zane\Zotero\storage\TCM4GZVA\Potter and Oxford - 1979 - Determinants of immunity to influenza infection in man.pdf}
}

@manual{racmacs,
  type = {Manual},
  title = {Racmacs: {{Antigenic}} Cartography Macros},
  author = {Wilks, Sam},
  year = {2024}
}

@article{reid1999,
  title = {Origin and Evolution of the 1918 "{{Spanish}}" Influenza Virus Hemagglutinin Gene},
  author = {Reid, A. H. and Fanning, T. G. and Hultin, J. V. and Taubenberger, J. K.},
  year = {1999},
  month = feb,
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {96},
  number = {4},
  pages = {1651--1656},
  issn = {0027-8424},
  doi = {10.1073/pnas.96.4.1651},
  abstract = {The "Spanish" influenza pandemic killed over 20 million people in 1918 and 1919, making it the worst infectious pandemic in history. Here, we report the complete sequence of the hemagglutinin (HA) gene of the 1918 virus. Influenza RNA for the analysis was isolated from a formalin-fixed, paraffin-embedded lung tissue sample prepared during the autopsy of a victim of the influenza pandemic in 1918. Influenza RNA was also isolated from lung tissue samples from two additional victims of the lethal 1918 influenza: one formalin-fixed, paraffin-embedded sample and one frozen sample obtained by in situ biopsy of the lung of a victim buried in permafrost since 1918. The complete coding sequence of the A/South Carolina/1/18 HA gene was obtained. The HA1 domain sequence was confirmed by using the two additional isolates (A/New York/1/18 and A/Brevig Mission/1/18). The sequences show little variation. Phylogenetic analyses suggest that the 1918 virus HA gene, although more closely related to avian strains than any other mammalian sequence, is mammalian and may have been adapting in humans before 1918.},
  langid = {english},
  pmcid = {PMC15547},
  pmid = {9990079},
  file = {C:\Users\Zane\Zotero\storage\C7J73GN3\Reid et al. - 1999 - Origin and evolution of the 1918 Spanish influenza virus hemagglutinin gene.pdf}
}

@manual{rstudioteam2024,
  type = {Manual},
  title = {{{RStudio}}: {{Integrated}} Development Environment for {{R}}},
  author = {{RStudio Team}},
  year = {2024},
  address = {Boston, MA},
  institution = {RStudio, PBC.}
}

@article{rubin1981,
  title = {The {{Bayesian Bootstrap}}},
  author = {Rubin, Donald B.},
  year = {1981},
  month = jan,
  journal = {The Annals of Statistics},
  volume = {9},
  number = {1},
  pages = {130--134},
  publisher = {Institute of Mathematical Statistics},
  issn = {0090-5364, 2168-8966},
  doi = {10.1214/aos/1176345338},
  urldate = {2025-05-26},
  abstract = {The Bayesian bootstrap is the Bayesian analogue of the bootstrap. Instead of simulating the sampling distribution of a statistic estimating a parameter, the Bayesian bootstrap simulates the posterior distribution of the parameter; operationally and inferentially the methods are quite similar. Because both methods of drawing inferences are based on somewhat peculiar model assumptions and the resulting inferences are generally sensitive to these assumptions, neither method should be applied without some consideration of the reasonableness of these model assumptions. In this sense, neither method is a true bootstrap procedure yielding inferences unaided by external assumptions.},
  keywords = {62A15,62F15,62G05,Dirichlet,jackknife,Model-free inference},
  file = {C:\Users\Zane\Zotero\storage\IJ4XBPUS\Rubin - 1981 - The Bayesian Bootstrap.pdf}
}

@article{sandbulte2011,
  title = {Discordant Antigenic Drift of Neuraminidase and Hemagglutinin in {{H1N1}} and {{H3N2}} Influenza Viruses},
  author = {Sandbulte, Matthew R. and Westgeest, Kim B. and Gao, Jin and Xu, Xiyan and Klimov, Alexander I. and Russell, Colin A. and Burke, David F. and Smith, Derek J. and Fouchier, Ron A. M. and Eichelberger, Maryna C.},
  year = {2011},
  month = dec,
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {108},
  number = {51},
  pages = {20748--20753},
  issn = {0027-8424},
  doi = {10.1073/pnas.1113801108},
  urldate = {2025-02-03},
  abstract = {Seasonal epidemics caused by influenza virus are driven by antigenic changes (drift) in viral surface glycoproteins that allow evasion from preexisting humoral immunity. Antigenic drift is a feature of not only the hemagglutinin (HA), but also of neuraminidase (NA). We have evaluated the antigenic evolution of each protein in H1N1 and H3N2 viruses used in vaccine formulations during the last 15 y by analysis of HA and NA inhibition titers and antigenic cartography. As previously shown for HA, genetic changes in NA did not always lead to an antigenic change. The noncontinuous pattern of NA drift did not correspond closely with HA drift in either subtype. Although NA drift was demonstrated using ferret sera, we show that these changes also impact recognition by NA-inhibiting antibodies in human sera. Remarkably, a single point mutation in the NA of A/Brisbane/59/2007 was primarily responsible for the lack of inhibition by polyclonal antibodies specific for earlier strains. These data underscore the importance of NA inhibition testing to define antigenic drift when there are sequence changes in NA.},
  pmcid = {PMC3251064},
  pmid = {22143798},
  file = {C:\Users\Zane\Zotero\storage\WWWB96EJ\Sandbulte et al. - 2011 - Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses.pdf}
}

@article{shah2024,
  title = {Seasonal Antigenic Prediction of Influenza {{A H3N2}} Using Machine Learning},
  author = {Shah, Syed Awais W. and Palomar, Daniel P. and Barr, Ian and Poon, Leo L. M. and Quadeer, Ahmed Abdul and Mckay, Matthew R.},
  year = {2024},
  month = may,
  journal = {NATURE COMMUNICATIONS},
  volume = {15},
  number = {1},
  pages = {3833},
  publisher = {Nature Portfolio},
  address = {Berlin},
  issn = {2041-1723},
  doi = {10.1038/s41467-024-47862-9},
  urldate = {2025-02-20},
  abstract = {Antigenic characterization of circulating influenza A virus (IAV) isolates is routinely assessed by using the hemagglutination inhibition (HI) assays for surveillance purposes. It is also used to determine the need for annual influenza vaccine updates as well as for pandemic preparedness. Performing antigenic characterization of IAV on a global scale is confronted with high costs, animal availability, and other practical challenges. Here we present a machine learning model that accurately predicts (normalized) outputs of HI assays involving circulating human IAV H3N2 viruses, using their hemagglutinin subunit 1 (HA1) sequences and associated metadata. Each season, the model learns an updated nonlinear mapping of genetic to antigenic changes using data from past seasons only. The model accurately distinguishes antigenic variants from non-variants and adaptively characterizes seasonal dynamics of HA1 sites having the strongest influence on antigenic change. Antigenic predictions produced by the model can aid influenza surveillance, public health management, and vaccine strain selection activities. This study presents a machine learning model that accurately predicts seasonal antigenic changes of influenza A H3N2 using genetic data. The model's predictions can aid influenza surveillance, vaccine strain selection, and public health management.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001215774800009},
  file = {C:\Users\Zane\Zotero\storage\FG5U28PQ\Shah et al. - 2024 - Seasonal antigenic prediction of influenza A H3N2 using machine learning.pdf}
}

@article{shrout1979,
  title = {Intraclass Correlations: Uses in Assessing Rater Reliability},
  shorttitle = {Intraclass Correlations},
  author = {Shrout, P. E. and Fleiss, J. L.},
  year = {1979},
  month = mar,
  journal = {Psychological Bulletin},
  volume = {86},
  number = {2},
  pages = {420--428},
  issn = {0033-2909},
  doi = {10.1037//0033-2909.86.2.420},
  abstract = {Reliability coefficients often take the form of intraclass correlation coefficients. In this article, guidelines are given for choosing among six different forms of the intraclass correlation for reliability studies in which n target are rated by k judges. Relevant to the choice of the coefficient are the appropriate statistical model for the reliability and the application to be made of the reliability results. Confidence intervals for each of the forms are reviewed.},
  langid = {english},
  pmid = {18839484},
  keywords = {Humans,Models Statistical,Reproducibility of Results}
}

@article{shu2017,
  title = {{{GISAID}}: {{Global}} Initiative on Sharing All Influenza Data -- from Vision to Reality},
  shorttitle = {{{GISAID}}},
  author = {Shu, Yuelong and McCauley, John},
  year = {2017},
  month = mar,
  journal = {Eurosurveillance},
  volume = {22},
  number = {13},
  pages = {30494},
  publisher = {{European Centre for Disease Prevention and Control}},
  issn = {1560-7917},
  doi = {10.2807/1560-7917.ES.2017.22.13.30494},
  urldate = {2025-06-09},
  abstract = {eurosurveillance.org is the online home of Eurosurveillance, Europe's journal on infectious disease surveillance, epidemiology, prevention and control.},
  langid = {english},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\LVGQ56H9\\Shu and McCauley - 2017 - GISAID Global initiative on sharing all influenza data  from vision to reality.pdf;C\:\\Users\\Zane\\Zotero\\storage\\KPMZSZ4F\\1560-7917.ES.2017.22.13.html}
}

@incollection{sitaras2020,
  title = {Antigenic {{Cartography}}: {{Overview}} and {{Current Developments}}},
  shorttitle = {Antigenic {{Cartography}}},
  booktitle = {Animal {{Influenza Virus}}},
  author = {Sitaras, Ioannis},
  editor = {Spackman, Erica},
  year = {2020},
  volume = {2123},
  pages = {61--68},
  publisher = {Springer US},
  address = {New York, NY},
  doi = {10.1007/978-1-0716-0346-8_5},
  urldate = {2025-02-26},
  abstract = {Antigenic cartography is a powerful method that allows for the calculation of antigenic distances between influenza viruses or sera and their positioning on a map, by quantifying raw data from hemagglutination inhibition assays. As a consequence, the antigenic drift of influenza viruses over time can be visualized in a straightforward manner. Antigenic cartography is not only useful in the research of influenza virus evolution but also in the surveillance of influenza viruses. Most importantly, antigenic cartography plays a very important role in vaccine updating decisions, since by calculating the antigenic distances between a vaccine strain and circulating strains, an informed decision can be made on whether the distances are large enough to warrant a vaccine update or not. Recent improvements in antigenic cartography calculations have significantly improved its accuracy.},
  isbn = {978-1-0716-0345-1 978-1-0716-0346-8},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\SPXBZ9EN\Sitaras - 2020 - Antigenic Cartography Overview and Current Developments.pdf}
}

@article{skowronski2010,
  title = {Association between the 2008-09 Seasonal Influenza Vaccine and Pandemic {{H1N1}} Illness during {{Spring-Summer}} 2009: Four Observational Studies from {{Canada}}},
  shorttitle = {Association between the 2008-09 Seasonal Influenza Vaccine and Pandemic {{H1N1}} Illness during {{Spring-Summer}} 2009},
  author = {Skowronski, Danuta M. and De Serres, Gaston and Crowcroft, Natasha S. and Janjua, Naveed Z. and Boulianne, Nicole and Hottes, Travis S. and Rosella, Laura C. and Dickinson, James A. and Gilca, Rodica and Sethi, Pam and Ouhoummane, Najwa and Willison, Donald J. and Rouleau, Isabelle and Petric, Martin and Fonseca, Kevin and Drews, Steven J. and Rebbapragada, Anuradha and Charest, Hugues and Hamelin, Marie-Eve and Boivin, Guy and Gardy, Jennifer L. and Li, Yan and Kwindt, Trijntje L. and Patrick, David M. and Brunham, Robert C. and {Canadian SAVOIR Team}},
  year = {2010},
  month = apr,
  journal = {PLoS medicine},
  volume = {7},
  number = {4},
  pages = {e1000258},
  issn = {1549-1676},
  doi = {10.1371/journal.pmed.1000258},
  abstract = {BACKGROUND: In late spring 2009, concern was raised in Canada that prior vaccination with the 2008-09 trivalent inactivated influenza vaccine (TIV) was associated with increased risk of pandemic influenza A (H1N1) (pH1N1) illness. Several epidemiologic investigations were conducted through the summer to assess this putative association. STUDIES INCLUDED: (1) test-negative case-control design based on Canada's sentinel vaccine effectiveness monitoring system in British Columbia, Alberta, Ontario, and Quebec; (2) conventional case-control design using population controls in Quebec; (3) test-negative case-control design in Ontario; and (4) prospective household transmission (cohort) study in Quebec. Logistic regression was used to estimate odds ratios for TIV effect on community- or hospital-based laboratory-confirmed seasonal or pH1N1 influenza cases compared to controls with restriction, stratification, and adjustment for covariates including combinations of age, sex, comorbidity, timeliness of medical visit, prior physician visits, and/or health care worker (HCW) status. For the prospective study risk ratios were computed. Based on the sentinel study of 672 cases and 857 controls, 2008-09 TIV was associated with statistically significant protection against seasonal influenza (odds ratio 0.44, 95\% CI 0.33-0.59). In contrast, estimates from the sentinel and three other observational studies, involving a total of 1,226 laboratory-confirmed pH1N1 cases and 1,505 controls, indicated that prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009, with estimated risk or odds ratios ranging from 1.4 to 2.5. Risk of pH1N1 hospitalization was not further increased among vaccinated people when comparing hospitalized to community cases. CONCLUSIONS: Prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009 in Canada. The occurrence of bias (selection, information) or confounding cannot be ruled out. Further experimental and epidemiological assessment is warranted. Possible biological mechanisms and immunoepidemiologic implications are considered.},
  langid = {english},
  pmcid = {PMC2850386},
  pmid = {20386731},
  keywords = {Canada,Disease Outbreaks,Humans,Influenza A Virus H1N1 Subtype,Influenza Human,Influenza Vaccines,Observation},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\F8FPHCEK\\Skowronski et al. - 2010 - Association between the 2008-09 seasonal influenza.pdf;C\:\\Users\\Zane\\Zotero\\storage\\HKUH2A6Z\\Appendix G.pdf}
}

@article{skowronski2011,
  title = {Mechanism for {{Seasonal Vaccine Effect}} on {{Pandemic H1N1 Risk Remains Uncertain}}},
  author = {Skowronski, Danuta M. and Janjua, Naveed Z. and Hottes, Travis S. and De Serres, Gaston},
  year = {2011},
  month = mar,
  journal = {Clinical Infectious Diseases},
  volume = {52},
  number = {6},
  pages = {831--832},
  issn = {1058-4838},
  doi = {10.1093/cid/cir036},
  urldate = {2023-04-11},
  abstract = {TO THE EDITOR---After correcting for possible cross-reactions, Cowling et al [1] report significantly higher rates of pandemic H1N1 (pH1N1) infection among children 6--15 years old randomized to receive trivalent inactivated influenza vaccine (TIV) versus placebo (31\% vs. 12\%; P\, =\, .04). As a randomized-controlled trial, their crude estimate of the risk ratio (RR\,=\,2.58) among randomized participants is conceptually the most valid. Surprisingly, that primary finding is conveyed in neither their manuscript title nor in the commentary by Glezen [1, 2]. Cowling et al instead draw inconsistent conclusions by combining the 119 randomized children with 312 nonrandomized household contacts (Table 6 [1]). This approach seems inappropriate given that 77\% of household contacts were \&gt;15 years old (Table 1 [1])---an age group not included in randomized subjects and in whom the pH1N1 attack rate was lower (Table 7 [1])---thereby diluting findings in the randomized children with noncomparable and mostly (90\%) nonvaccinated adults (Table 1 [1]).},
  file = {C:\Users\Zane\Zotero\storage\849HDTSQ\Skowronski et al. - 2011 - Mechanism for Seasonal Vaccine Effect on Pandemic .pdf}
}

@article{skowronski2017,
  title = {Serial {{Vaccination}} and the {{Antigenic Distance Hypothesis}}: {{Effects}} on {{Influenza Vaccine Effectiveness During A}}({{H3N2}}) {{Epidemics}} in {{Canada}}, 2010--2011 to 2014--2015},
  shorttitle = {Serial {{Vaccination}} and the {{Antigenic Distance Hypothesis}}},
  author = {Skowronski, Danuta M. and Chambers, Catharine and De Serres, Gaston and Sabaiduc, Suzana and Winter, Anne-Luise and Dickinson, James A. and Gubbay, Jonathan B. and Fonseca, Kevin and Drews, Steven J. and Charest, Hugues and Martineau, Christine and Krajden, Mel and Petric, Martin and Bastien, Nathalie and Li, Yan and Smith, Derek J.},
  year = {2017},
  month = apr,
  journal = {The Journal of Infectious Diseases},
  volume = {215},
  number = {7},
  pages = {1059--1099},
  issn = {0022-1899},
  doi = {10.1093/infdis/jix074},
  urldate = {2025-06-02},
  abstract = {Background. The antigenic distance hypothesis (ADH) predicts that negative interference from prior season's influenza vaccine (v1) on the current season's vaccine (v2) protection may occur when the antigenic distance is small between v1 and v2 (v1 {$\approx$} v2) but large between v1 and the current epidemic (e) strain (v1 {$\neq$} e). Methods. Vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza A(H3N2) illness was estimated by test-negative design during 3 A(H3N2) epidemics (2010--2011, 2012--2013, 2014--2015) in Canada. Vaccine effectiveness was derived with covariate adjustment across v2 and/or v1 categories relative to no vaccine receipt among outpatients aged {$\geq$}9 years. Prior vaccination effects were interpreted within the ADH framework. Results. Prior vaccination effects varied significantly by season, consistent with the ADH. There was no interference by v1 in 2010--2011 when v1 {$\neq$} v2 and v1 {$\neq$} e, with comparable VE for v2 alone or v2 + v1: 34\% (95\% confidence interval [CI] = -51\% to 71\%) versus 34\% (95\% CI = -5\% to 58\%). Negative interference by v1 was suggested in 2012--2013 with nonsignificant reduction in VE when v1 {$\approx$} v2 and v1 {$\neq$} e: 49\% (95\% CI = -47\% to 83\%) versus 28\% (95\% CI = -12\% to 54\%). Negative effects of prior vaccination were pronounced and statistically significant in 2014--2015 when v1 {$\equiv$} v2 and v1 {$\neq$} e: 65\% (95\% CI = 25\% to 83\%) versus -33\% (95\% CI = -78\% to 1\%). Conclusions. Effects of repeat influenza vaccination were consistent with the ADH and may have contributed to findings of low VE across recent A(H3N2) epidemics since 2010 in Canada.},
  langid = {english},
  pmcid = {PMC5853783},
  pmid = {28180277},
  keywords = {*Influenza A Virus H3N2 Subtype,Adolescent,Adult,Aged,antigenic distance hypothesis,antigenic site.,Canada/epidemiology,Case-Control Studies,Child,Epidemics/*prevention & control,Female,genomic sequencing,hemagglutination inhibition,Hemagglutination Inhibition Tests,Humans,influenza,influenza A(H3N2) subtype,Influenza Human/epidemiology/*prevention & control,influenza vaccine,Influenza Vaccines/immunology/*therapeutic use,Logistic Models,Male,Middle Aged,negative interference,repeat vaccination,Seasons,Sentinel Surveillance,Vaccination/*statistics & numerical data,vaccine effectiveness,Young Adult},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\ECTBMUIS\\skowronski17jid - Serial Vaccination and the Antigenic Distance Hypothesis - Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics.pdf;C\:\\Users\\Zane\\Zotero\\storage\\MVE7L26K\\Skowronski et al. - 2017 - Serial Vaccination and the Antigenic Distance Hypothesis Effects on Influenza Vaccine Effectiveness.pdf}
}

@article{smeenk1994,
  title = {The Influenza Virus Variant {{A}}/{{FM}}/1/47-{{MA}} Possesses Single Amino Acid Replacements in the Hemagglutinin, Controlling Virulence, and in the Matrix Protein, Controlling Virulence as Well as Growth},
  author = {Smeenk, C. A. and Brown, E. G.},
  year = {1994},
  month = jan,
  journal = {Journal of Virology},
  volume = {68},
  number = {1},
  pages = {530--534},
  issn = {0022-538X},
  doi = {10.1128/JVI.68.1.530-534.1994},
  abstract = {Genetic analysis of mouse-adapted influenza virus variant A/FM/1/47 (FM) MA has previously identified four genome segments, 4, 5, 7, and 8, that are statistically associated with virulence. On sequencing these genome segments, we found single amino acid replacements at amino acid 47 of the HA2 subunit of the hemagglutinin and at amino acid 139 of the matrix protein. Mutation was not detected in segments 5 and 8, obviating a role for these genes in FM-MA virulence. FM-MA replicates to higher titer than FM in MDCK cells and in mouse lung. FM X FM-MA reassortants were used to show that the M1 gene controlled replication in MDCK cells as well as in mouse lung.},
  langid = {english},
  pmcid = {PMC236317},
  pmid = {8254767},
  file = {C:\Users\Zane\Zotero\storage\GW9SCLFK\Smeenk and Brown - 1994 - The influenza virus variant AFM147-MA possesses single amino acid replacements in the hemagglutin.pdf}
}

@article{smith1999,
  title = {Variable Efficacy of Repeated Annual Influenza Vaccination},
  author = {Smith, Derek J. and Forrest, Stephanie and Ackley, David H. and Perelson, AlanS.},
  year = {1999},
  month = nov,
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  volume = {96},
  number = {24},
  pages = {14001--14006},
  issn = {0027-8424},
  urldate = {2024-05-22},
  abstract = {Conclusions have differed in studies that have compared vaccine efficacy in groups receiving influenza vaccine for the first time to efficacy in groups vaccinated more than once. For example, the Hoskins study [Hoskins, T. W., Davis, J. R., Smith, A. J., Miller, C. L. \& Allchin, A. (1979) Lancet i, 33--35] concluded that repeat vaccination was not protective in the long term, whereas the Keitel study [Keitel, W. A., Cate, T. R., Couch, R. B., Huggins, L. L. \& Hess, K. R. (1997) Vaccine 15, 1114--1122] concluded that repeat vaccination provided continual protection. We propose an explanation, the antigenic distance hypothesis, and test it by analyzing seven influenza outbreaks that occurred during the Hoskins and Keitel studies. The hypothesis is that variation in repeat vaccine efficacy is due to differences in antigenic distances among vaccine strains and between the vaccine strains and the epidemic strain in each outbreak. To test the hypothesis, antigenic distances were calculated from historical hemagglutination inhibition assay tables, and a computer model of the immune response was used to predict the vaccine efficacy of individuals given different vaccinations. The model accurately predicted the observed vaccine efficacies in repeat vaccinees relative to the efficacy in first-time vaccinees (correlation 0.87). Thus, the antigenic distance hypothesis offers a parsimonious explanation of the differences between and within the Hoskins and Keitel studies. These results have implications for the selection of influenza vaccine strains, and also for vaccination strategies for other antigenically variable pathogens that might require repeated vaccination.},
  pmcid = {PMC24180},
  pmid = {10570188},
  keywords = {Antigens Viral/immunology,B-Lymphocytes/immunology/virology,Computer Simulation,Disease Outbreaks,Humans,Influenza A virus/*immunology,Influenza B virus/*immunology,Influenza Human/epidemiology/*prevention & control,Influenza Vaccines/*administration & dosage,Models Immunological,Vaccination},
  file = {C:\Users\Zane\Zotero\storage\R7DEZ66Z\Smith et al. - 1999 - Variable efficacy of repeated annual influenza vaccination.pdf}
}

@article{smith2004,
  title = {Mapping the {{Antigenic}} and {{Genetic Evolution}} of {{Influenza Virus}}},
  author = {Smith, Derek J. and Lapedes, Alan S. and {de Jong}, Jan C. and Bestebroer, Theo M. and Rimmelzwaan, Guus F. and Osterhaus, Albert D. M. E. and Fouchier, Ron A. M.},
  year = {2004},
  month = jul,
  journal = {Science},
  volume = {305},
  number = {5682},
  pages = {371--376},
  publisher = {American Association for the Advancement of Science},
  doi = {10.1126/science.1097211},
  urldate = {2025-02-03},
  abstract = {The antigenic evolution of influenza A (H3N2) virus was quantified and visualized from its introduction into humans in 1968 to 2003. Although there was remarkable correspondence between antigenic and genetic evolution, significant differences were observed: Antigenic evolution was more punctuated than genetic evolution, and genetic change sometimes had a disproportionately large antigenic effect. The method readily allows monitoring of antigenic differences among vaccine and circulating strains and thus estimation of the effects of vaccination. Further, this approach offers a route to predicting the relative success of emerging strains, which could be achieved by quantifying the combined effects of population level immune escape and viral fitness on strain evolution.},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\WGZAMJ5F\Smith et al. - 2004 - Mapping the Antigenic and Genetic Evolution of Influenza Virus.pdf}
}

@article{smith2009,
  title = {Origins and Evolutionary Genomics of the 2009 Swine-Origin {{H1N1}} Influenza {{A}} Epidemic},
  author = {Smith, Gavin J. D. and Vijaykrishna, Dhanasekaran and Bahl, Justin and Lycett, Samantha J. and Worobey, Michael and Pybus, Oliver G. and Ma, Siu Kit and Cheung, Chung Lam and Raghwani, Jayna and Bhatt, Samir and Peiris, J. S. Malik and Guan, Yi and Rambaut, Andrew},
  year = {2009},
  month = jun,
  journal = {Nature},
  volume = {459},
  number = {7250},
  pages = {1122--1125},
  publisher = {Nature Publishing Group},
  issn = {1476-4687},
  doi = {10.1038/nature08182},
  urldate = {2025-02-03},
  abstract = {A phylogenetic analysis of swine-origin H1N1 influenza A virus provides evidence that the virus is a reassortment possessing genes from avian, swine and human origin viruses. The pandemic virus appears to have evolved in way typical of swine flu sequences prior to entering humans, and is derived from several viruses circulating in swine. Initial transmission to humans appears to have occurred several months before recognition of the outbreak. An estimate of the gaps in genetic surveillance points to a period of years between the reassortment of swine lineages and the transfer to humans and the multiple genetic ancestry is inconsistent with an artificial origin for the virus. The gaps in out knowledge revealed by this work highlight the need for the systematic surveillance of influence in swine as a means of identifying potentially pandemic strains before they cross into human populations.},
  copyright = {2009 The Author(s)},
  langid = {english},
  keywords = {Humanities and Social Sciences,multidisciplinary,Science},
  file = {C:\Users\Zane\Zotero\storage\B3VAUNCS\Smith et al. - 2009 - Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.pdf}
}

@article{spearman1904,
  title = {The Proof and Measurement of Association between Two Things},
  author = {Spearman, C.},
  year = {1904},
  journal = {The American Journal of Psychology},
  volume = {15},
  number = {1},
  eprint = {1412159},
  eprinttype = {jstor},
  pages = {72--101},
  publisher = {University of Illinois Press},
  issn = {00029556},
  urldate = {2025-05-26}
}

@article{stacey2025,
  title = {Leveraging Pre-Vaccination Antibody Titres across Multiple Influenza {{H3N2}} Variants to Forecast the Post-Vaccination Response},
  author = {Stacey, Hannah and Carlock, Michael A. and Allen, James D. and Hanley, Hannah B. and Crotty, Shane and Ross, Ted M. and Einav, Tal},
  year = {2025},
  month = may,
  journal = {EBioMedicine},
  volume = {116},
  pages = {105744},
  issn = {2352-3964},
  doi = {10.1016/j.ebiom.2025.105744},
  abstract = {BACKGROUND: Despite decades of research on the influenza virus, we still lack a predictive understanding of how vaccination reshapes each person's antibody response, which impedes efforts to design better vaccines. Models using pre-vaccination antibody haemagglutination inhibition (HAI) titres against the vaccine strain alone poorly predict post-vaccination responses. METHODS: We combined fifteen prior H3N2 influenza vaccine studies from 1997 to 2021, collectively containing 20,000 data points, and develop of a machine learning model that uses pre-vaccination HAI titres against multiple influenza variants to predict post-vaccination responses. To further test the model, four new vaccine studies were conducted in 2022-2023 spanning two geographic locations and three influenza vaccine types. FINDINGS: The most predictive pre-vaccination features were HAI titres against the vaccine strain and against historical influenza variants, with smaller predictive power derived from age, sex, vaccine dose, and geographic location. The resulting model predicted future responses even when the vaccine strain or vaccine formulation changed. A pre-vaccination feature-the time between peak HAI across recent variants-distinguished large versus small post-vaccination responses with 73\% accuracy. Model predictions against prior vaccine studies had 2.4-fold error (95\% CI: 2.34-2.40x, no large outliers with {$>$}4-fold error), yielding more accurate and robust predictions than a null model with 3.2-fold error (95\% CI: 3.12-3.21x, 12\% large outliers). The four new vaccine studies presented here were predicted with comparable accuracy to the intrinsic 2-fold error of the experimental assay. INTERPRETATION: A person's pre-vaccination influenza HAI titres using multiple variants are highly predictive of their post-vaccination response. Many individuals exhibited little-to-no vaccine response, as exhibited by the null model's accuracy, yet the machine learning model identified and accurately predicted both weak and strong responses with statistical superiority. Taken together, this approach paves the way to better utilise current influenza vaccines, especially for individuals that exhibit the weakest responses. FUNDING: NIAID, UCSD PREPARE Institute, LJI \& Kyowa Kirin, Inc. (KKNA-Kyowa Kirin North America), UGA, Cleveland Clinic, the Georgia Research Alliance, and the Bodman family.},
  langid = {english},
  pmid = {40424667},
  keywords = {Antibody-virus interactions,Haemagglutination inhibition,Influenza,Machine learning,Prediction,Vaccine response},
  file = {C:\Users\Zane\Zotero\storage\VPZ9DAFW\Stacey et al. - 2025 - Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the p.pdf}
}

@misc{standevelopmentteam2024,
  title = {Stan {{Modeling Language Users Guide}} and {{Reference Manual}}},
  author = {{Stan Development Team}},
  year = {2024}
}

@article{sullivan2025,
  title = {Antibody Responses against Influenza {{A}} Decline with Successive Years of Annual Influenza Vaccination},
  author = {Sullivan, Sheena G. and Khvorov, Arseniy and Carolan, Louise and Dowson, Leslie and Hadiprodjo, A. Jessica and {Sanchez-Ovando}, Stephany and Liu, Yi and Leung, Vivian K. Y. and Hodgson, David and Blyth, Christopher C. and Macnish, Marion and Cheng, Allen C. and Haugenauer, Michelle and Clark, Julia and Dougherty, Sonia and Macartney, Kristine and Koirala, Archana and Khatami, Ameneh and Jadhav, Ajay and Marshall, Helen and Riley, Kathryn E. and Wark, Peter A. B. and Delahunty, Catherine and Subbarao, Kanta and Kucharski, Adam J. and Fox, Annette},
  year = {2025},
  month = jan,
  journal = {NPJ VACCINES},
  volume = {10},
  number = {1},
  pages = {11},
  publisher = {Nature Portfolio},
  address = {Berlin},
  issn = {2059-0105},
  doi = {10.1038/s41541-024-01057-x},
  urldate = {2025-02-20},
  abstract = {Influenza vaccine effectiveness and immunogenicity can be compromised with repeated vaccination. We assessed immunological markers in a cohort of healthcare workers (HCW) from six public hospitals around Australia during 2020-2021. Sera were collected pre-vaccination and similar to 14 and similar to 180 days post-vaccination and assessed in haemagglutination inhibition assay against egg-grown vaccine and equivalent cell-grown viruses. Responses to vaccination were compared by the number of prior vaccinations. Baseline sera were available for 595 HCW in 2020 and 1031 in 2021. 5\% had not been vaccinated during five years prior to enrolment and 55\% had been vaccinated every year. Post-vaccination titres for all vaccine antigens were lowest among HCW vaccinated in all 5-prior years and highest among HCW with 0 or 1 prior vaccinations, even after adjustment. This was observed for both influenza A subtypes and was dependent on pre-vaccination titre. Expanded cohorts are needed to better understand how this translates to vaccine effectiveness.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001401175200001},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\EPSRI4RF\\41541_2024_1057_MOESM1_ESM.pdf;C\:\\Users\\Zane\\Zotero\\storage\\ZHWB4MHH\\Sullivan et al. - 2025 - Antibody responses against influenza A decline with successive years of annual influenza vaccination.pdf}
}

@article{sun2013,
  title = {Using Sequence Data to Infer the Antigenicity of Influenza Virus},
  author = {Sun, Hailiang and Yang, Jialiang and Zhang, Tong and Long, Li-Ping and Jia, Kun and Yang, Guohua and Webby, Richard J. and Wan, Xiu-Feng},
  editor = {Perlman, Stanley and Biron, Christine},
  year = {2013-08-30, 2013-08},
  journal = {mBio},
  volume = {4},
  number = {4},
  doi = {10.1128/mbio.00230-13},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\UNE937HF\Sun et al. - 2013 - Using sequence data to infer the antigenicity of i.pdf}
}

@article{trovao2024,
  title = {Comparative Evolution of Influenza {{A}} Virus {{H1}} and {{H3}} Head and Stalk Domains across Host Species},
  author = {Trovao, Nidia S. and Khan, Sairah M. and Lemey, Philippe and Nelson, Martha I. and Cherry, Joshua L.},
  year = {2024},
  month = jan,
  journal = {MBIO},
  volume = {15},
  number = {1},
  publisher = {Amer Soc Microbiology},
  address = {Washington},
  issn = {2150-7511},
  doi = {10.1128/mbio.02649-23},
  urldate = {2025-02-20},
  abstract = {The influenza A virus hemagglutinin protein (HA) has been studied extensively in humans but less so in other host species. Here, we compared the rates of nucleotide substitution, protein evolution, and glycosylation in the H1 and H3 head and stalk domains among five host classes (avian, canine, equine, human, and swine). For further resolution, we separately analyzed 49 lineages differentiated by host and geography. HA evolution in non-human hosts was more dynamic than expected. For example, the classical swine H1 head domain accumulated glycosylation sites in the antigenically important head domain at a rate as high as in humans. However, whereas the stalk domain was highly conserved in humans, with a low ratio of non-synonymous to synonymous changes, this ratio was approximately 2.5-fold higher in canines. Together, these findings highlight the need for further study of HA evolution in non-human hosts.IMPORTANCEFor decades, researchers have studied the rapid evolution of influenza A viruses for vaccine design and as a useful model system for the study of host/parasite evolution. By performing an exhaustive analysis of hemagglutinin protein (HA) sequences from 49 lineages independently evolving in birds, swine, canines, equines, and humans over the last century, our work uncovers surprising features of HA evolution. In particular, the canine H3 stalk, unlike human H3 and H1 stalk domains, is not evolving slowly, suggesting that evolution in the stalk domain is not universally constrained across all host species. Therefore, a broader multi-host perspective on HA evolution may be useful during the evaluation and design of stalk-targeted vaccine candidates. For decades, researchers have studied the rapid evolution of influenza A viruses for vaccine design and as a useful model system for the study of host/parasite evolution. By performing an exhaustive analysis of hemagglutinin protein (HA) sequences from 49 lineages independently evolving in birds, swine, canines, equines, and humans over the last century, our work uncovers surprising features of HA evolution. In particular, the canine H3 stalk, unlike human H3 and H1 stalk domains, is not evolving slowly, suggesting that evolution in the stalk domain is not universally constrained across all host species. Therefore, a broader multi-host perspective on HA evolution may be useful during the evaluation and design of stalk-targeted vaccine candidates.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001120072100001},
  file = {C:\Users\Zane\Zotero\storage\RD3ETPK2\Trovao et al. - 2024 - Comparative evolution of influenza A virus H1 and H3 head and stalk domains across host species.pdf}
}

@article{uniprot2025,
  title = {{{UniProt}}: The {{Universal Protein Knowledgebase}} in 2025},
  shorttitle = {{{UniProt}}},
  author = {{The UniProt Consortium}},
  year = {2025},
  month = jan,
  journal = {Nucleic Acids Research},
  volume = {53},
  number = {D1},
  pages = {D609-D617},
  issn = {1362-4962},
  doi = {10.1093/nar/gkae1010},
  urldate = {2025-06-09},
  abstract = {The aim of the UniProt Knowledgebase (UniProtKB; https://www.uniprot.org/) is to provide users with a comprehensive, high-quality and freely accessible set of protein sequences annotated with functional information. In this publication, we describe ongoing changes to our production pipeline to limit the sequences available in UniProtKB to high-quality, non-redundant reference proteomes. We continue to manually curate the scientific literature to add the latest functional data and use machine learning techniques. We also encourage community curation to ensure key publications are not missed. We provide an update on the automatic annotation methods used by UniProtKB to predict information for unreviewed entries describing unstudied proteins. Finally, updates to the UniProt website are described, including a new tab linking protein to genomic information. In recognition of its value to the scientific community, the UniProt database has been awarded Global Core Biodata Resource status.},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\6QQNN6KC\\The UniProt Consortium - 2025 - UniProt the Universal Protein Knowledgebase in 2025.pdf;C\:\\Users\\Zane\\Zotero\\storage\\EVYVHDKD\\7902999.html}
}

@article{vandesandt2012,
  title = {Evasion of {{Influenza A Viruses}} from {{Innate}} and {{Adaptive Immune Responses}}},
  author = {{van de Sandt}, Carolien E. and Kreijtz, Joost H. C. M. and Rimmelzwaan, Guus F.},
  year = {2012},
  month = sep,
  journal = {Viruses},
  volume = {4},
  number = {9},
  pages = {1438--1476},
  issn = {1999-4915},
  doi = {10.3390/v4091438},
  urldate = {2025-02-03},
  abstract = {The influenza A virus is one of the leading causes of respiratory tract infections in humans. Upon infection with an influenza A virus, both innate and adaptive immune responses are induced. Here we discuss various strategies used by influenza A viruses to evade innate immune responses and recognition by components of the humoral and cellular immune response, which consequently may result in reduced clearing of the virus and virus-infected cells. Finally, we discuss how the current knowledge about immune evasion can be used to improve influenza A vaccination strategies.},
  pmcid = {PMC3499814},
  pmid = {23170167},
  file = {C:\Users\Zane\Zotero\storage\KYPQ4HW9\van de Sandt et al. - 2012 - Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses.pdf}
}

@article{vehtari2017,
  title = {Practical {{Bayesian}} Model Evaluation Using Leave-One-out Cross-Validation and {{WAIC}}},
  author = {Vehtari, Aki and Gelman, Andrew and Gabry, Jonah},
  year = {2017},
  journal = {Statistics and Computing},
  volume = {27},
  number = {5},
  pages = {1413--1432},
  issn = {1573-1375},
  doi = {10.1007/s11222-016-9696-4},
  urldate = {2025-02-03},
  abstract = {Leave-one-out cross-validation (LOO) and the widely applicable information criterion (WAIC) are methods for estimating pointwise out-of-sample prediction accuracy from a fitted Bayesian model using the log-likelihood evaluated at the posterior simulations of the parameter values. LOO and WAIC have various advantages over simpler estimates of predictive error such as AIC and DIC but are less used in practice because they involve additional computational steps. Here we lay out fast and stable computations for LOO and WAIC that can be performed using existing simulation draws. We introduce an efficient computation of LOO using Pareto-smoothed importance sampling (PSIS), a new procedure for regularizing importance weights. Although WAIC is asymptotically equal to LOO, we demonstrate that PSIS-LOO is more robust in the finite case with weak priors or influential observations. As a byproduct of our calculations, we also obtain approximate standard errors for estimated predictive errors and for comparison of predictive errors between two models. We implement the computations in an R package called loo and demonstrate using models fit with the Bayesian inference package Stan.},
  langid = {english},
  keywords = {Artificial Intelligence,Bayesian computation,K-fold cross-validation,Leave-one-out cross-validation (LOO),Pareto smoothed importance sampling (PSIS),Stan,Statistics - Computation,Statistics - Methodology,Widely applicable information criterion (WAIC)},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\2NDVUSSQ\\Vehtari et al. - 2017 - Practical Bayesian model evaluation using leave-on.pdf;C\:\\Users\\Zane\\Zotero\\storage\\CCZXZZDZ\\Vehtari et al. - 2017 - Practical Bayesian model evaluation using leave-on.pdf}
}

@misc{vehtari2024,
  title = {Pareto {{Smoothed Importance Sampling}}},
  author = {Vehtari, Aki and Simpson, Daniel and Gelman, Andrew and Yao, Yuling and Gabry, Jonah},
  year = {2024},
  month = mar,
  number = {arXiv:1507.02646},
  eprint = {1507.02646},
  primaryclass = {stat},
  publisher = {arXiv},
  doi = {10.48550/arXiv.1507.02646},
  urldate = {2025-04-24},
  abstract = {Importance weighting is a general way to adjust Monte Carlo integration to account for draws from the wrong distribution, but the resulting estimate can be highly variable when the importance ratios have a heavy right tail. This routinely occurs when there are aspects of the target distribution that are not well captured by the approximating distribution, in which case more stable estimates can be obtained by modifying extreme importance ratios. We present a new method for stabilizing importance weights using a generalized Pareto distribution fit to the upper tail of the distribution of the simulated importance ratios. The method, which empirically performs better than existing methods for stabilizing importance sampling estimates, includes stabilized effective sample size estimates, Monte Carlo error estimates, and convergence diagnostics. The presented Pareto \${\textbackslash}hat\{k\}\$ finite sample convergence rate diagnostic is useful for any Monte Carlo estimator.},
  archiveprefix = {arXiv},
  keywords = {Statistics - Computation,Statistics - Machine Learning,Statistics - Methodology},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\E2SWS2US\\Vehtari et al. - 2024 - Pareto Smoothed Importance Sampling.pdf;C\:\\Users\\Zane\\Zotero\\storage\\XQKX6I5R\\1507.html}
}

@article{vijaykrishna2015,
  title = {The Contrasting Phylodynamics of Human Influenza {{B}} Viruses},
  author = {Vijaykrishna, Dhanasekaran and Holmes, Edward C and Joseph, Udayan and Fourment, Mathieu and Su, Yvonne CF and Halpin, Rebecca and Lee, Raphael TC and Deng, Yi-Mo and Gunalan, Vithiagaran and Lin, Xudong and Stockwell, Timothy B and Fedorova, Nadia B and Zhou, Bin and Spirason, Natalie and K{\"u}hnert, Denise and Bo{\v s}kov{\'a}, Veronika and Stadler, Tanja and Costa, Anna-Maria and Dwyer, Dominic E and Huang, Q Sue and Jennings, Lance C and Rawlinson, William and Sullivan, Sheena G and Hurt, Aeron C and {Maurer-Stroh}, Sebastian and Wentworth, David E and Smith, Gavin JD and Barr, Ian G},
  editor = {Neher, Richard A},
  year = {2015},
  month = jan,
  journal = {eLife},
  volume = {4},
  pages = {e05055},
  publisher = {eLife Sciences Publications, Ltd},
  issn = {2050-084X},
  doi = {10.7554/eLife.05055},
  urldate = {2025-02-26},
  abstract = {A complex interplay of viral, host, and ecological factors shapes the spatio-temporal incidence and evolution of human influenza viruses. Although considerable attention has been paid to influenza A viruses, a lack of equivalent data means that an integrated evolutionary and epidemiological framework has until now not been available for influenza B viruses, despite their significant disease burden. Through the analysis of over 900 full genomes from an epidemiological collection of more than 26,000 strains from Australia and New Zealand, we reveal fundamental differences in the phylodynamics of the two co-circulating lineages of influenza B virus (Victoria and Yamagata), showing that their individual dynamics are determined by a complex relationship between virus transmission, age of infection, and receptor binding preference. In sum, this work identifies new factors that are important determinants of influenza B evolution and epidemiology.},
  keywords = {antigenic drift,epidemiology,evolution,influenza virus},
  file = {C:\Users\Zane\Zotero\storage\Q4LR95G5\Vijaykrishna et al. - 2015 - The contrasting phylodynamics of human influenza B viruses.pdf}
}

@article{waldock2021,
  title = {Assay Harmonization and Use of Biological Standards to Improve the Reproducibility of the Hemagglutination Inhibition Assay: A {{FLUCOP}} Collaborative Study},
  shorttitle = {Assay {{Harmonization}} and {{Use}} of {{Biological Standards To Improve}} the {{Reproducibility}} of the {{Hemagglutination Inhibition Assay}}},
  author = {Waldock, Joanna and Zheng, Lingyi and Remarque, Edmond J. and Civet, Alexandre and Hu, Branda and Jalloh, Sarah Lartey and Cox, Rebecca Jane and Ho, Sammy and Hoschler, Katja and Ollinger, Thierry and Trombetta, Claudia Maria and Engelhardt, Othmar G. and Caillet, Catherine},
  editor = {Pasetti, Marcela F.},
  year = {2021-08-25, 2021-08},
  journal = {mSphere},
  volume = {6},
  number = {4},
  pages = {10.1128/msphere.00567-21},
  doi = {10.1128/msphere.00567-21},
  urldate = {2025-03-13},
  abstract = {The hemagglutination inhibition (HAI) assay is an established technique for assessing influenza immunity, through measurement of antihemagglutinin antibodies. Improved reproducibility of this assay is required to provide meaningful data across different testing laboratories. This study assessed the impact of harmonizing the HAI assay protocol/reagents and using standards on interlaboratory variability. Human pre- and postvaccination sera from individuals (n\,=\,30) vaccinated against influenza were tested across six laboratories. We used a design of experiment (DOE) method to evaluate the impact of assay parameters on interlaboratory HAI assay variability. Statistical and mathematical approaches were used for data analysis. We developed a consensus protocol and assessed its performance against in-house HAI testing. We additionally tested the performance of several potential biological standards. In-house testing with four reassortant viruses showed considerable interlaboratory variation (geometric coefficient of variation [GCV] range of 50\% to 117\%). The age, concentration of turkey red blood cells, incubation duration, and temperature were key assay parameters affecting variability. Use of a consensus protocol with common reagents, including viruses, significantly reduced GCV between laboratories to 22\% to 54\%. Pooled postvaccination human sera from different vaccination campaigns were effective as biological standards. Our results demonstrate that the harmonization of protocols and critical reagents is effective in reducing interlaboratory variability in HAI assay results and that pools of postvaccination human sera have potential as biological standards that can be used over multiple vaccination campaigns. Moreover, the use of standards together with in-house protocols is as potent as the use of common protocols and reagents in reducing interlaboratory variability. IMPORTANCE The hemagglutination inhibition (HAI) assay is the most commonly used serology assay to detect antibodies from influenza vaccination or influenza virus infection. This assay has been used for decades but requires improved standardization of procedures to provide meaningful data. We designed a large study to assess selected parameters for their contribution to assay variability and developed a standard protocol to promote consistent HAI testing methods across laboratories. The use of this protocol and common reagents resulted in lower levels of variability in results between participating laboratories than achieved using in-house HAI testing. Human sera sourced from vaccination campaigns over several years, and thus including antibody to different influenza vaccine strains, served as effective assay standards. Based on our findings, we recommend the use of a common protocol and/or human serum standards, if available, for testing human sera for the presence of antibodies against seasonal influenza using turkey red blood cells.},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\95WCBG8Q\Waldock et al. - 2021 - Assay harmonization and use of biological standard.pdf}
}

@article{wang2021b,
  title = {Antigenic Characterization of Influenza and {{SARS-CoV-2}} Viruses},
  author = {Wang, Yang and Tang, Cynthia Y. and Wan, Xiu-Feng},
  year = {2021-12-14, 2021-12},
  journal = {Analytical and Bioanalytical Chemistry},
  volume = {414},
  number = {9},
  pages = {2841--2881},
  issn = {1618-2650},
  doi = {10.1007/s00216-021-03806-6},
  urldate = {2025-03-13},
  abstract = {Antigenic characterization of emerging and re-emerging viruses is necessary for the prevention of and response to outbreaks, evaluation of infection mechanisms, understanding of virus evolution, and selection of strains for vaccine development. Primary analytic methods, including enzyme-linked immunosorbent/lectin assays, hemagglutination inhibition, neuraminidase inhibition, micro-neutralization assays, and antigenic cartography, have been widely used in the field of influenza research. These techniques have been improved upon over time for increased analytical capacity, and some have been mobilized for the rapid characterization of the SARS-CoV-2 virus as well as its variants, facilitating the development of highly effective vaccines within 1 year of the initially reported outbreak. While great strides have been made for evaluating the antigenic properties of these viruses, multiple challenges prevent efficient vaccine strain selection and accurate assessment. For influenza, these barriers include the requirement for a large virus quantity to perform the assays, more than what can typically be provided by the clinical samples alone, cell- or egg-adapted mutations that can cause antigenic mismatch between the vaccine strain and circulating viruses, and up to a 6-month duration of vaccine development after vaccine strain selection, which allows viruses to continue evolving with potential for antigenic drift and, thus, antigenic mismatch between the vaccine strain and the emerging epidemic strain. SARS-CoV-2 characterization has faced similar challenges with the additional barrier of the need for facilities with high biosafety levels due to its infectious nature. In this study, we review the primary analytic methods used for antigenic characterization of influenza and SARS-CoV-2 and discuss the barriers of these methods and current developments for addressing these challenges.},
  copyright = {{\copyright} 2021. Springer-Verlag GmbH Germany, part of Springer Nature.},
  langid = {english},
  keywords = {*COVID-19,*Influenza Human/epidemiology/prevention & control,*Influenza Vaccines,Antigenic analysis,Antigenic characterization,Antigenic drift,Antigens Viral,Hemagglutinin Glycoproteins Influenza Virus,Humans,Influenza,SARS-CoV-2,Vaccine strain selection},
  file = {C:\Users\Zane\Zotero\storage\ZHT82EFW\Wang et al. - 2021 - Antigenic characterization of influenza and SARS-C.pdf}
}

@misc{wang2024,
  title = {Using Pathogen Genomics to Predict Antigenic Changes of Influenza {{H3N2}} Virus},
  author = {Wang, Lin and Yao, Sidan and Pei, Yao and Huang, Angkana and {lefrancq}, Noemie and Sun, Kaiyuan and Du, Zhanwei and Luo, Wei and Han, Alvin and Liu, Yong and Goh, Rick Siow Mong and Xu, Yani and Lee, Raphael and Russell, Colin and Cauchemez, Simon and {Maurer-Stroh}, Sebastian and Luo, Tao and Salje, Henrik},
  year = {2024},
  month = aug,
  publisher = {Research Square},
  issn = {2693-5015},
  doi = {10.21203/rs.3.rs-4788510/v1},
  urldate = {2025-02-10},
  abstract = {Influenza viruses evolve their antigenic phenotype in response to immune-driven selection, necessitating regular updates to the antigens used in influenza vaccines. Characterising antigenic change of influenza virus currently requires intensive serology-based laboratory work to analyse the movements of viruses in antigenic space. By contrast, pathogen genomics can generate large numbers of sequences in near real-time. However, using genetic sequences to predict antigenic changes remains challenging due to the complex relationship between genetic and antigenic changes. Here we develop a deep learning approach to predict the antigenic distance between influenza H3N2 viruses using 83,145 hemagglutinin (HA) sequences. We first train an elementary protein language model to encode the HA sequences, and then couple the trained language model with a deep regression model to realise the sequence-based prediction. Our method provides stable and accurate prediction on the antigenic distance between H3N2 viruses using their HA sequences. This facilitates the prediction of antigenic movements of viruses in each influenza season using their sequence data. Our sequence-based method will enable real-time prediction of influenza antigenic changes and support vaccine strain selection.},
  archiveprefix = {Research Square},
  keywords = {aiml,antigenic-cartography,antigenic-distance,cartography prediction,influenza,vaccines},
  file = {C:\Users\Zane\Zotero\storage\JPNZ7LYH\Wang et al. - 2024 - Using pathogen genomics to predict antigenic changes of influenza H3N2 virus.pdf}
}

@article{watanabe2010,
  title = {Asymptotic {{Equivalence}} of {{Bayes Cross Validation}} and {{Widely Applicable Information Criterion}} in {{Singular Learning Theory}}},
  author = {Watanabe, Sumio},
  year = {2010},
  journal = {Journal of Machine Learning Research},
  volume = {11},
  number = {116},
  pages = {3571--3594},
  issn = {1533-7928},
  urldate = {2025-04-24},
  abstract = {In regular statistical models, the leave-one-out cross-validation is asymptotically equivalent to the Akaike information criterion. However, since many learning machines are singular statistical models, the asymptotic behavior of the cross-validation remains unknown. In previous studies, we established the singular learning theory and proposed a widely applicable information criterion, the expectation value of which is asymptotically equal to the average Bayes generalization loss. In the present paper, we theoretically compare the Bayes cross-validation loss and the widely applicable information criterion and prove two theorems. First, the Bayes cross-validation loss is asymptotically equivalent to the widely applicable information criterion as a random variable. Therefore, model selection and hyperparameter optimization using these two values are asymptotically equivalent. Second, the sum of the Bayes generalization error and the Bayes cross-validation error is asymptotically equal to 2{$\lambda$}/n, where {$\lambda$} is the real log canonical threshold and n is the number of training samples. Therefore the relation between the cross-validation error and the generalization error is determined by the algebraic geometrical structure of a learning machine. We also clarify that the deviance information criteria are different from the Bayes cross-validation and the widely applicable information criterion.},
  file = {C:\Users\Zane\Zotero\storage\X6BYAJSN\Watanabe - 2010 - Asymptotic Equivalence of Bayes Cross Validation and Widely Applicable Information Criterion in Sing.pdf}
}

@article{welsh2024,
  title = {Age-Dependent Heterogeneity in the Antigenic Effects of Mutations to Influenza Hemagglutinin},
  author = {Welsh, Frances C. and Eguia, Rachel T. and Lee, Juhye M. and Haddox, Hugh K. and Galloway, Jared and Chau, Nguyen Van Vinh and Loes, Andrea N. and Huddleston, John and Yu, Timothy C. and Le, Mai Quynh and Nhat, Nguyen T. D. and Thanh, Nguyen Thi Le and Greninger, Alexander L. and Chu, Helen Y. and Englund, Janet A. and Bedford, Trevor and Matsen, Frederick A. and Boni, Maciej F. and Bloom, Jesse D.},
  year = {2024},
  month = aug,
  journal = {CELL HOST \& MICROBE},
  volume = {32},
  number = {8},
  publisher = {Cell Press},
  address = {Cambridge},
  issn = {1931-3128, 1934-6069},
  doi = {10.1016/j.chom.2024.06.015},
  urldate = {2025-02-20},
  abstract = {Human influenza virus evolves to escape neutralization by polyclonal antibodies. However, we have a limited understanding of how the antigenic effects of viral mutations vary across the human population and how this heterogeneity affects virus evolution. Here, we use deep mutational scanning to map how mutations to the hem- agglutinin (HA) proteins of two H3N2 strains, A/Hong Kong/45/2019 and A/Perth/16/2009, affect neutralization by serum from individuals of a variety of ages. The effects of HA mutations on serum neutralization differ across age groups in ways that can be partially rationalized in terms of exposure histories. Mutations that were fixed in influenza variants after 2020 cause greater escape from sera from younger individuals compared with adults. Overall, these results demonstrate that influenza faces distinct antigenic selection regimes from different age groups and suggest approaches to understand how this heterogeneous selection shapes viral evolution.},
  langid = {english},
  annotation = {Web of Science ID: WOS:001296829000001}
}

@article{wickham2019,
  title = {Welcome to the {{tidyverse}}},
  author = {Wickham, Hadley and Averick, Mara and Bryan, Jennifer and Chang, Winston and McGowan, Lucy D'Agostino and Fran{\c c}ois, Romain and Grolemund, Garrett and Hayes, Alex and Henry, Lionel and Hester, Jim and Kuhn, Max and Pedersen, Thomas Lin and Miller, Evan and Bache, Stephan Milton and M{\"u}ller, Kirill and Ooms, Jeroen and Robinson, David and Seidel, Dana Paige and Spinu, Vitalie and Takahashi, Kohske and Vaughan, Davis and Wilke, Claus and Woo, Kara and Yutani, Hiroaki},
  year = {2019},
  journal = {Journal of Open Source Software},
  volume = {4},
  number = {43},
  pages = {1686},
  doi = {10.21105/joss.01686},
  file = {C:\Users\Zane\Zotero\storage\SQS8YSJE\Wickham et al. - 2019 - Welcome to the Tidyverse.pdf}
}

@article{wood2003,
  title = {Thin-Plate Regression Splines},
  author = {Wood, S. N.},
  year = {2003},
  journal = {Journal of the Royal Statistical Society (B)},
  volume = {65},
  number = {1},
  pages = {95--114}
}

@article{wood2004,
  title = {Stable and Efficient Multiple Smoothing Parameter Estimation for Generalized Additive Models},
  author = {Wood, S. N.},
  year = {2004},
  journal = {Journal of the American Statistical Association},
  volume = {99},
  number = {467},
  pages = {673--686}
}

@article{wood2011,
  title = {Fast Stable Restricted Maximum Likelihood and Marginal Likelihood Estimation of Semiparametric Generalized Linear Models},
  author = {Wood, S. N.},
  year = {2011},
  journal = {Journal of the Royal Statistical Society (B)},
  volume = {73},
  number = {1},
  pages = {3--36}
}

@article{wood2016,
  title = {Smoothing Parameter and Model Selection for General Smooth Models (with Discussion)},
  author = {Wood, S.N. and {N.} and {Pya} and S"afken, B.},
  year = {2016},
  journal = {Journal of the American Statistical Association},
  volume = {111},
  pages = {1548--1575}
}

@book{wood2017,
  title = {Generalized Additive Models: {{An}} Introduction with {{R}}},
  author = {Wood, S.N},
  year = {2017},
  edition = {2},
  publisher = {{Chapman and Hall/CRC}}
}

@book{wood2017a,
  title = {Generalized {{Additive Models}}: {{An Introduction}} with {{R}}, {{Second Edition}}},
  shorttitle = {Generalized {{Additive Models}}},
  author = {Wood, Simon N.},
  year = {2017},
  month = may,
  edition = {2},
  publisher = {{Chapman and Hall/CRC}},
  address = {New York},
  doi = {10.1201/9781315370279},
  abstract = {The first edition of this book has established itself as one of the leading references on generalized additive models (GAMs), and the only book on the topic to be introductory in nature with a wealth of practical examples and software implementation. It is self-contained, providing the necessary background in linear models, linear mixed models, and generalized linear models (GLMs), before presenting a balanced treatment of the theory and applications of GAMs and related models.  The author bases his approach on a framework of penalized regression splines, and while firmly focused on the practical aspects of GAMs, discussions include fairly full explanations of the theory underlying the methods. Use of R software helps explain the theory and illustrates the practical application of the methodology. Each chapter contains an extensive set of exercises, with solutions in an appendix or in the book's R data package gamair, to enable use as a course text or for self-study.},
  isbn = {978-1-315-37027-9}
}

@article{xie2015,
  title = {{{H3N2 Mismatch}} of 2014--15 {{Northern Hemisphere Influenza Vaccines}} and {{Head-to-head Comparison}} between {{Human}} and {{Ferret Antisera}} Derived {{Antigenic Maps}}},
  author = {Xie, Hang and Wan, Xiu-Feng and Ye, Zhiping and Plant, Ewan P. and Zhao, Yangqing and Xu, Yifei and Li, Xing and Finch, Courtney and Zhao, Nan and Kawano, Toshiaki and Zoueva, Olga and Chiang, Meng-Jung and Jing, Xianghong and Lin, Zhengshi and Zhang, Anding and Zhu, Yanhong},
  year = {2015},
  month = oct,
  journal = {Scientific Reports},
  volume = {5},
  pages = {15279},
  issn = {2045-2322},
  doi = {10.1038/srep15279},
  urldate = {2025-02-03},
  abstract = {The poor performance of 2014--15 Northern Hemisphere (NH) influenza vaccines was attributed to mismatched H3N2 component with circulating epidemic strains. Using human serum samples collected from 2009--10, 2010--11 and 2014--15 NH influenza vaccine trials, we assessed their cross-reactive hemagglutination inhibition (HAI) antibody responses against recent H3 epidemic isolates. All three populations (children, adults, and older adults) vaccinated with the 2014--15 NH egg- or cell-based vaccine, showed {$>$}50\% reduction in HAI post-vaccination geometric mean titers against epidemic H3 isolates from those against egg-grown H3 vaccine strain A/Texas/50/2012 (TX/12e). The 2014--15 NH vaccines, regardless of production type, failed to further extend HAI cross-reactivity against H3 epidemic strains from previous seasonal vaccines. Head-to-head comparison between ferret and human antisera derived antigenic maps revealed different antigenic patterns among representative egg- and cell-grown H3 viruses characterized. Molecular modeling indicated that the mutations of epidemic H3 strains were mainly located in antibody-binding sites A and B as compared with TX/12e. To improve vaccine strain selection, human serologic testing on vaccination-induced cross-reactivity need be emphasized along with virus antigenic characterization by ferret model.},
  pmcid = {PMC4607887},
  pmid = {26472175},
  file = {C:\Users\Zane\Zotero\storage\EZ9MIPDP\Xie et al. - 2015 - H3N2 Mismatch of 201415 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between.pdf}
}

@article{xu1994,
  title = {Nonimmunoselected {{Intrastrain Genetic Variation Detected In Pairs Of Highyielding Influenza A}} ({{H3N2}}) {{Vaccine And Parental Viruses}}},
  author = {Xu, X. and Kilbourne, E. D. and Hall, H. E. and Cox, N. J.},
  year = {1994},
  month = dec,
  journal = {Journal of Infectious Diseases},
  volume = {170},
  number = {6},
  pages = {1432--1434},
  issn = {0022-1899, 1537-6613},
  doi = {10.1093/infdis/170.6.1432},
  urldate = {2024-08-13},
  langid = {english},
  file = {C:\Users\Zane\Zotero\storage\FNHL98VH\Xu et al. - 1994 - Nonimmunoselected Intrastrain Genetic Variation De.pdf}
}

@article{yamashita1988,
  title = {Influenza {{B}} Virus Evolution: Co-Circulating Lineages and Comparison of Evolutionary Pattern with Those of Influenza {{A}} and {{C}} Viruses},
  shorttitle = {Influenza {{B}} Virus Evolution},
  author = {Yamashita, M. and Krystal, M. and Fitch, W. M. and Palese, P.},
  year = {1988},
  month = mar,
  journal = {Virology},
  volume = {163},
  number = {1},
  pages = {112--122},
  issn = {0042-6822},
  doi = {10.1016/0042-6822(88)90238-3},
  abstract = {Sequence analyses and comparison of the genes coding for the nonstructural (NS) and hemagglutinin (HA) proteins of different influenza B viruses isolated between 1940 and 1987 reveal that the number of substitutions is not always proportional to the time between isolates. Examination of 14 influenza B virus NS gene and 10 HA gene sequences by the maximum parsimony method suggested that--as with influenza C viruses--there are multiple evolutionary lineages which can coexist for considerable periods of time. Comparison of the sequence divergence among genes of viruses belonging to type A, B, and C virus suggests that, in man, influenza B viruses evolve slower than A viruses and faster than C viruses. We propose an evolutionary model for influenza B viruses that is intermediate between the pattern for human influenza A viruses and that for influenza C viruses.},
  langid = {english},
  pmid = {3267218}
}

@article{yang2020,
  title = {Life Course Exposures Continually Shape Antibody Profiles and Risk of Seroconversion to Influenza},
  author = {Yang, Bingyi and Lessler, Justin and Zhu, Huachen and Jiang, Chao Qiang and Read, Jonathan M. and Hay, James A. and Kwok, Kin On and Shen, Ruiyin and Guan, Yi and Riley, Steven and Cummings, Derek A. T.},
  year = {2020},
  month = jul,
  journal = {PLOS Pathogens},
  volume = {16},
  number = {7},
  pages = {e1008635},
  publisher = {Public Library of Science},
  issn = {1553-7374},
  doi = {10.1371/journal.ppat.1008635},
  urldate = {2023-02-20},
  abstract = {Complex exposure histories and immune mediated interactions between influenza strains contribute to the life course of human immunity to influenza. Antibody profiles can be generated by characterizing immune responses to multiple antigenically variant strains, but how these profiles vary across individuals and determine future responses is unclear. We used hemagglutination inhibition titers from 21 H3N2 strains to construct 777 paired antibody profiles from people aged 2 to 86, and developed novel metrics to capture features of these profiles. Total antibody titer per potential influenza exposure increases in early life, then decreases in middle age. Increased titers to one or more strains were seen in 97.8\% of participants during a roughly four-year interval, suggesting widespread influenza exposure. While titer changes were seen to all strains, recently circulating strains exhibited the greatest titer rise. Higher pre-existing, homologous titers at baseline reduced the risk of seroconversion to recent strains. After adjusting for homologous titer, we also found an increased frequency of seroconversion against recent strains among those with higher immunity to older previously exposed strains. Including immunity to previously exposures also improved the deviance explained by the models. Our results suggest that a comprehensive quantitative description of immunity encompassing past exposures could lead to improved correlates of risk of influenza infection.},
  langid = {english},
  keywords = {Age groups,Antibodies,Antibody response,Immune response,Immunity,Influenza,Medical risk factors,Vaccination and immunization},
  file = {C:\Users\Zane\Zotero\storage\CXXS99XJ\Yang et al. - 2020 - Life course exposures continually shape antibody profiles and risk of seroconversion to influenza.pdf}
}

@article{yao2017a,
  title = {Using Stacking to Average {{Bayesian}} Predictive Distributions},
  author = {Yao, Yuling and Vehtari, Aki and Simpson, Daniel and Gelman, Andrew},
  year = {2017},
  journal = {Bayesian Analysis},
  volume = {13},
  number = {3},
  pages = {917--1007},
  issn = {1936-0975, 1931-6690},
  doi = {10.1214/17-BA1091},
  urldate = {2025-02-03},
  abstract = {Bayesian model averaging is flawed in the M-open setting in which the true data-generating process is not one of the candidate models being fit. We take the idea of stacking from the point estimation literature and generalize to the combination of predictive distributions. We extend the utility function to any proper scoring rule and use Pareto smoothed importance sampling to efficiently compute the required leave-one-out posterior distributions. We compare stacking of predictive distributions to several alternatives: stacking of means, Bayesian model averaging (BMA), Pseudo-BMA, and a variant of Pseudo-BMA that is stabilized using the Bayesian bootstrap. Based on simulations and real-data applications, we recommend stacking of predictive distributions, with bootstrapped-Pseudo-BMA as an approximate alternative when computation cost is an issue.},
  keywords = {Bayesian model averaging,model combination,predictive distribution,proper scoring rule,stacking,Stan},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\QWFVVJRI\\Yao et al. - 2018 - Using Stacking to Average Bayesian Predictive Dist.pdf;C\:\\Users\\Zane\\Zotero\\storage\\YQA44BA8\\Yao et al. - 2018 - Using Stacking to Average Bayesian Predictive Distributions (with Discussion).pdf}
}

@article{zacour2016,
  title = {Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproducibility between Laboratories},
  author = {Zacour, Mary and Ward, Brian J. and Brewer, Angela and Tang, Patrick and Boivin, Guy and Li, Yan and Warhuus, Michelle and McNeil, Shelly A. and LeBlanc, Jason J. and Hatchette, Todd F.},
  editor = {Hodinka, R. L.},
  year = {2016},
  month = mar,
  journal = {Clinical and Vaccine Immunology},
  volume = {23},
  number = {3},
  pages = {236--242},
  doi = {10.1128/cvi.00613-15},
  urldate = {2025-03-13},
  abstract = {Standardization of the hemagglutination inhibition (HAI) assay for influenza serology is challenging. Poor reproducibility of HAI results from one laboratory to another is widely cited, limiting comparisons between candidate vaccines in different clinical trials and posing challenges for licensing authorities. In this study, we standardized HAI assay materials, methods, and interpretive criteria across five geographically dispersed laboratories of a multidisciplinary influenza research network and then evaluated intralaboratory and interlaboratory variations in HAI titers by repeatedly testing standardized panels of human serum samples. Duplicate precision and reproducibility from comparisons between assays within laboratories were 99.8\% (99.2\% to 100\%) and 98.0\% (93.3\% to 100\%), respectively. The results for 98.9\% (95\% to 100\%) of the samples were within 2-fold of all-laboratory consensus titers, and the results for 94.3\% (85\% to 100\%) of the samples were within 2-fold of our reference laboratory data. Low-titer samples showed the greatest variability in comparisons between assays and between sites. Classification of seroprotection (titer {$\geq$} 40) was accurate in 93.6\% or 89.5\% of cases in comparison to the consensus or reference laboratory classification, respectively. This study showed that with carefully chosen standardization processes, high reproducibility of HAI results between laboratories is indeed achievable.},
  langid = {english},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\3VRKWYHU\\Zacour et al. - 2016 - Standardization of hemagglutination inhibition ass.pdf;C\:\\Users\\Zane\\Zotero\\storage\\GR8TGWQ6\\Zacour et al. - 2016 - Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproduc.pdf}
}

@article{zarnitsyna2015,
  title = {Masking of Antigenic Epitopes by Antibodies Shapes the Humoral Immune Response to Influenza},
  author = {Zarnitsyna, Veronika I. and Ellebedy, Ali H. and Davis, Carl and Jacob, Joshy and Ahmed, Rafi and Antia, Rustom},
  year = {2015},
  month = sep,
  journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
  volume = {370},
  number = {1676},
  pages = {20140248},
  publisher = {Royal Society},
  doi = {10.1098/rstb.2014.0248},
  urldate = {2021-04-14},
  abstract = {The immune responses to influenza, a virus that exhibits strain variation, show complex dynamics where prior immunity shapes the response to the subsequent infecting strains. Original antigenic sin (OAS) describes the observation that antibodies to the first encountered influenza strain, specifically antibodies to the epitopes on the head of influenza's main surface glycoprotein, haemagglutinin (HA), dominate following infection with new drifted strains. OAS suggests that responses to the original strain are preferentially boosted. Recent studies also show limited boosting of the antibodies to conserved epitopes on the stem of HA, which are attractive targets for a `universal vaccine'. We develop multi-epitope models to explore how pre-existing immunity modulates the immune response to new strains following immunization. Our models suggest that the masking of antigenic epitopes by antibodies may play an important role in describing the complex dynamics of OAS and limited boosting of antibodies to the stem of HA. Analysis of recently published data confirms model predictions for how pre-existing antibodies to an epitope on HA decrease the magnitude of boosting of the antibody response to this epitope following immunization. We explore strategies for boosting of antibodies to conserved epitopes and generating broadly protective immunity to multiple strains.},
  keywords = {Antibodies Viral,Antigens Viral,B-Lymphocytes,epitope masking model,Epitopes,Hemagglutinin Glycoproteins Influenza Virus,Humans,humoral immunity,Immunity Humoral,influenza,Influenza Human,Mathematical Concepts,Models Immunological,Orthomyxoviridae,strain-variation},
  file = {C\:\\Users\\Zane\\Zotero\\storage\\35I9X5TL\\Zarnitsyna et al. - 2015 - Masking of antigenic epitopes by antibodies shapes.pdf;C\:\\Users\\Zane\\Zotero\\storage\\BQG6AZKU\\rstb.2014.html}
}

@article{zarnitsyna2016,
  title = {Multi-Epitope {{Models Explain How Pre-existing Antibodies Affect}} the {{Generation}} of {{Broadly Protective Responses}} to {{Influenza}}},
  author = {Zarnitsyna, Veronika I. and Lavine, Jennie and Ellebedy, Ali and Ahmed, Rafi and Antia, Rustom},
  year = {2016},
  month = jun,
  journal = {PLoS Pathogens},
  volume = {12},
  number = {6},
  pages = {e1005692},
  issn = {1553-7366},
  doi = {10.1371/journal.ppat.1005692},
  urldate = {2021-04-14},
  abstract = {The development of next-generation influenza vaccines that elicit strain-transcendent immunity against both seasonal and pandemic viruses is a key public health goal. Targeting the evolutionarily conserved epitopes on the stem of influenza's major surface molecule, hemagglutinin, is an appealing prospect, and novel vaccine formulations show promising results in animal model systems. However, studies in humans indicate that natural infection and vaccination result in limited boosting of antibodies to the stem of HA, and the level of stem-specific antibody elicited is insufficient to provide broad strain-transcendent immunity. Here, we use mathematical models of the humoral immune response to explore how pre-existing immunity affects the ability of vaccines to boost antibodies to the head and stem of HA in humans, and, in particular, how it leads to the apparent lack of boosting of broadly cross-reactive antibodies to the stem epitopes. We consider hypotheses where binding of antibody to an epitope: (i) results in more rapid clearance of the antigen; (ii) leads to the formation of antigen-antibody complexes which inhibit B cell activation through Fc{$\gamma$} receptor-mediated mechanism; and (iii) masks the epitope and prevents the stimulation and proliferation of specific B cells. We find that only epitope masking but not the former two mechanisms to be key in recapitulating patterns in data. We discuss the ramifications of our findings for the development of vaccines against both seasonal and pandemic influenza., The current influenza vaccine requires frequent updating in order to protect against small changes in the virus from one year to the next as well as larger changes associated with the emergence of new influenza strains from zoonotic reservoirs that cause pandemics. There is a considerable interest in developing ``universal'' vaccines that will boost immune responses to the conserved regions of the virus, in particular, to the stem region of the major virus surface molecule hemagglutinin (HA). However, recent data reveals that vaccination results in very limited boosting of antibodies to the stem of HA. We use mathematical models to explore different hypotheses that may explain why vaccination does not boost antibodies to the conserved parts of the virus. By confronting our models with the data from the human vaccination trials we found that the key mechanism preventing effective boosting of the responses to the stem of HA is masking of the stem by pre-existing antibodies developed during previous infections and vaccinations. We discuss how this masking effect could be overcome in a ``universal'' influenza vaccine.},
  pmcid = {PMC4918916},
  pmid = {27336297},
  file = {C:\Users\Zane\Zotero\storage\8KX6F9AT\Zarnitsyna et al. - 2016 - Multi-epitope Models Explain How Pre-existing Anti.pdf}
}

@article{zinder2013,
  title = {The {{Roles}} of {{Competition}} and {{Mutation}} in {{Shaping Antigenic}} and {{Genetic Diversity}} in {{Influenza}}},
  author = {Zinder, Daniel and Bedford, Trevor and Gupta, Sunetra and Pascual, Mercedes},
  year = {2013},
  month = jan,
  journal = {PLOS Pathogens},
  volume = {9},
  number = {1},
  pages = {e1003104},
  publisher = {Public Library of Science},
  issn = {1553-7374},
  doi = {10.1371/journal.ppat.1003104},
  urldate = {2025-02-26},
  abstract = {Influenza A (H3N2) offers a well-studied, yet not fully understood, disease in terms of the interactions between pathogen population dynamics, epidemiology and genetics. A major open question is why the virus population is globally dominated by a single and very recently diverged (2--8 years) lineage. Classically, this has been modeled by limiting the generation of new successful antigenic variants, such that only a small subset of progeny acquire the necessary mutations to evade host immunity. An alternative approach was recently suggested by Recker et al. in which a limited number of antigenic variants are continuously generated, but most of these are suppressed by pre-existing host population immunity. Here we develop a framework spanning the regimes described above to explore the impact of rates of mutation and levels of competition on phylodynamic patterns. We find that the evolutionary dynamics of the subtype H3N2 influenza is most easily generated within this framework when it is mutation limited as well as being under strong immune selection at a number of epitope regions of limited diversity.},
  langid = {english},
  keywords = {Antigenic variation,Epidemiology,Genetic epidemiology,Influenza,Phylogenetic analysis,Population genetics,Southern Hemisphere,Species diversity},
  file = {C:\Users\Zane\Zotero\storage\LEASM5HD\Zinder et al. - 2013 - The Roles of Competition and Mutation in Shaping Antigenic and Genetic Diversity in Influenza.pdf}
}
